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Abstract 
Elongator is a conserved, multi-subunit protein complex (Elp1-6) that was first 
discovered in Saccharomyces cerevisiae (Budding yeast).  The complex is nonessential 
in yeast but loss of function leads to pleiotropic phenotypes such as temperature 
sensitivity and slow growth adaptations. In higher eukaryotes Elongator is required for 
normal growth and development and in humans, a mutation in the largest subunit 
(Elp1) causes Familial Dysautonomia, a severe autosomal recessive neuropathy.  
It has now been shown that the main role of yeast Elongator is to promote mcm5 and 
ncm5 tRNA wobble uridine modifications that are required for these tRNAs to function 
efficiently in protein translation. This function is conserved in higher eukaryotes, 
including mammals, and it is now thought that a common translation defect may 
underlie the pleiotropic phenotypes associated with Elongator dysfunction.  
The Elp1 subunit has a C-terminal domain that is predicted to be mainly alpha-helical 
in structure and contains a highly conserved arginine/lysine rich region that was 
previously annotated as a putative nuclear localisation sequence (NLS). Since tRNA 
modifications are thought to occur in the cytoplasm, which is where Elongator is 
mainly localised, it was not immediately clear why an NLS would be required.  
In order to define the function of this basic region, an elp1-KR9A mutant was created 
with nine alanine substitutions throughout its sequence. The Elp1 basic region was 
found to be essential for the tRNA wobble uridine modification function of Elongator. 
However, the distribution of Elp1 between the cytoplasm and nucleus was unaffected 
by the elp1-KR9A mutation and therefore it is unlikely to function as a nuclear 
localisation sequence. Since the Elp1 basic region is of functional importance we 
 xii 
 
hypothesised that it could be involved in binding tRNA to the Elongator complex. This 
was tested by examining the binding of tRNA to recombinant Elp1 and Elp1-KR9A C-
terminal domains. The wild-type Elp1 C-terminal domain formed a complex with tRNA 
that was abolished by mutations in the basic region, indicating that the conserved 
basic region in Elp1 is essential for tRNA wobble uridine modification most likely 
through its role as a tRNA binding motif.   
 
 
 1 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1: Introduction 
 
 
 
 
 
 
 
 
 
 
 
 2 
 
1.1 Overview of the budding yeast Elongator complex 
The complexity of higher eukaryotes, particularly mammalian cells, can make the study 
of basic cellular functions difficult. Saccharomyces cerevisiae (budding yeast) is a 
unicellular eukaryote that is well established as a model organism. In contrast to 
higher eukaryotes, yeast are simpler and more amenable to genetic manipulations that 
are invaluable for the analysis of proteins function. Although higher eukaryotes have 
larger genomes and therefore correspondingly larger proteomes, many proteins are 
highly conserved across eukaryotes. In studies of basic cellular functions such as the 
cell cycle, gene transcription and protein translation, research in yeast as a eukaryotic 
model have provided valuable contributions to the understanding of these processes. 
Proteins that are conserved from yeast to man can therefore be studied in yeast to 
provide meaningful insight into the function of their human counterparts.  
Elongator is a six subunit protein complex, which is present in all eukaryotes.  It was 
first discovered in budding yeast associated with chromatin bound RNA polymerase II 
(Otero et al., 1999). Due to this association and the finding that one of the subunits 
(Elp3) contained a histone acetyl transferase (HAT) domain (Wittschieben et al., 1999), 
the principle function of the complex was proposed to be as a histone 
acetyltransferase, acting on nucleosomes during transcript elongation(Otero et al., 
1999, Wittschieben et al., 1999). However, this role of Elongator is now disputed due 
to various other data that have emerged from work in yeast and other organisms, 
including the finding that most of the cellular pool of Elongator is present in the 
cytoplasm rather than the nucleus (Pokholok et al., 2002).  Subsequently, a number of 
other functions have been proposed for the complex and it was suggested that 
 3 
 
Elongator could have distinct functions in both the nucleus and the cytoplasm 
(Svejstrup, 2007).   
The Elongator complex was first described as a heterotrimer made up of subunits Elp1-
Elp3 (Otero et al., 1999) .A smaller, more salt labile subcomplex was later discovered 
consisting of Elp4-Elp6 (Krogan and Greenblatt, 2001, Winkler et al., 2001), which 
together with the Elp1-3 heterotrimer was proposed to form a hexameric holocomplex 
(Figure 1.1). 
 
 
Figure 1.1: Schematic of the Elongator subunits. The Elp1-6 subunits and accessory protein 
Kti12 are displayed showing known structural and functional domains, features and molecular 
weights. 
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i) Elp1 
Elp1 is the largest Elongator subunit and is thought to act as a core scaffold, since it is 
essential for assembly of the complex.  Interactions between Elp2, Elp3 and across the 
two subcomplexes are lost when Elp1 is deleted (Frohloff et al., 2003, Fichtner et al., 
2002b).  Elp1 has an interesting proposed secondary structure, the N-terminal portion 
is predicted to be mainly beta-sheet and the C-terminal portion largely alpha-helix 
(Figure  1.2). The N-terminus contains WD40 repeat domains, which are predicted to 
form beta propellers connected to a more flexible C-terminus. The Elp1 C-terminus 
also has a basic region, annotated as a putative Nuclear localisation sequence (Fichtner 
et al., 2003), which is highly conserved across eukaryotes.  
 
ii) Elp2 
The Elp2 subunit has multiple WD40 repeats that are predicted to form two seven- 
bladed beta propeller domains (Glatt and Muller, 2013). Unlike the other subunits of 
Elongator, although Elp2 is  required for function, it is not essential for Elongator 
complex assembly as its deletion does not disrupt subunit contacts between Elp1, Elp3 
or the Elp4-6 subcomplex (Frohloff et al., 2003, Petrakis et al., 2004).  Since Elp2 is 
made up of WD40 repeats, which are reported to mediate protein-protein interactions 
(Fellows et al., 2000), it has been suggested that Elp2 may mediate the binding of 
other factors. In support of this the Elp2 C-terminus is required for binding of the 
accessory factor Kti12 (see below) to the assembled complex (Frohloff et al., 2003, 
Fichtner et al., 2002b).   
 
 5 
 
 
Figure 1.2: The predicted secondary structure of the yeast Elp1 subunit. The N-terminal half 
of Elp1 is mainly beta sheet while the C-terminal half is predicted to consist of alpha helix. 
Generated by the server PSIPred (McGuffin et al., 2000) using NCBI sequence accession 
NP_013488.3. 
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iii) Elp3  
The Elp3 subunit is presumed to be the catalytic core of Elongator since it contains two 
functionally important enzymatic domains (Figure 1.1).  Elp3 has an N-terminal Radical 
S-Adenosylmethionine (SAM) like domain (Chinenov, 2002) and a C-terminal GNAT-
type histone acetyltransferase (HAT) like domain (Wittschieben et al., 1999).  
Radical SAM domains use a bound iron-sulphur cluster as an electron donor for 
cleavage of their SAM substrate into methionine and a 5’-deoxyadenosyl radical. The 
generated radical is then able to remove protons from other substrate molecules in 
order to carry out a number of functions, such as the transfer of methyl groups (Frey et 
al., 2008). Members of the GNAT-type HAT family share common core A, B and D 
sequence motifs that mediate the binding of Acetyl CoA and transfer of Acetyl groups 
onto the N-terminal Lysine residues of Histone tails (Marmorstein, 2001).  
In Elp3, these domains are highly conserved and essential to Elongator function. Point 
mutations of cysteines predicted to co-ordinate the iron-sulphur cluster in the Radical 
SAM domain (Paraskevopoulou et al., 2006, Greenwood et al., 2009) and in the B motif 
of the HAT domain (Wittschieben et al., 2000) result in dysfunctional Elongator 
phenotypes (Section 1.2). Both of these domains also appear to be enzymatically 
active, since Elongator can acetylate Histone H3 and H4 in vitro and Elp3 has been 
shown to co-ordinate an iron-sulphur cluster, which can bind and may cleave SAM 
(Paraskevopoulou et al., 2006, Greenwood et al., 2009). Although the HAT-like domain 
of Elp3 has activity towards Histones, it does not appear to be coupled to a chromatin 
binding domain, unlike other HATs of this family (Marmorstein, 2001). It seems likely 
that this domain works in conjunction with the Radical SAM domain for its unknown in 
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vivo enzymatic role. Unlike other Elongator subunits, Elp3 is also conserved in Archaea, 
which illustrates the importance of this coupled enzymatic function (Chinenov, 2002). 
Elp1 is required for Elp3 stability (Petrakis et al., 2004) and these subunits directly 
interact (Fichtner et al., 2002b, Frohloff et al., 2003). The Elp3 subunit also mediates 
the Elp2-Elp1 interaction (Fichtner et al., 2002b, Petrakis et al., 2004) and the iron-
sulphur cluster of the Elp3 Radical SAM domain is integral to the overall assembly of 
Elongator (Greenwood et al., 2009).  
 
iv) Elp 4,5,6 
Very little was previously known about the Elp4-6 subcomplex of Elongator but all of 
its subunits have homologues in humans and it was suggested that this complex binds 
across interfaces created by assembled Elp1-3 (Hawkes et al., 2002, Close et al., 2012b, 
Petrakis et al., 2004).  Recently the crystal structure of this subcomplex was solved. 
The Elp4-6 subunits all contain a common RecA-like fold, made up of a nine-stranded 
parallel beta sheet between alpha helices. Further to this, the subcomplex was 
assembled as a heterohexameric ring complex made up of two copies of each subunit 
(Glatt et al., 2012).  
This architecture is related to the RecA-like NTPase superfamily, which hydrolyse 
nucleoside triphosphates and couple this to movements along substrates. Each subunit 
of a RecA-like NTPase hexamer donates residues to the NTPase active site of the 
adjacent subunit allowing for coordinated hydrolysis. This is coupled to conformational 
changes that allow translocation of a substrate molecule, such as DNA or RNA into the 
central cavity of the hexamer (Lyubimov et al., 2011).  The bacterial Rho factor is 
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classic example of this superfamily and functions as a transcription terminator. Rho 
uses the energy from ATP hydrolysis to power the translocation of RNA transcripts 
through its central pore using transient associations with the protruding helices that 
line this pore. The dynamic movement of RNA through this cavity has the effect of 
pulling the mRNA away from the RNA polymerase II complex and the template gene 
(Kaplan and O'Donnell, 2003).  
Like RecA-like NTPase family counterparts, the Elp4-6 hexamer has a basal ATPase 
activity, which is comparable in levels to other members of the family. This was 
unexpected since key signature residues of a P-loop motif, required for nucleotide 
binding (Ponting, 2002, Glatt et al., 2012, Lyubimov et al., 2011) are not present in 
these subunits.  Mutations in other potential catalytic residues of Elp5 and Elp6 led to 
reduced ATPase activity and these mutant proteins can only a partially rescue the 
equivalent gene deletions (Glatt et al., 2012). Therefore the Elongator subcomplex 
hexamer has a functionally important basal ATPase activity.  
The work by Muller and colleagues has also changed our view of the overall 
architecture of the complex. It was shown that, as in the Elp4-6 subcomplex, each 
Elp1-3 subunit can associate with itself, suggesting at least two copies are present in 
the holocomplex.  Further to this the Elongator complex purified by gel filtration was 
estimated to be ~850 kDa. Elongator is therefore likely to be made up of two copies of 
each of its six subunits, forming a dodecamer. It is now proposed that two Elp1-3 
heterotrimers are bridged by the Elp4-6 hexameric ring (Figure 1.3, Glatt et al., 2012, 
Glatt and Muller, 2013).  
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Figure 1.3: Proposed dodecamer assembly of the Elongator complex. In this model, proposed 
by Glatt et al (2012), Elongator is made up of two copies of each of its six subunits. The Elp4-6 
hexamer bridges two Elp1-3 complexes. The schematic shown here is not representative of the 
exact contacts between all subunits.    
 
v) Kti12 
Kti12 is an accessory factor that binds to the preassembled Elongator complex, since 
the interaction is lost when complex assembly is disrupted (Fichtner et al., 2002a). 
Therefore it is likely that Kti12 binds across interfaces created by assembled subunits 
and the C-terminus of Elp2 is required for this (Fichtner et al., 2002b).  
The role of Kti12 is unknown but like the Elongator subunits, Kti12 has homologues in 
other eukaryotes, including humans (Fichtner et al., 2002a).  It has a highly conserved 
P-loop containing NTPase domain (Figure 1.1, Fichtner et al., 2002a, Petrakis et al., 
2005) and is closely related to O-phosphoseryl-tRNASec kinase (PSTK), an enzyme 
involved in selenocysteine-tRNA biosynthesis (Sherrer et al., 2008, Araiso et al., 2009).  
Deletion or multicopy expression of KTI12 phenocopies loss of Elongator function, 
suggesting that the correct balance of Kti12 is essential in this regard (Butler et al., 
1994).  The P-loop motif is also functionally important, since truncation of this region 
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alone causes these dysfunctional phenotypes (Fichtner et al., 2002a).  It is likely that 
Kti12 regulates Elongator complex function or participates directly in its poorly 
understood enzymatic mechanism.  
 
1.2 Phenotypes associated with Elongator dysfunction 
A mutation in the human homologue of the ELP1 gene, IKBKAP, causes Familial 
Dysautonomia, a severe recessive neurodevelopmental disease (Anderson et al., 2001, 
Slaugenhaupt et al., 2001).  Familial Dysautonomia is characterised by autonomic and 
sensory nervous system defects caused by the improper development and progressive 
loss of neurons. The symptoms of the disorder include dysphagia, gastric dysmotility, 
postural hypotension, loss of overflow tears as well as reduced sensitivity to pain and 
temperature. The disorder is fatal in adulthood due to the progressive loss of 
autonomic nervous system functions (Gold-von Simson and Axelrod, 2006).  
Familial Dysautonomia (FD) has a high carrier frequency in the Ashkenazi Jewish 
population and within this faction the disease occurs every 1 in 3,600 births 
(Slaugenhaupt et al., 2001). The most common causative IKBKAP mutation is a single (T 
to C) base change in intron 20 of the gene.  This causes a splicing defect that results in 
exon 20 skipping in the RNA transcript and production of a truncated protein 
(Anderson et al., 2001, Slaugenhaupt et al., 2001).  This splicing defect is tissue specific 
as both the wild-type and mutant transcripts can be detected in patients at varying 
ratios in different cell types. The mutant transcript is most prominent in brain tissues 
where IKBKAP is normally highly expressed and loss of the wild-type protein causes the 
severe neurological defects of the disease (Slaugenhaupt et al., 2001).  
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The human homologues of ELP3 and ELP4 genes have also been linked to the 
neurological disorders Amyotrophic Lateral Sclerosis and Rolandic Epliepsy, 
respectively (Simpson et al., 2009, Strug et al., 2009). In human derived cell lines, 
Elongator dysfunction results in cell migration defects that may contribute to defects 
in neurodevelopment (Close et al., 2006, Johansen et al., 2008, Lee et al., 2009, Close 
et al., 2012b). Taken together there is a clear requirement for functional Elongator in 
the proper development and function of human neurons.  
In mice deletion of ELP1 is embryonic lethal, suggesting that Elongator function is also 
required during embryogenesis. The defects resulting in lethality are rescued by 
expression of the human IKBKAP transgene, which demonstrates the functional 
conservation of the Elongator complex (Chen et al., 2009b). Elongator is also required 
for meiotic progression and fertility in mice (Lin et al., 2013) and therefore plays a 
fundamental role in mammalian development.  There are no human mutations yet 
identified corresponding to  complete deletion of any Elongator subunits, this is in 
agreement with evidence that the complex plays an essential role during development.  
In other higher eukaryotes, loss of Elongator function is also associated with a range of 
developmental and growth defects. Deletion of the ELP3 homolog in Drosophilia leads 
to larval lethality (Walker et al., 2011) and targeted depletion of Elp3 results in 
neurological defects, such as a hyperactive phenotype and sleep loss (Singh et al., 
2010).  The Drosophilia ELP3 gene was also identified in a screen for genes required for 
neuronal communication and survival (Simpson et al., 2009).  In C. elegans mutations 
in either ELP1 or ELP3 homologs causes salt avoidance learning defects, slow growth 
and reduced fertility (Chen et al., 2009a). Mutation of Elongator subunits in 
Arabadopsis is associated with defective leaf and root growth and development as well 
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as altered responses to environmental stresses (Nelissen et al., 2005, DeFraia and 
Mou, 2011). The Elongator complex is therefore essential for normal development and 
growth in a range of higher eukaryotes.  
In yeast, Elongator subunits are non-essential but deletion of any of the Elongator 
genes results in common pleiotropic phenotypes. Combined subunit gene deletions do 
not alter these phenotypes illustrating that each subunit is required independently for 
formation of a fully functional complex (Fellows et al., 2000).  Deletion of Elongator 
genes causes slow growth adaptations, temperature sensitivity and sensitivity to 
various chemicals such as hydroxyurea, caffiene and rapamycin (Otero et al., 1999, Li 
et al., 2009, Frohloff et al., 2001, Schaffrath., personal communication).  Mutations in 
Elongator subunits also result in resistance to the Kluyveromyces lactis (K. lactis) 
derived toxin, Zymocin (Frohloff et al., 2001, see section 1.5). Interestingly, 
complementation studies have demonstrated that expression of human Elp3 can 
partially rescue the equivalent yeast deletion phenotypes (Li et al., 2005), suggesting 
that the structure and function of Elongator is highly conserved across all eukaryotes.  
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1.3 The many proposed functions of the Elongator complex 
A role in gene transcription was originally proposed for the Elongator complex, since it 
was first purified from yeast chromatin, associated with the elongating form of RNA 
polymerase II.  Since the Elp3 subunit contained a conserved HAT domain, it was 
suggested that the complex facilitated transcription by the acetylation of histones 
ahead of the elongating RNA polymerase (Otero et al., 1999, Wittschieben et al., 
1999).  This was supported by the observed “slow start” phenotypes in Elongator 
mutants, which were characterised by delayed induction of genes required for new 
growth conditions. For example, deletion of ELP1 caused a slow growth phenotype 
upon switching cells from glucose to galactose and this was shown to be due to a 
delayed accumulation of galactose induced transcripts (Otero et al., 1999). In fact 
subsets of mRNAs were differentially expressed in Elongator mutants when analysed 
by microarray (Krogan and Greenblatt, 2001).  
Deletions of Elongator subunits displayed synthetic growth defects with a number of 
RNA polymerase II regulatory subunit gene deletions as well as Gcn5, a HAT involved in 
transcriptional co-activation as part of the SAGA complex (Jona et al., 2001, Van 
Mullem et al., 2002, Kong et al., 2005, Wittschieben et al., 2000). Deletion of histone 
tails or point mutations in histone acetylation sites were also synthetically lethal with 
Elongator gene deletions, suggesting these could be a substrate for the complex 
(Wittschieben et al., 2000). Further to this, the complex was able to acetylate histones 
in vitro and in Elongator mutants levels of in vivo acetylated histone H3 were reduced 
(Winkler et al., 2002).  
A role for Elongator in transcription was also proposed in higher eukaryotes. 
Arabidopsis, mice and human cells lacking Elongator function have lower levels of 
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acetylated histone H3 and display differential gene expression (Nishimura et al., 2009, 
Close et al., 2006, Chen et al., 2009b).  The patterns of gene expression were argued to 
correlate with phenotypes.  In Arabadopsis, genes involved in auxin dependent 
responses were misregulated; this is an essential signalling pathway during growth and 
development (Nelissen et al., 2010). Several genes required for cell migration in FD 
patient fibroblasts (Close et al., 2006) and for embryo development in mice (Chen et 
al., 2009b) were also shown to be down-regulated.  In Drosophila, deletion of ELP3 is 
also associated with differential gene expression and the phenotypes and transcription 
profile were suggested to be similar to deletion of Domino, a SWI/SNF like chromatin 
remodelling enzyme (Walker et al., 2011). 
A direct role in transcription was argued since depletion of Elongator from human cell 
extracts resulted in an Acetyl-CoA dependent reduction in RNA polymerase II 
transcription in vitro, which was rescued by addition of purified Elongator (Kim et al., 
2002).  Elongator was also shown to be associated with chromatin in higher 
eukaryotes, suggesting that it directly affects gene expression (Metivier et al., 2003, 
Close et al., 2006, Nelissen et al., 2010).  
Taken together, it was therefore initially proposed that the pleiotropic phenotypes 
caused by Elongator dysfunction resulted from misregulation of transcription and that 
the complex was directly involved in this process.  However, the function of Elongator 
in transcription has been questioned for a number of reasons.  A global role for the 
complex in transcript elongation is not in line with the finding that only certain genes 
were affected in Elongator mutants (Krogan and Greenblatt, 2001).  Elongator subunits 
also could not be detected associated with Chromatin or any RNA polymerase II 
elongation factors in yeast (Pokholok et al., 2002, Close et al., 2012a). Further, deletion 
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of the ELP2 subunit still supported the assembly and in vitro HAT activity of the 
complex but displayed identical phenotypes in vivo to other subunit deletions (Petrakis 
et al., 2004).  Although in higher eukaryotes Elongator was shown to interact with 
chromatin, association was at both target and non-target genes (Kouskouti and 
Talianidis, 2005, Close et al., 2006) and Elongator’s HAT activity was also found to be 
less efficient against nucleosomes compared with purified histones (Winkler et al., 
2002, Kim et al., 2002). Purified yeast and human Elongator also failed to stimulate 
RNA pol II transcription in vitro, unlike other known elongation factors (Kim et al., 
2002, Krogan et al., 2002). Therefore despite a large amount of data implicating 
Elongator in transcription, it remained difficult to pinpoint the exact role of the 
complex in this process.  
An alternative hypothesis for Elongator function was in the regulation of histone 
coupled chromatin assembly. This was initially suggested since yeast Elongator 
deletion strains show genetic interactions with several histone chaperone gene 
deletions, display telomeric silencing defects and are sensitive to DNA damaging 
agents (Li et al., 2009). An interaction between Elongator and the DNA clamp protein 
PCNA was also demonstrated in yeast and plants (Li et al., 2009, Xu et al., 2012). Based 
on these data it was proposed that Elongator may function to acetylate histones to aid 
assembly into chromatin during DNA replication and DNA damage.  
Surprisingly, despite these proposed roles, Elongator was found to be mainly localised 
to the cytoplasm of cells (Pokholok et al., 2002), which does not support a central role 
in transcription or other nuclear processes.  Given the cytoplasmic localisation of 
Elongator a number of other functions were proposed for the complex.   
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The Elongator complex was implicated in the regulation of exocytosis.  Deletion of 
yeast ELP1 supresses the defect caused by a mutation in the SEC2 gene (sec2-59), 
encoding a guanine nucleotide exchange factor involved in the regulation of vesicle 
docking and secretion. Exocytosis is blocked in sec2-59 mutants, which have a 
premature stop codon in the coding region of the gene, resulting in truncation and 
mislocalisation of Sec2. Deletion of ELP1 rescued the secretion defect of sec2-59 
strains and Elp1 could also be crosslinked to wild-type Sec2 in cell extracts. It was 
therefore argued that the major role of Elongator was to negatively regulate Sec2 
dependent exocytosis (Rahl et al., 2005).  
There has also been some evidence that Elongator may be directly involved in 
cytoplasmic protein acetylation.  In C. elegans and mice, mutation of ELP1 and ELP3 
subunits was reported to decrease endogenous α-tubulin acetylation and these 
subunits could be co-purified from microtubules (Solinger et al., 2010, Creppe et al., 
2009). Elongator gene deletions displayed genetic interactions with gene deletions of 
various α-tubulin regulators  and Elp3 could also acetylate α-tubulin in vitro (Gardiner 
et al., 2007, Creppe et al., 2009).  However, the levels of acetylated α-tubulin in C. 
elegans and various other organisms, including FD patient fibroblasts, have since been 
reported to be normal when Elongator is deleted and this brings these data in question 
(Chen et al., 2009a, Simpson et al., 2009, Cheishvili et al., 2011, Miskiewicz et al., 
2011). A major α-tubulin acetylase, MEC-17, has also since been described and is 
present across multiple organisms (Akella et al., 2010). In Drosophila, Elp3 was also 
implicated in the acetylation of Bruchpilot, a protein involved in synaptic morphology 
and function. The levels of acetylated Bruchpilot were also reduced in Elongator 
mutants and a weak acetylation of the protein by Elp3 was shown in vitro (Miskiewicz 
et al., 2011). It should be noted that acetylation of α-tubulin and Bruchpilot by Elp3 
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was demonstrated in vitro alongside Histone H3, which appeared to be acetylated 
more efficiently in both cases. This makes it difficult to argue whether either of these 
substrates is physiologically relevant.  
The substrate specificity and function of the Elongator complex has historically been 
controversial and this has shaped the idea that Elongator may have multiple roles in 
the cell (Versees et al., 2010). However, a convincing alternative to the functions of 
Elongator proposed above is a central role in the modification of wobble uridine 
containing transfer RNAs (tRNAs) that has emerged as a conserved function of 
Elongator. This role may underlie all of the seemingly unrelated functions of Elongator 
and will be discussed in the following sections.   
 
1.4 Transfer RNA function and modification 
The amino acid sequence of a protein is coded within its corresponding gene by a 
universal genetic code consisting of 61 triplet nucleotide codons that are transcribed 
into messenger RNA (mRNA).  Codons are interpreted during the process of translation 
in cytoplasmic ribosomes such that the corresponding amino acids are incorporated 
into a growing polypeptide chain. This is how the transcribed genes act as a blueprint 
for the synthesis of functional proteins and the process must be both rapid and 
accurate to meet the cell’s demands (Alberts, 2008, Berg et al., 2007).  
Transfer RNAs (tRNAs) act as adaptor molecules in the process of translation, since 
they read the genetic code and couple this to the incorporation of an amino acid at the 
ribosome. These small molecules are made up of ~73-93 RNA bases and all share a 
similar ‘cloverleaf’ secondary structure made up of base paired stem regions and 
 18 
 
loops. Further structure is governed by hydrogen bonding between these various 
structural regions to form an upside down ‘L shape’ made up of several helices and 
loops (Figure 1.4). The 3’ end of each tRNA protrudes out of this structure and contains 
a single stranded three nucleotide CCA sequence with a free 3’-hydroxyl group for the 
attachment of a particular amino acid. The attachment of amino acids to tRNA is 
carried out by aminoacyl-tRNA synthetases, which bind substrate tRNAs and amino 
acids and catalyse the formation of an aminoacyl-tRNA, or a ‘charged’ tRNA.  Another 
important functional feature of tRNA is a loop that resides at the bottom of the 
structure, termed the anticodon loop. This contains a three nucleotide sequence, 
bases 34-36 in the universal structure, which ‘decodes’ or complements a particular 
codon of the genetic code (Figure 1.4A). The accurate charging of tRNAs with amino 
acids and codon recognition by tRNAs at the ribosome are both essential for 
maintenance of the universal genetic code (Berg et al., 2007).  
Eukaryotic ribosomes are made up of a small (40S) and large (60S) subunits consisting 
of proteins and ribosomal RNAs (rRNAs) that associate to form the active translation 
machinery (80S). The 40S subunit contains an 18S rRNA and is the site at which 
decoding occurs, it binds the mRNA molecule and interacts with the anticodon loop 
portion of the tRNA. The 60S subunit contains 28S, 5.8S and 5S rRNAs and interacts 
with the amino acid charged portion of tRNA. This subunit contains the catalytic centre 
for peptide bond formation between a growing polypeptide and a bound aminoacyl-
tRNA (Berg et al., 2007, Alberts, 2008).  
The process of mRNA translation proceeds by formation of an initiation complex, 
assembly of the 80S ribosome, elongation of the growing polypeptide chain and finally 
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termination and release of the synthesised protein. A brief overview of Elongation will 
be described, for review of general translation please refer to Steitz (2008).  
The assembled ribosome contains three sites for the binding of tRNA molecules, the 
Aminoacyl site (A-site), the Peptidyl site (P-site) and the Exit site (E-site). The A-site 
positions the mRNA codon for recognition and accepts tRNA as an active ternary 
complex associated with GTP-bound Elongator factor 1 (EF1). The correct anticodon-
codon contacts form a small mini-helix, which is proofread by hydrogen bonding with 
the 18S rRNA in the 40S subunit. This converts the small subunit to a closed 
conformation causing GTP hydrolysis and release of EF1 and places the aminoacyl 
region of the tRNA into the catalytic centre of the ribosome. Peptide bond formation is 
catalysed by the 28S rRNA (a ribozyme) and the growing polypeptide chain is 
transferred to the A site bound tRNA. Binding of GTP-bound Elongator factor 2 (EF2) to 
the ribosome and coupled GTP hydrolysis causes movement of the A-site bound tRNA 
into the P-site, moving the mRNA along with it. This displaces the previous P-site tRNA 
into the E-site for exit from the ribosome and positions the next codon in the mRNA at 
the empty A-site (Figure 1.5). These cycles are repeated until termination is signalled 
by a stop codon in the mRNA, which rather than specifying a tRNA leads instead to the 
binding of release factors that free the completed polypeptide and break apart the 
assembled ribosome (Berg et al., 2007, Alberts, 2008, Steitz, 2008). The process of 
polypeptide elongation at the ribosome proceeds rapidly and with high fidelity 
(Cochella et al., 2007). 
 
 
 20 
 
 
Figure 1.4: Universal structural features of tRNA molecules. A) Schematic of general tRNA 
secondary structure illustrating conserved features, stems and loops. B) Views of higher order 
tRNA structure. Schematic of L shaped folded tRNA with stacked helices and loop regions (left) 
and skeletal model showing bases in yeast tRNAPhe (right). Images are adapted from Berg et al 
(2007).  
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Figure 1.5: Translation elongation at the ribosome. A) Structure of the bacterial ribosome 
with bound tRNAs to illustrate conserved overall architecture and schematic of tRNA binding 
sites, A-site, P-site and E-site. Image taken from Alberts (2008). B) Schematic overview of the 
Elongation steps of translation at the eukaryotic ribosome adapted from Steitz (2008).  
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In all organisms the genetic code is degenerate such that most amino acids can be 
specified by more than one codon during translation. In fact of the 20 amino acids only 
methionine and tryptophan are specified by a single triplet codon. However, not all of 
the 61 codons have an exact match to the anticodon of the tRNA molecule that 
decodes them and cells have a lot less than 61 specific tRNA species. This means that 
many tRNAs recognise more than one codon and this is due to ‘wobble’ at the first 
base of the anticodon (third base in the codon) that allows relaxation of the usual rules 
of base pairing (Crick, 1966).  Interactions between the first and second bases of a 
codon have to be strictly complemented by Watson-Crick base pairing with the tRNA 
anticodon, this is monitored by the conserved hydrogen bonding contacts with the 18S 
rRNA in the A-site of Ribosome, mentioned above. The third base of a codon is less 
restrictive so that non-cognate base pairing can occur with the first base of the 
anticodon (Ogle et al., 2001, Selmer et al., 2006). This nucleotide (position 34 in the 
universal structure) is therefore termed the ‘wobble’ position. An overview of the 
decoding capacity of tRNAs across the genetic code in yeast is summarised in Figure 
1.6.  
 
Figure 1.6: The genetic code and distribution of tRNA molecules in yeast. Modifications on 
particular tRNA species are also shown. A= Adenosine, U= Uridine, G= Guanosine, C= Cytosine, 
I= Inosine,  Gm= 2’-O-methylguanosine, ncm5U=  5-carbamoylmethyluridine, mcm5U= 5-
methoxycarbonylmethyl, mcm5s2U= 5-methoxycarbonylmethyl-2-thio-uridine, Ψ= 
Pseudouridine.  Taken from Johansson et al (2008) 
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Although tRNA molecules must conform to a rigid global structure in order to bind 
efficiently to the A-site of the ribosome they each have particular identities. These are 
imparted not only by their nucleotide sequences but also by extensive nucleoside 
modifications that occur in both the loop and stem regions of the tRNA (Figure 1.7). 
These modifications can affect the folding, stability, charging and decoding properties 
of a tRNA species and are conserved in all kingdoms of life (Björk, 1995).   
Modifications in the anticodon loop affect the translational properties of a given tRNA 
species, contribute to reading frame maintenance, efficient codon recognition at the 
A-site and restrict misreading (Agris et al., 2007, Agris, 2008). The wobble position 34 
and position 37 of the tRNA anticodon loop are the most commonly and extensively 
modified bases. These modifications appear to be especially important in structuring 
anticodon loops that are enriched in pyrimidines (U and C) and the wobble uridine in 
eukaryotic tRNA is almost never unmodified. Modification of wobble uridine imparts 
extra stability and improves base stacking contacts, while modification of the 
conserved purine 37 position is important for maintaining the width of the loop (Agris, 
2008, Agris et al., 2007). Modifications play a key role in the function of tRNAs and so 
are essential to the accurate and efficient translation of the genetic code.  
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Figure 1.7: Schematic overview of tRNA modifications in yeast. Green circle=Unmodified 
base, Pink circle=Modified base in some or all tRNAs, Red circle=Anticodon base, Blue 
circle=Amino acid acceptor stem base. Modifications are as follows; Ψ=Pseudouridine, m1G=  
1-methylguanosine, m2G= 2-methylguanosine, ac4C= 4acetylcytidine, D= dihydrouridine, Gm= 
2’-O-methylguanosine, m2,2G= N2,N2-dimethylguanosine, m3C= 3-methylcytidine, I= Inosine,  
m5C= 5-methylcytidine, mcm5U=  5-methoxycarbonylmethyl, mcm5s2U= 5-
methoxycarbonylmethyl-2-thiouridine, ncm5U= 5-carbamoylmethyluridine, ncm5Um= 5-
carbamoylmethyl-2’-O-methyuridine,  m1I= 1-methylinosine, i6A= N6-isopentenyladenosine, 
yW= wybutosine, t6A=  N6-threonylcarbamoyladenosine, Um= 2’-O-methyluridine, m7G=  7-
methylguanosine,  rT=  Ribothymidine,  Ar(p)= 2’-O-ribosyladenosine(phosphate). Taken from 
Phizicky and Hopper (2010a) 
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1.5 Elongator’s role in Zymocin resistance and tRNA wobble 
uridine modification 
In order to gain a growth advantage the dairy yeast Kluyveromyces lactis has gained 
‘Killer’ capabilities that allow it to inhibit the growth of other yeasts. This is mediated 
by secretion of a toxin, Zymocin, which is taken up by budding yeast and consequently 
induces a G1 cell cycle arrest (Butler et al., 1991c).  Zymocin is a trimeric toxin, made 
up of α, β and γ subunits that are encoded by a linear plasmid system. Zymocin’s killer 
activity resides in the γ subunit whereas the α and β subunits mediate entry into the 
cell (Tokunaga et al., 1989, Butler et al., 1991b).  Zymocin likely docks onto cell wall 
chitin using the α subunit, which has exochitinase activity, and the hydrophobic β 
subunit may then mediate interactions with the exposed membrane for insertion of 
the γ subunit (Butler et al., 1991a, Jablonowski et al., 2001b, Zink et al., 2005).   
A number of mutations in budding yeast have been identified that confer resistance to 
Zymocin and these can be separated into two classes (Table 1.1, Butler et al., 1991b). 
Mutants that are defective in proteins involved in binding and uptake of Zymocin are 
resistant to extracellular Zymocin but sensitive to expression of the intracellular 
expression of the γ subunit. These ‘Class I’ mutants include strains with mutations in 
genes of the chitin synthesis pathway, such as chitin synthase. The ‘Class II’ mutants 
are resistant to both extracellular Zymocin and intracellular γ subunit expression and 
encode proteins involved in regulating the intracellular target of the toxin. Among the 
Class II mutants were deletions of genes encoding the Elongator complex, which 
implicated the complex in the cellular response to the toxin (Frohloff et al., 2001).  
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Gene Protein Description  Role in Zymocin Toxicity 
Class I 
CHS3 Chitin synthase III Docking 
CHS4 Activator of Chitin Synthase III Docking 
CHS5 Chitin targetting protein Docking 
CHS6 Regulation of Chitin synthesis Docking 
CHS7 Regulation of Chitin synthesis Docking 
ISR1* Putative Kinase Docking 
UGP1* UDP-glucose pyrophosphorylase Docking 
GRX3* Glutaredoxin Not known, activation? 
IPT1 Inositolphosphotransferase Import 
PMA1 H+-ATPase Not known, activation? 
PTK2 Activator of Pma1 Not known, activation? 
Class II 
ELP1 Elongator subunit Target tRNA modification 
ELP2 Elongator subunit Target tRNA modification 
ELP3 Elongator subunit Target tRNA modification 
ELP4 Elongator subunit Target tRNA modification 
ELP5 Elongator subunit Target tRNA modification 
ELP6 Elongator subunit Target tRNA modification 
KTI11 Elongator accessory factor Target tRNA modification 
KTI12 Elongator accessory factor Target tRNA modification 
KTI13 Elongator accessory factor Target tRNA modification 
HRR25 Caesin Kinase 1 Target tRNA modification 
SIT4 Sit4 phosphatase Target tRNA modification 
SAP185/SAP190 Sit4 binding partners Target tRNA modification 
TRM9 tRNA methyltransferase Target tRNA modification 
TRM112 Trm9 accessory factor Target tRNA modification 
NCS2 Sulphur relay factor Target tRNA modification 
TUC1 Sulphur relay factor Target tRNA modification 
URM1 Sulphur carrier Target tRNA modification 
UBA4 Urm1 activator Target tRNA modification 
TUM1 Sulphur transferase Target tRNA modification 
Class II Multicopy suppressors 
tRNAGlu(UUC) - Toxin target 
tRNALys(UUU)/tRNA
Gln
(UUG) - Toxin target 
KTI12 Elongator accessory factor Target tRNA modification 
Table 1.1. Summary of Zymocin resistant mutants in yeast. Class I genes when deleted confer 
resistance to the extracellular Zymocin. Class II genes when deleted confer resistance to both 
extracellular and intracellular toxin. Multicopy suppressors cause Zymocin resistance when 
expressed in multicopy. Genes separated with ‘ /’ denote that only the double mutant causes 
Zymocin resistance. The ‘*’ denotes multicopy Class I suppressors. This table summaries data 
from Butler et al.,(1994) Huang et al., (2008) Jablonowski et al., (2001a, 2001b, 2006), 
Dephoure et al., (2005), Mehlgarten et al., (2007), Zink et al., (2005), Mehlgarten and 
Schaffrath, (2003, 2004), Frohloff et al.,(2001) Fichtner and Schaffrath (2002), Fichtner et al., 
(2003). 
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Interestingly, it was also shown that the tRNA gene encoding  tRNAGluUUC is a multicopy 
suppressor of Zymocin action and this led on to the discovery that transfer RNAs are 
the intracellular target of the toxin (Butler et al., 1994, Lu et al., 2005). The γ subunit of 
Zymocin is a tRNA anticodon nuclease that cleaves tRNAGluUUC (and to a lesser extent 
tRNALysUUU and tRNA
Gln
UUG) containing a 5-methoxycarbonymethyl-2-thio-uridine 
(mcm5s2U) at the anticodon wobble position (Lu et al., 2005). The mcm5s2U 
modification is essential for substrate recognition, targetting tRNAGluUUC for cleavage at 
the 3’ side of the wobble position (Figure 1.8). Depletion of substrate tRNA by Zymocin 
is thought to cause defects in translation resulting in G1 cell cycle arrest of sensitive 
yeasts (Figure 1.8, Lu et al., 2005). 
The resistance of Elongator mutants to Zymocin was shown to be due to lack of the 
mcm5 moiety at the wobble uridine position in substrate tRNA, which protects them 
from recognition and cleavage by the toxin.  This uncovered a novel function of the 
complex:  Elongator is required for an early step in synthesis of  5-
methyoxycarbonylmethyl (mcm5) and 5-carbamoylmethyl (ncm5) modifications on 
wobble uridine containing tRNAs (Huang et al., 2005).  In yeast, out of a total of 42 
tRNAs, 11 require Elongator dependent modifications (Figure 1.9A) and these are 
required for efficient decoding at the wobble position during translation (Percudani et 
al., 1997, Huang et al., 2005, Lim, 1994).   
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Figure 1.8: Zymocin mechanism of action. A) Zymocin inhibits the growth of sensitive yeast 
strains. Sensitivity is assayed by innoculating the edge of the strain of interest with K. lactis. 
This is called an ‘Eclipse’ assay as Zymocin sensitive yeast show a halo of growth inhibition 
around the K. lactis colony. B) Zymocin is a tRNA anticodon nuclease that cleaves at the 3’ side 
of a mcm5s2U at the wobble position. To illustrate the Zymocin mechanism of action 
tRNAGlu(mcm5s2UUC) is shown. 
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It is not yet known if Elongator acts directly in the catalysis of the cm5 step of these 
tRNA modifications but the Radical SAM and HAT domains of Elp3 are essential to this 
function (Huang et al., 2005, Chen et al., 2011b). The combination of these two 
functional domains in Elp3 is highly conserved and Radical SAM domain containing 
enzymes have already been implicated in a number of RNA modification reactions 
(Agarwalla et al., 2002, Pierrel et al., 2004, Anton et al., 2008, Yan et al., 2010, Grove et 
al., 2011). Labelling experiments have shown that carbon atoms from acetyl-CoA are 
not immediate donors for synthesis of the mcm5 and ncm5 modifications and the 
actual donor remains unknown (Tumaitis and Lane, 1970). It is tempting to speculate 
that the HAT and Radical SAM domains may work cooperatively for synthesis of 
precursors and attachment of these tRNA modifications. In line with this, 
immunoprecipitated Elp1 and Elp3 subunits could be specifically crosslinked to 
exogenous substrate tRNAs and the Elp4-6 subcomplex has been shown to bind tRNAs 
in vitro (Huang et al., 2005, Glatt et al., 2012).  
Other class II Zymocin resistant genes have also been shown to be required for target 
tRNA modifications; these include proteins involved in the thiolation and final 
methylation steps of the mcm5s2U modification and putative Elongator accessory 
factors (Table 1.1 and Figure 1.9B).  
In a screen for Zymocin resistant mutants, a number of factors were discovered whose 
substrate tRNAs were subsequently shown to lack their 2-thio moiety, which is also 
required for toxin recognition (Huang et al., 2008, Fichtner et al., 2003). The Ubiquitin 
like modifier Urm1 and its activating enzyme Uba4, are required for 2-thio 
incorporation along with Tuc1, Ncs2 and Tum1. The pathway for this modification 
proceeds by a sulphur relay system (Noma et al., 2009, Leidel et al., 2009). 
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Figure 1.9: Elongator is required for tRNA wobble uridine modifications. A) Summary of yeast 
tRNAs with a modified uridine at the wobble position of the anticodon. ncm5U=  5-
carbamoylmethyluridine, mcm5U= 5-methoxycarbonylmethyl, mcm5s2U= 5-
methoxycarbonylmethyl-2-thio-uridine. B) Proteins required for the synthesis of the different 
moieties (boxed) of mcm5s2U.  Elongator is thought to be required for cm5 incorporation. 
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Urm1 has been implicated in the urmylation of proteins but is also related to bacterial 
sulphur carriers (Goehring et al., 2003, Zhang et al., 2009). It acts as a sulphur carrier in 
the modification of tRNA alongside its binding partner, Uba4.  A model has been 
proposed whereby thiolated Tum1 donates the sulphur moiety to Uba4, which 
adenylates and then thiolates Urm1 using two different functional domains. This 
thiocarboxylated group in Urm1 acts as a donor for the tRNA modification and sulphur 
is transferred onto uridine by an unknown mechanism that may involve Tuc1 and Ncs2 
(Noma et al., 2009, Leidel et al., 2009).  In yeast this thiolation pathway occurs 
independently of Elongator, since the normally undetectable intermediate s2U 
modification is detected in Elongator deletion strains (Huang et al., 2005).  
The final methylation step in the synthesis of mcm5 modifications is catalysed by a 
SAM dependent tRNA methyltransferase, Trm9 alongside its accessory partner Trm112 
(Kalhor and Clarke, 2003, Jablonowski et al., 2006, Studte et al., 2008). Apart from 
Zymocin resistance, deletion of TRM9 does not result in other elp like phenotypes and 
so it acts downstream of the Elongator dependent step (Jablonowski et al., 2006). This 
also suggests that loss of the methyl group of mcm5 may not have a particularly severe 
effect on tRNA function, though such effects have been suggested to become more 
severe under stress conditions (Kalhor and Clarke, 2003).  
Mutations in the Killer insensitive genes KTI11-KTI13 result in loss of mcm5U and 
ncm5U modification, suggesting that these act in the same pathway as the Elongator 
complex (Huang et al., 2008). Deletion of these genes also results in typical elp 
phenotypes and homologues of these factors are also found from yeast to man 
(Frohloff et al., 2001, Fichtner and Schaffrath, 2002).  
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KTI12 causes Zymocin resistance when deleted or expressed in multicopy and this 
suggests that wild-type levels are essential for Elongator dependent tRNA modification 
(Butler et al., 1994, Section 1.1 for Kti12 details). Deletion of KTI12 completely 
abolishes Elongator dependent tRNA modification (Huang et al., 2008). 
Kti11 is a small, highly acidic protein containing a zinc ribbon motif that is required for 
Elongator dependent tRNA modifications (Sun et al., 2005, Huang et al., 2008). Kti11 
has also been identified as Dph3, a factor involved in the synthesis of the Diphthamide 
(2-[3-carboxyamido-3-(trimethylamino)-propyl]-histidine), a unique modification that 
occurs on Translation Elongation Factor 2 (eEF2) and is the target of Diphtheria toxin 
(Liu et al., 2004). The function of this modification is unknown but it may be required 
for the fidelity of translation and is conserved from yeast to man (Liu et al., 2012, 
Collier, 2001).  Kti11 forms a trimeric complex with Dph1 and Dph2, other factors in 
the Diphthamide synthesis pathway, and is thought to be involved in an early step of 
synthesis (Liu et al., 2004). Consequently, deletion of KTI11 causes concurrent Zymocin 
and Diphtheria toxin resistance due to lack of mcm5U and Diphthamide modifications 
respectively (Fichtner and Schaffrath, 2002, Liu et al., 2006). It has been proposed that 
Kti11 is involved in multiple processes, since it interacts independently with the 
Elongator complex, the accessory factor Kti13, eEF2 and ribosomal proteins (Fichtner 
and Schaffrath, 2002, Liu et al., 2004). Truncation of the Kti11 C-terminus results in 
resistance to Zymocin but not Diphtheria toxin, demonstrating that its cellular roles 
can be uncoupled (Bar et al., 2008).  Deletion of KTI11 also causes an increase in the 
level of an N-terminally truncated form of Elp1 that may reflect a role for Kti11 in 
stability of this subunit (Fichtner et al., 2003).  
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Kti13 does not appear to interact with the Elongator complex directly but rather is 
associated through its tight interaction with Kti11 (Fichtner and Schaffrath, 2002). 
Unlike KTI11 and KTI12, deletion of KTI13 does not completely abolish Elongator 
dependent tRNA modifications but these are significantly reduced (Huang et al., 2008). 
This suggests that Kti13 may play a regulatory role in Elongator function; this is 
supported by the fact that it contains a guanine nucleotide exchange factor (GEF) like 
domain at its N-terminus. Like its binding partner Kti11, Kti13 may also play roles in 
other complexes. It was originally identified in a screen for suppressors of α-tubulin 
mutants and interacts with Nap1, a protein involved in microtubule dynamics 
(Kirkpatrick and Solomon, 1994, Kellogg and Murray, 1995).  
Deletions of KTI11 and KTI13 display genetic interactions with Elongator gene 
deletions, suggesting they are not part of the same complex but rather are acting as 
regulatory factors that may have other independent functions. When kti13 and elp3 
deletions are combined there is a more severe growth defect than either alone.  
Deletion of KTI11 alone confers a severe growth defect that can be partially rescued by 
deletion of ELP3 (Fichtner and Schaffrath, 2002). Combined deletion of both KTI11 and 
KTI13 is lethal and each single deletion can be partially rescued by overexpression of 
KTI12, suggesting functional interplay between these factors (Zabel et al., 2008, Butler 
et al., 1991b).  
Interestingly, the casein kinase Hrr25 and Sit4 protein phosphatase are also class II 
mutants and are required for the Elongator dependent tRNA modifications 
(Mehlgarten and Schaffrath, 2003, Jablonowski et al., 2001a, Huang et al., 2008), this 
will be discussed in Section 1.8. Although not yet well understood there appear to be a 
number of factors that impinge on Elongator’s role in tRNA wobble uridine 
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modification. The fact that so many genes have been shown to be required for these 
modifications demonstrates their likely functional importance.  
 
1.6 The central function of the Elongator complex is in tRNA 
wobble uridine modification 
It is now thought that the major role of the Elongator complex in yeast is to promote 
mcm5 and ncm5 tRNA wobble uridine modifications. This is because multicopy 
expression of two hypomodified tRNAs in yeast, which normally receive the mcm5s2 
modification, is sufficient to rescue nearly all elp mutant phenotypes tested so far 
(Esberg et al., 2006, Chen et al., 2011b). This suppression is presumed to be due to 
elevated levels of the encoded tRNAs, which are increased two-fold, compensating for 
their reduced function due to lack of wobble uridine modification (Bjork et al., 2007). 
This is strong evidence that these mutant phenotypes could all be caused by a 
common translational defect.  
Increased levels of both tRNALysUUU and tRNA
Gln
UUG suppresses the slow start 
phenotypes of elp mutants, including the underlying delay in gene activation and 
histone H3 hypoacetylation. Elevated levels of these tRNAs also reverses the synthetic 
defects associated with combining an ELP3 deletion with deletions of GCN5 or genes 
encoding other histone chaperones, as well as suppressing sensitivity to caffiene, 
hydroxyurea and high temperature. Overexpression of tRNALysUUU and tRNA
Gln
UUG also 
mimics the presence of functional Elongator in the elp1∆ sec2-59 double mutant 
(Esberg et al., 2006). This argues against a direct role of Elongator in transcription, 
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chromatin assembly and exocytosis and suggests that these phenotypes occur due to a 
defect in the translation of proteins involved in these processes.  
To further corroborate this, deletion of genes involved in the thiolation step of tRNA 
wobble uridine modifications were shown to confer identical phenotypes to Elongator 
deletions strains that were also rescued by overexpression of these specific tRNAs 
(Esberg et al., 2006, Chen et al., 2011b). Taken together, this illustrates that these 
pleiotropic phenotypes are likely to arise from the reduced function of these tRNAs. 
The fact that only these particular hypomodified tRNAs can rescue the defects suggests 
that the mcm5s2 modification must have the most important consequences for tRNA 
function.  
The requirement of Elongator for tRNA wobble uridine modification is conserved in 
higher eukaryotes since it has been demonstrated in plants, worms and mice (Chen et 
al., 2009a, Mehlgarten et al., 2010, Lin et al., 2013). The accessory factors Kti11-13 also 
have homologs in higher eukaryotes including humans, suggesting a common mode of 
regulation.  The phenotypes associated with Elongator dysfunction in these organisms 
have also been proposed to be caused by a translational defect. This has important 
implications for Familial Dysautonomia, as defects in translation may be central to the 
pathogenesis of the disease.  A central role for Elongator in tRNA wobble uridine 
modification is also in agreement with the reported localisation of the complex, as 
these tRNA modifications normally occur in the cytoplasm (Hopper and Phizicky, 2003). 
In this work, any further references to Elongator function will therefore relate to its 
role in tRNA wobble uridine modification.  
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1.7 Elongator and translational defects 
Modifications on the anticodon loop of tRNA frequently occur at the wobble position 
and are thought to structure the anticodon for efficient decoding at the ribosome 
(Agris et al., 2007, Agris, 2008). In eukaryotes tRNA wobble uridine can be modified to 
ncm5U, mcm5U and mcm5s2U and the Elongator complex is essential for an early step 
in the synthesis of these groups (Figure 1.9, Huang et al., 2005). These modifications 
are generally involved in the recognition of A ending codons and mcm5U and ncm5U 
may also be important in ‘wobbling’ to allow recognition of G ending codons 
(Johansson et al., 2008).  
The mcm5s2U34 modification is found on tRNA species that decode –AA ending codons 
(tRNALysUUU, tRNA
Gln
UUG, tRNA
Glu
UUC) and both the mcm
5 and s2 groups work 
cooperatively to increase the efficiency of cognate codon binding (Johansson et al., 
2008, Yarian et al., 2000, Murphy et al., 2004, Bjork et al., 2007). This is important 
because the stability of the pyrimidine-rich UUN anticodon loops is very poor and it 
has been reported that affinity of the hypomodified tRNAs for the ribosome A-site is 
reduced two-fold (Agris, 2008, Yarian et al., 2000). It should be noted that the 
hypomodified tRNAs isolated from Elongator mutants show no steady state defects in 
stability or charging with amino acid (Johansson et al., 2008, Bjork et al., 2007). These 
tRNAs decode in ‘split’ codon boxes where the U/C ending codons specify a different 
amino acid than A/G ending codons and where the G ending codons are read by a 
synonymous cognate tRNA (Figure 1.6).    
In yeast, phenotypes associated with Elongator dysfunction are nearly all rescued by 
multicopy expression of hypomodified tRNALysUUU and tRNA
Gln
UUG   but no other 
Elongator dependent tRNAs, which suggests these are the most compromised in terms 
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of function (Esberg et al., 2006). This also suggests that loss of Elongator-dependent 
modifications results in less efficient codon recognition at the A-site, rather than 
misreading errors, since it would be expected that the latter would be exacerbated by 
overexpression of the hypomodified tRNAs.  The importance of the mcm5s2U34 
modification for tRNA function is further illustrated by the fact that deletion of ELP 
genes alongside TUC1, which abolishes both mcm5 and s2 modifications, is lethal in 
budding yeast.  Amazingly, this lethality can be rescued by overexpression of the 
pyrimidine rich hypomodified tRNALysUUU,  suggesting this tRNA is the most reliant on 
modification for function (Bjork et al., 2007).  
The phenotypes associated with Elongator dysfunction are hypothesised to be caused 
by inefficient translation of particular mRNAs that require decoding by Elongator 
dependent tRNAs. Overexpression of these tRNAs likely increases the formation of A-
site binding ternary complexes, which may compensate for reduced efficiency of 
translation in susceptible mRNA transcripts and thus reverse phenotypes. Recent work 
has begun to address these translational defects in Elongator mutants.  
In Schizosaccharomyces pombe deletion of ELP3 is non-lethal even though it results in 
loss of both mcm5 and s2 modifications, suggesting that the thiolation occurs 
downstream in this organism. These elp3 knockouts have defects in mitosis and 
cytokinesis and have negative genetic interactions with several mitosis inducing genes. 
To assess translation defects in S. pombe elp3∆ strains, the relative expression levels of 
all proteins was determined and compared to wild-type: 494 proteins were down-
regulated but the overall changes were two-fold or less. This constituted only a 
moderate defect in overall translation with approximately 87% of the proteome 
unaffected. The down-regulated proteins could all be categorised into four functional 
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groups in which the AAA lysine codon was over-represented. The levels of mRNAs in 
these functional groups were largely unaffected but they were highly dependent on 
Elongator for their efficient translation. This was exemplified by a candidate kinase, 
Cdr2, which is involved in cell cycle control in fission yeast. Cdr2 was strongly down-
regulated in elp3∆ cells but overexpression of hypomodified tRNALysUUU restored its 
protein levels.  Codon re-engineering of CDR2 to replace all AAA codons with the 
synonymous AAG lysine codon uncoupled its expression from dependence on 
Elongator function. Since deletion of ELP3 causes similar cell cycle defects to deletions 
of CDR2 the dependence of Cdr2 translation on Elongator function was suggested to 
be at least partially responsible for this phenotype in elp3∆ cells (Bauer et al., 2012). 
Another study in S. pombe highlighted a connection between Elongator and the 
expression of certain stress response genes that could also similarly be uncoupled from 
Elongator dependency by altering their codon usage (Fernandez-Vazquez et al., 2013). 
Therefore in S. pombe, certain mRNAs involved in cell cycle control and stress 
responses require Elongator dependent tRNA modifications for efficient translation.  
In budding yeast the translation defects associated with loss of Elongator or Urm1 
function have also been investigated.  Similar to the findings in fission yeast, deletion 
of ELP3 had little effect on the overall translation of the proteome and only a small 
subset of proteins appeared to be affected.  The down-regulated proteins were 
enriched in AAA, CAA and GAA codons, which suggests that these mRNAs were 
particularly dependent on Elongator function for expression. Deletion of URM1 
conferred an almost identical pattern of altered protein expression and the levels of 
altered proteins were almost all rescued by multicopy expression of tRNALysUUU, 
tRNAGlnUUG and tRNA
Glu
UUC. In vitro ribosome binding assays using an mRNA construct 
with the AAA codon and tRNALysUUU isolated from wild type, urm1∆ and elp3∆ strains 
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showed a 60% reduction in A-site binding and a five-fold reduced rate of dipeptide 
bond formation with the hypomodied tRNALysUUU compared to wild-type (Rezgui et al., 
2013).   
Recently it was also shown by ribosome profiling in yeast that AAA, CAA and GAA 
codon occupancy by the ribosome is generally increased in elp3∆ and urm1∆ cells. This 
directly demonstrates that hypomodified tRNALysUUU,  tRNA
Gln
UUG  and tRNA
Glu
UUC, 
function less efficiently in translation under normal growth conditions (Zinshteyn and 
Gilbert, 2013). The authors suggest that the slowing of Elongation due to lack of 
wobble uridine modification is insufficient to affect global protein levels and no 
ribosome queuing was detected in codons surrounding mcm5s2 dependent codons. 
Targets have been identified in S. pombe that can be uncoupled from Elongator 
function by altering codon usage, suggesting that certain proteins are nonetheless 
affected in expression due to bias codon usage (Bauer et al., 2012, Fernandez-Vazquez 
et al., 2013).  
Taken together, this suggests that loss of Elongator does not globally disrupt 
translation and that the majority of proteins are still translated normally. Rather, 
certain mRNAs are susceptible, due to a skewed Elongator dependent codon content, 
to reduced efficiency of translation at the ribosome. It is possible that under different 
growth or stress conditions that elongation defects may become more pronounced 
and this has not been investigated. Other defects arising from lack of tRNA 
modifications may also play a significant role in phenotypes associated with Elongator 
mutants, but how these could be mediated is not understood (Zinshteyn and Gilbert, 
2013).  
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Deletion of TRM9, encoding the tRNA methyltransferase responsible for methylation 
of the mcm5U moiety, has also been linked to codon dependent regulation of 
translation (Begley et al., 2007, Chen et al., 2011a). Interestingly, the translation defect 
in trm9 knockouts may be distinct from that seen in Elongator and urm1 knockouts. It 
has been shown that in trm9∆ strains ncm5U accumulates in tRNAArgUCU and tRNA
Glu
UUC 
and the loss of the methyl group has been suggested to increase misreading of U/C 
ending codons (Chen et al., 2011a, Johansson et al., 2008). This is in agreement with 
the fact that trm9∆ cells show increased frameshifting and missense errors and are 
associated with activation of heat shock and unfolded protein responses (Patil et al., 
2012).  
The modification of tRNA by Elongator appears to be a basic function that should be 
required in all cells for the proper translation of mRNAs. However, analyses so far have 
reported that certain functional groups of proteins are particularly over-represented in 
modification dependent codons (Bauer et al., 2012, Rezgui et al., 2013, Begley et al., 
2007, Bauer and Hermand, 2012).  For example, yeast proteins down-regulated in 
elp3∆ cells were reported to be generally associated with anabolic functions whereas 
up-regulated proteins were associated with catabolic functions (Rezgui et al., 2013). 
This has led to the suggestion that tRNA modifications could be modulated in order to 
rapidly down-regulate the expression of a subset of mRNAs based on the reduced 
decoding efficiency of the tRNAs that read them. This would result in preferential 
down-regulation of mRNAs that require these Elongator-dependent tRNAs for efficient 
translation. Under the influence of external stimuli or developmental cues, reduced 
tRNA modification would allow rapid mRNA expression control at the post-
transcriptional level.  
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There are a few lines of evidence that support this hypothesis. In yeast, the levels of 
several tRNA modifications have been shown to change in response to certain stresses. 
However, this does not take into account tRNA turnover and the changes do not 
always reflect phenotypes associated with loss of the corresponding modification. For 
example, Elongator mutant strains are sensitive to hydrogen peroxide but mcm5s2 
levels are not altered upon hydrogen peroxide treatment and so it remains to be seen 
if these modifications could be dynamically regulated (Chan et al., 2010). The levels of 
thiolation in mcm5s2 containing tRNAs are also dependent on the availability of 
cysteine and methionine amino acids, which links tRNA modification and translational 
efficiency to nutrient status. It appears that s2U34 is a gauge for the sulphur status of 
the cell and reduced levels of this modification results in general down-regulation of 
translation and carbohydrate metabolism and up-regulation of cysteine, methionine 
and lysine biosynthesis and sulphur salvage pathways (Laxman et al., 2013). It has also 
been suggested that mcm5s2U modifications could be regulated by mTOR signalling, 
since Uba4 reportedly interacts with TORC1 and elp and urm1 mutants are 
hypersensitive to rapamycin, although no such crosstalk has been identified for the 
Elongator pathway (Laxman and Tu, 2011, Schaffrath., Personal Communication , 
Leidel et al., 2009, Jablonowski et al., 2009). The expression of the human homologue 
of TRM9 (ABH8) has been shown to be induced by the ATM DNA damage response 
kinase, which implies that higher eukaryotes may regulate these tRNA modifications in 
response to stress (Fu et al., 2010). The distribution of Elongator subunits in some 
higher eukaryotes is tissue specific and this may underlie a modulation of translation in 
certain tissues and developmental stages (Chen et al., 2009a, Nelissen et al., 2010, Lin 
et al., 2013, Cuajungco et al., 2003).  
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The possible regulation of tRNA modification provides an exciting new level of gene 
expression control but this requires further investigation. Since the tRNA modification 
function of Elongator relies on the function of Hrr25 (a casein kinase) and Sit4 (a 
protein phosphatase), such regulation could potentially be mediated through 
reversible phosphorylation of Elongator subunits. 
 
1.8 The regulation of Elongator by phosphorylation 
Mutations that disrupt the kinase activity of Hrr25 or deletion of the protein 
phosphatase Sit4 cause Class II Zymocin resistance (Table 1.1), which suggested a role 
for reversible protein phosphorylation in Elongator-dependent tRNA modification 
(Mehlgarten and Schaffrath, 2003, Jablonowski et al., 2001a, Butler et al., 1991b). In 
fact the Elp1 subunit is subject to phosphorylation, since it is recognised by generic 
anti-phospho-serine and anti-phospho-threonine antibodies. In wild-type strains, Elp1 
can be separated into distinct ‘phospho’ and ‘non-phospho’ forms based on loss of the 
slower migrating form upon phosphatase treatment and immunoreactivity with 
phosphospecific antibodies (Jablonowski et al., 2004, Mehlgarten et al., 2009).  This 
indicates that under normal conditions Elp1 is balanced between ‘hyper’ and ‘hypo’ 
phosphorylated forms. Hrr25 kinase dead mutants alter this balance and only the 
‘hypo’ phosphorylated Elp1 can be detected (Mehlgarten et al., 2009). In contrast, 
deletion of SIT4 causes accumulation of the ‘hyper’ phosphorylated form (Mehlgarten 
et al., 2009, Jablonowski et al., 2004). These proteins therefore appear to have 
opposing roles in regulating the phosphorylation state of the Elp1 subunit. Since both 
HRR25 and SIT4 mutations cause Zymocin resistance then a balance between these 
phospho-forms must be essential for Elongator function.  
 43 
 
Hrr25 is a member of the Caesin Kinase I (CKI) family, of which there are four members 
in yeast. It contains an N-terminal serine/threonine kinase domain, a P/Q rich C-
terminus and has homologues in higher eukaryotes, including humans (Hoekstra et al., 
1994). The kinase is involved in multiple cellular processes, including DNA damage 
responses, meiosis and Ca2+/Calmodulin signalling (Ho et al., 1997, Kafadar et al., 2003, 
Petronczki et al., 2006). Interestingly, Hrr25 is also implicated in ribosome biogenesis 
(Schafer et al., 2006, Ray et al., 2008).  Zymocin resistant mutants of HRR25 were 
isolated initially with a point mutation in a conserved residue (E52D) that rendered the 
kinase inactive. The levels of Elongator subunit mRNAs are not altered in this mutant 
and deletion of downstream targets and inactivation of other CKI family members do 
not cause Zymocin resistance (Mehlgarten and Schaffrath, 2003). However, the mcm5 
and ncm5 modifications were absent in the hrr25 mutant (Huang et al., 2008) and 
therefore the kinase activity of Hrr25 is essential to Elongator tRNA modification. 
Consistent with a role in DNA damage repair, hrr25 mutant strains are sensitive to 
methyl methanesulfonate (MMS). Truncation of the Hrr25 P/Q rich domain rescues 
this phenotype but this mutant is still Zymocin resistant, demonstrating that the 
cellular functions of the kinase can be uncoupled (Mehlgarten and Schaffrath, 2003).  
Sit4 is a PP2A-like serine/threonine protein phosphatase that is implicated in a large 
number of processes including Protein Kinase C and mTOR signalling (Arndt et al., 
1989, Angeles de la Torre-Ruiz et al., 2002, Di Como and Arndt, 1996). It is required for 
normal cell cycle progression and stress responses (Sutton et al., 1991, Lopez-Mirabal 
et al., 2008, Douville et al., 2004). The different functions of Sit4 are mediated by its 
interaction with Sit4 associated proteins, or Saps, that direct its activity towards 
different substrates. There are four Sap proteins in yeast Sap4, Sap155, Sap185 and 
Sap190. The Sap4/Sap155 and Sap190/185 proteins are functionally distinct and likely 
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direct Sit4 towards different groups of substrates (Luke et al., 1996). Deletion of both 
SAP190 and SAP185 results in Zymocin sensitivity so these direct its activity towards 
the Elongator complex (Jablonowski et al., 2009). Like Hrr25 mutants, there were no 
changes in the mRNA or protein levels of Elongator subunits in Sit4 deletion strains, 
which suggested post-translational regulation of the complex (Jablonowski et al., 
2001a). Both Sit4 and Hrr25 have been demonstrated to interact, which is consistent 
with a combined regulatory role (Jablonowski et al., 2004, Ho et al., 2002).  
The Hrr25 kinase interacts with the assembled Elongator complex but this interaction 
is dependent on the accessory factor Kti12. Deletion of KTI12 abolishes this interaction 
and mutations in hrr25 also cause increased association of Kti12 with Elongator 
(Mehlgarten et al., 2009). Further to this, Kti12 also appears to regulate Elongator 
phosphorylation, deletion or multicopy expression of KTI12 causes Elp1 ‘hypo’ or 
‘hyper’ phosphorylation, respectively (Jablonowski et al., 2004).  
It has been proposed that Hrr25 is bridged to Elongator by its interaction with Kti12 
and that both factors may regulate Sit4 activity towards Elp1.  Such a role as a 
regulator of Sit4 is supported by the fact that ‘kinase-dead’ hrr25 in combination with 
a SIT4 deletion results in a wild-type balance of Elp1 phospho-forms, as described 
above, suggesting that Hrr25 cannot be the only Elp1 kinase and that both these 
proteins have functional interplay (Mehlgarten et al., 2009).  Multicopy KTI12 in 
combination with multicopy SIT4 also results in a wild-type balance of phosphorylated 
Elp1, suggesting that Kti12 antagonises Sit4 phosphatase activity (Jablonowski et al., 
2004). Therefore the balance of phosphorylated Elp1 is dependent on the interplay 
between Hrr25, Sit4 and Kti12, but this is not yet well understood (Figure 1.10). 
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In order to understand better the regulation of Elp1 by phosphorylation, our lab 
carried out phosphopeptide mapping combined with alanine substitutions in putative 
phosphorylation sites (Abdel-Fattah and Stark unpublished). Several putative 
phosphorylation sites at the C-terminus of Elp1 were found to be functionally essential 
and are currently under investigation (Figure 1.11). Of significance to this work, serine 
1209 was found to be functionally essential since mutation to alanine caused Elongator 
dysfunction, as did the combined mutation of serines 1198 and 1202 to alanine. 
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Figure 1.10: Balanced Elp1 phosphorylation depends on the interplay between Hrr25, Sit4 
and Kti12. Kti12 and Hrr25 promote phosphorylation that is opposed by Sit4 
dephosphorylation.  Hrr25 may work alongside Kti12 to inhibit Sit4 dephosphorylation of Elp1. 
Boxes denote the various gene deletions and multicopy expressions that correspond to each 
Elp1 phosphorylation state. This schematic summaries data from Mehlgarten and Schaffrath 
(2003), Mehlgarten et al (2009), Jablonowski et al (2001a, 2004, 2009) 
 
 
 
 
 
 
 
 
 47 
 
 
 
Figure 1.11: Putative phosphorylation sites and basic region in the Elp1 subunit. 
Phosphopeptide mapping has revealed putative phosphorylation sites that lie near a basic 
region in the Elp1 C-terminus. Orange balls indicate phosphorylation and the residue number is 
shown where the exact site has been mapped. Blue residues indicate putative phosphorylation 
sites and purple residues indicate the basic region.  
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1.9 A basic region in the Elp1 C-terminal domain 
The Elp1 C-terminal domain contains a lysine/arginine rich basic region (Figure 1.11) 
that is highly conserved across eukaryotes, including humans. This region has been 
annotated as a putative bipartite nuclear localisation sequence (NLS) but this potential 
function has not yet been fully investigated. In yeast, truncation of the Elp1 C-
terminus, including this basic region, results in loss of Elongator function and it was 
shown that when fused to GFP, the Elp1 C-terminal domain (CTD) can direct import of 
the fusion protein into the nucleus (Fichtner et al., 2003). It was suggested by the 
authors that Elp1 may require import into the nucleus for a role in transcription. 
However, Elp1 has been reported to be mainly cytoplasmic in both yeast and human 
cells (Pokholok et al., 2002, Kim et al., 2002).   
A cytoplasmic localisation is consistent with a role in anticodon tRNA modification so it 
was unclear why Elp1 would require nuclear import (Hopper and Phizicky, 2003). Other 
work has also shown that addition of a bona fide NLS (from Cap binding protein 80, 
Cbp80) onto the Elp1 C-terminus traps the subunit in the nucleus but causes loss of 
Elongator function, consistent with a cytoplasmic role (Rahl et al., 2005). The C-
terminus of Elp1 is predicted to be mainly α-helical indicating that it may be quite 
flexible (Figure 1.2).  Furthermore, the  functionally important phosphorylation sites 
discussed above also lie just upstream of this basic region (Figure 1.11) raising the 
possibility that there could be some interplay between these regions. The importance 
and function of the Elp1 basic region has not yet been extensively studied. 
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1.10 Aims of this work 
The key aim of this thesis is to investigate the role of the highly conserved basic region 
in the Elp1 subunit of Elongator using budding yeast as a eukaryotic model organism. 
Budding yeast is an excellent tool for basic research and to date a significant amount of 
work on the Elongator complex has been carried out using this organism as a model. 
The Elp1 basic region resides in the C-terminal domain and although annotated as a 
putative NLS this function has not been extensively studied. The work presented in this 
thesis addresses several aspects of how this basic region in Elp1 impinges on Elongator 
function. It is hoped that the conclusions of this thesis will provide valuable 
information on the function of the Elp1 basic region from yeast to man.  
 
i) The functional significance of the Elp1 basic region 
In order to study the function of the Elp1 basic region alanine substitutions 
were created throughout its sequence. Various functional assays were used 
to determine the effect of these mutations on Elongator tRNA wobble 
uridine modification. To assay the effects of these mutations on the 
distribution of Elp1 between the nucleus and cytoplasm of cells microscopy 
of GFP tagged Elp1 and Elp1 mutant proteins was used.  
 
ii) What effects do mutations in the Elp1 basic region have on Elongator 
complex assembly and phosphorylation? 
To determine whether the basic region in Elp1 is important for the 
assembly of the Elongator complex the association of tagged subunits in the 
context of wild-type and mutant Elp1 were analysed by pulldowns and 
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western blotting. Phosphorylation could also be altered in Elp1 basic region 
mutants if certain sites regulated the recognition or function of this region. 
To investigate the possible relationship between the Elp1 basic region and 
functionally important phosphorylation, wild-type and mutant Elp1 proteins 
were analysed by western blotting using an Elp1 phospho-specific antibody 
against the functionally important serine 1209 site.  
 
iii) If the Elp1 basic region is not required for nuclear import then is it 
required for interaction with tRNA? 
We hypothesised that the basic region may be required for tRNA binding to 
Elongator. This alternative function was addressed using recombinant Elp1 
fusion proteins and electromobility shift assays with yeast tRNA.  
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Chapter 2: Materials and Methods 
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2.1 Yeast Cell Culture and Strain Construction 
Standard Saccharomyces cerevisiae (yeast) culture and molecular biology techniques 
were used, unless otherwise stated (Sherman, 2002, Stansfield, 2006, Amberg et al., 
2005, Sambrook and Russell, 2001). All culture media used in this study were provided 
by Media Services, University of Dundee and media recipes along with working drug 
concentrations are described in the Appendix.  Unless otherwise stated ultrapure 
water was purified by a 0.22 μm milli-Q filter (denoted mQH20 throughout) and 
sterilised by autoclaving.  
2.1.1   Yeast Cell Culture 
Haploid budding yeast strains were cultured in rich Yeast-Peptone-Adenine-Dextrose 
(YPAD) medium or the appropriate selective dropout media (DOA) at 26°C or 30°C 
unless otherwise stated. Strains were stored long term at -80°C as glycerol stocks, 
made by growing strains from single colonies on agar media and then scraping into 
20% (v/v) Glycerol.  To recover strain from these stocks, a small amount of cells were 
plated from glycerol stocks on the appropriate agar medium and grown overnight. 
Overnight cultures were made by inoculating ~5 ml of medium with yeast from an agar 
plate and incubated with shaking. The concentration of cells in liquid culture was 
determined using optical density at 600 nm (OD600). For log phase cultures, overnights 
were diluted to the appropriate OD600 (~ 0.1) in fresh medium and grown for at least 2 
doublings (usually around 6-8 hours) to reach log phase (OD600 of ~1).  Unless stated 
otherwise all strains were derived from BY4741 (MATa his3∆1 leu2∆0 met15∆0 
ura3∆0).  A list of strains used and/or generated in this study is shown (Table 2.1).  
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Table 2.1: List of strains used and/or generated in this study. 
Strain Genotype Source 
K. lactis 
IFO1267 MATa prototroph [pGLK2+ pGLK1+] Lab Stock 
S. cerevisiae 
BY4741 MATa his3∆1 ura3∆0 leu2∆0 met15∆0  Lab Stock 
BY4742 MATα his3∆1 ura3∆0 leu2∆0 lys2∆0  Lab Stock 
WAY034 BY4741 elp1∆::KanMX4 Euroscarf 
YRDS250 BY4741 elp1∆::HIS3MX This Study 
YRDS225 BY4742 elp1∆::hph This Study 
SBY128 BY4741 his3∆1::URA3-SUP4-NatRMX S. Bandau 
SBY132 BY4741 his3∆1::ura3oc22-SUP4-NatRMX S. Bandau 
SBY134 WAY034 his3∆1::URA3-SUP4-NatRMX S. Bandau 
SBY138 WAY034 his3∆1:: ura3oc22-SUP4-NatRMX S. Bandau 
YRDS1 BY4741 NIC96-4mcherry-NatRMX This Study 
YRDS59 YRDS1 ELP1-L-GFP-HIS3MX 1 This Study 
YRDS84 MATa NIC96-4mcherry-NatRMX6  lys2∆  This Study 
YRDS228 BY4741 elp1::CORE  This Study 
YRDS229 YRDS59 elp1::CORE-L-GFP-HIS3MX This Study 
YRDS256 YRDS228 ELP1 (delitto perfetto)2 This Study 
YRDS258 YRDS228 elp1-KR9A (delitto perfetto) This Study 
YRDS253 YRDS229 ELP1-L-GFP-HIS3MX (delitto perfetto) This Study 
YRDS255 YRDS229 elp1-KR9A-L-GFP-HIS3MX (delitto perfetto) This Study 
YRDS317 YRDS229 elp1-KR5A-L-GFP-HIS3MX (delitto perfetto) This Study 
YRDS319 YRDS229 elp1-KR4A-L-GFP-HIS3MX (delitto perfetto) This Study 
YRDS321 YRDS229 elp1-1209A-L-GFP-HIS3MX (delitto perfetto) This Study 
YRDS323 YRDS229 elp1-1198A-1202A-L-GFP-HIS3MX (delitto perfetto) This Study 
YRDS270 YRDS228 ELP1 (delitto perfetto) his3∆1::URA3-SUP4-NatRMX This Study 
YRDS272 YRDS228 ELP1 (delitto perfetto) his3∆1:: ura3oc22-SUP4-NatRMX This Study 
YRDS278 YRDS228 elp1-KR9A (delitto perfetto) his3∆1::URA3-SUP4-NatRMX This Study 
YRDS280 YRDS228 elp1-KR9A (delitto perfetto) his3∆1:: ura3oc22-SUP4-NatRMX This Study 
YRDS153 YRDS1 ELP1-L-NES(Rev)-GFP-HIS3MX This Study 
YRDS545 YRDS1 ELP1-L-NLS(Cbp80)-L-GFP-HIS3MX This Study 
YRDS539 YRDS1 ELP1-L-NLS4A(Cbp80)-L-GFP-HIS3MX This Study 
YRDS269 BY4741 ELP1-L-3HA-HIS3MX This Study 
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CLY6 WAY034 TRP1::(pGAL-TEV-myc3-HIS3::TRP1)n  
3 C. Lloyd 
YRDS331 MATα ∆elp1::hph TRP1::(pGAL-TEV-3myc-HIS3::TRP1)n   This Study  
YRDS370 YRDS269 elp1::CORE-L-3HA-HIS3MX  This Study 
YRDS450 
MATa elp1::CORE-L-3HA-HIS3MX  TRP1::(pGAL-TEV-3myc-HIS3::TRP1)n 
met15∆0  This Study 
YRDS494 YRDS450 ELP1-TEV-L-3HA-HIS3MX (delitto perfetto) This Study 
YRDS338 YRDS269 ADH1::TIR1-9myc-URA3 This Study 
YRDS393 YRDS338 ADH1::TIR1-9myc-URA3  ELP1-L-3HA-AID-NatRMX This Study 
YRDS439 YRDS1 ARG4-L-GFP-HIS3MX This Study 
YRDS437 YRDS1 KTI12-L-GFP-HIS3MX This Study 
YRDS447 YRDS1 ELP3-L-GFP-HIS3MX This Study 
YRDS443 YRDS1 ELP5-L-GFP-HIS3MX This Study 
YRDS526 YRDS439 KTI12-L-3HA-KanMX This Study 
YRDS461 YRDS253 KTI12-L-3HA-KanMX  This Study 
YRDS467 YRDS255 KTI12-L-3HA-KanMX  This Study 
YRDS529 YRDS321 KTI12-L-3HA-KanMX This Study 
YRDS537 YRDS439 ELP3-L-3HA-KanMX  This Study 
YRDS463 YRDS253 ELP3-L-3HA-KanMX  This Study 
YRDS482 YRDS255 ELP3-L-3HA-KanMX  This Study 
YRDS528 YRDS439 ELP5-L-3HA-KanMX This Study 
YRDS474 YRDS253 ELP5-L-3HA-KanMX  This Study 
YRDS487 YRDS255 ELP5-L-3HA-KanMX  This Study 
YRDS492 BY4741 GLN4-GFP-HIS3MX Invitrogen 
YRDS493 BY4741 CEX1-GFP-HIS3MX Invitrogen 
YRDS531 YRDS253 kti12∆::KanMX  This Study 
YRDS533 YRDS255 kti12∆::KanMX This Study 
YRDS535 YRDS321 kti12∆::KanMX This Study 
 
1 “L” indicates the linker region discussed in Section 2.1.5. 2 Integration by ‘delitto perfetto’ 
method discussion in Section 2.1.12. 3  Integration of >1 copy pCAL7(copy number not 
determined).  
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2.1.2    Eclipse Assays and Growth Tests 
For Eclipse assays, cells from overnight cultures were suspended in sterile mQH20 at an 
OD600=1.0 and 5 µl was spotted onto YPAD (made with Roth agar).  Once dry, the edge 
of each spot was inoculated with Kluyveromyces lactis (IFO1267) and assays were 
incubated at 30°C for 1-2 days. Strains with functional Elongator are sensitive to the 
Zymocin toxin secreted by K. lactis resulting in a halo of growth inhibition.  
For Growth tests, cells from overnight cultures were resuspended in sterile mQH20 at 
an OD600=1.0. Four or five ten-fold serial dilutions were made and 5 µl of each dilution 
was spotted on the appropriate media. These were incubated at the appropriate 
temperature, usually 30°C for 2-3 days. 
2.1.3   Crossing and tetrad dissection 
Strains were crossed and sporulated by standard methods (Stansfield, 2006, Amberg et 
al., 2005). Briefly, haploid strains of MATa and MATα mating types were mixed 
together in a small volume of sterile mQH20 and spread in a small patch on YPAD agar. 
This was incubated overnight at 30°C and diploids were selected on the appropriate 
medium (commonly DOA -Met -Lys for crosses involving BY4741/BY4742 derivatives).  
For sporulation, diploids were grown on GNA medium overnight and then thickly 
patched onto VB Sporulation media and incubated at 26°C for 5-10 days. Sporulation 
of diploids occurs in response to nitrogen starvation and was confirmed by 
visualisation of meiotic tetrad spores under the microscope. Tetrads consist of four 
haploid spores within an ascus (protective sac) and have a distinctive cruciform 
appearance.  Cells were suspended in sterile mQH20 and the asci digested with 
Zymolyase (0.5 mg/ml) for ~10 mins so that tetrad spores could be separated on a 
YPAD agar plate using a tetrad dissection microscope (Sporeplay, Singer instruments). 
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Dissected spores were allowed to grow for 2-3 days at 30°C, patched onto YPAD and 
then screened for the appropriate marker to obtain haploids of the desired genotypes. 
If required, these were confirmed by colony PCR and fluorescent microscopy (Sections 
2.1.8 and 2.3.1).  
2.1.4   Yeast Transformation 
Yeast transformations were carried out using the Lithium acetate/PEG method (Gietz 
and Woods, 2002). Overnight cultures were diluted into fresh media at an OD600 of  
~0.25 and grown for 6 hours to allow at least two doublings. Cells were then harvested 
by centrifugation at 3000 rpm for 2 min, washed once in sterile mQH20 and 
resuspended in 1/50th the culture volume of sterile mQH20 (i.e. 0.5 ml for 25 ml 
culture).  In general 1/5th of this was used per transformation reaction and cells were 
aliquoted and harvested as before. Cell pellets were resuspended in 360 μl of T-Mix 
(33% (w/v) PEG, 0.3 mg/ml boiled single stranded Herring sperm DNA, 0.1 M lithium 
acetate and 34 μl of transforming DNA).  For plasmid transformations a maximum of 
50 ng of DNA was used whereas for PCR generated cassettes the full allowed volume 
(34 μl) was used without dilution to allow an excess for the less efficient process of 
homologous recombination. Transformation reactions were heat shocked at 42°C for 
40 min and then cells were harvested.  Transformed cell pellets were resuspended in 
sterile mQH20, plated on the appropriate selective medium and grown at 30°C for 2-3 
days. For drug selection transformed cell pellets were first resuspended in YPAD 
medium and incubated at 26°C with shaking for 3-4 hours before plating out as above. 
Positive transformants were streaked out on selective agar to single colonies and then 
checked by colony PCR (Section 2.1.8). Usually at least 2 verified clones from each 
transformation were saved as glycerol stocks.  
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2.1.5   Yeast Gene Manipulation 
Knockout and tagging cassettes for transformation were generated using Longtine 
vectors (Longtine et al., 1998) with the appropriate gene-specific primers unless 
otherwise indicated. Gene specific knockout cassettes were amplified by polymerase 
chain reaction (Section 2.1.7) for transformation into the appropriate yeast strain.  This 
method deletes the open reading frame of the gene and replaces it with a marker 
gene. Each set of knockout primers was designed with a gene specific sequence of 
around 50-55 base pairs upstream (forward primer) and downstream (reverse primer) 
of the open reading frame. A forward F1 primer sequence 
(CGGATCCCCGGGTTAATTAA) and a reverse R1 primer sequence 
(GAATTCGAGCTCGTTTAAAC), which are used as generic sequences for amplification of 
the marker gene from a Longtine plasmid template, were added onto the 3’ end of 
these gene specific sequences.  Gene specific primers for amplification were therefore 
generically designed as; Forward 5’-Gene specific sequence-F1-3’ and Reverse 5’-Gene 
specific sequence-R1-3’. 
C-terminal tagging of genes was carried out similarly, except the gene specific forward 
primer was designed just upstream of the stop codon of the gene. A forward F2 primer 
sequence (CGGATCCCCGGGTTAATTAA) and the R1 reverse sequence 
(GAATTCGAGCTCGTTTAAAC) bind within the appropriate Longtine tagging plasmid 
template to amplify the Tag sequence and a marker gene. This generates a cassette 
that excludes the stop codon of the gene and inserts a C-terminal tag followed by the 
ADH1 transcription terminator and a selectable marker gene when transformed into 
the appropriate strain. When necessary to preserve full functionality, the forward 
primer for C-terminal tagging also contained a linker sequence (encoding the amino 
acid sequence GSAGSAAGSG) between the end of the gene specific sequence and the 
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tag. To visualise the nuclear periphery of yeast strains, the nuclear pore complex 
component Nic96 was tagged with 4mCherry as outlined above, using pT909 as the 
template (gift from Tomo Tanaka). Correct integration of gene knockout or C-terminal 
tagging cassettes were confirmed by colony PCR and if appropriate by fluorescence 
microscopy (Sections 2.1.8 and 2.3.1).   
2.1.6  Integration of SUP4 ochre suppressor system 
Plasmids containing the SUP4 ochre suppressor system (Susanne Bandau, unpublished; 
see Appendix) were linearised by restriction digest using MscI and transformed into 
appropriate strains for integration at the his3∆1 locus. The system cassettes contain 
either the wild-type URA3 gene (pSB1) or ura3o22 with a premature stop codon (pSB3) 
as well as the SUP4 suppressor tRNA gene and the NatRMX marker for selection. 
Positive integrants were selected for by growth on YPAD + ClonNAT and verified by 
colony PCRs (Section 2.1.8).  
2.1.7   Polymerase chain reactions for amplification of DNA 
For the amplification of certain cassettes and for colony PCR Taq DNA polymerase 
(prepared as described in Pluthero, (1993)) was used, under the following standard 
reaction conditions: Reactions contained 1× Taq DNA polymerase buffer (10 mM Tris-
HCl pH 8.8, 1.5 mM MgCl2, 50 mM KCl and 0.08% (v/v) NP40), 0.2 mM of each dNTP, 
0.2 μM of each primer, template DNA and Taq DNA polymerase enzyme (typically 1/10 
the final reaction volume). Cycling conditions were 95°C for 1 min then 30-35 cycles of 
denaturation at 95°C  for 30 s, annealing at 55°C  for 30 s and extension at 72°C  for 1 
min/kb product. A final extension step at 72°C for 10 min was always used and the 
annealing temperature was sometimes adjusted based on the melting temperature of 
the primer pair.   
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For the amplification of cassettes where  product fidelity was especially important we 
used Phusion DNA polymerase (Finnzymes) under the following standard conditions: 
Reactions contained 1× Phusion High fidelity polymerase buffer (proprietary), 0.2 mM 
of each dNTP, 0.5 μM of each primer, template DNA and 0.02 U/μl of Phusion DNA 
Polymerase. Cycling conditions were 98°C for 30 s then 25-30 cycles of denaturation at 
98°C for 30 s, annealing at 55°C  for 30 s and extension at 72°C  for 30 s/kb product. A 
final extension step at 72°C for 10 min was always used and the annealing temperature 
was sometimes adjusted based on the melting temperature of the primer pair.  
Template DNA was either plasmid DNA, generally used at no more than 1 ng/μl, or a 
standard yeast genomic DNA prep used at 1/10th the final reaction volume (Section 
2.1.8). A list of primers used in this study are provided in the Appendix.  
2.1.8 Colony PCRs 
For yeast colony PCRs, genomic DNA was prepared by digestion of the yeast cell wall 
by Zymolyase.  A small amount of cells were resuspended in SPZ buffer (1.2 M Sorbitol, 
81 mM Na2HPO4, 19 mM NaH2PO4, 2.5 mg/ml Zymolyase) and incubated at 37°C for 30 
min, then 95°C for 5 min. The reactions were then diluted 10 fold and used as a 
template for colony PCR at 1/10th of the final reaction volume. Amplification is carried 
out using Taq DNA polymerase as described (Section 2.1.7). 
To check for correct integration of cassettes at the target gene locus, primers that bind 
upstream or downstream of the integration were used in combination with primers 
that bind within the integration cassette. Only positive integrants at that locus will give 
a PCR product. Often a PCR reaction diagnostic for negative integration was also 
assayed using primers that amplify a product from within the replaced region.   
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For bacterial colony PCRs, a small amount of cells were resuspended directly in the Taq 
polymerase reaction mix and this was boiled at 95°C for 5 min before PCR amplification 
with appropriate primers.  
2.1.9   DNA sequencing 
DNA sequencing was carried out by the DNA Sequencing Service, University of Dundee 
(http://www.dnaseq.co.uk/). Between 500-600 ng of plasmid DNA was typically sent 
for sequencing along with the appropriate primer at a stock concentration of 3.2 μM. 
For PCR products, typically a 1 in 10 dilution of the final reaction in mQH20 was sent 
directly. Problematic PCR products were treated with Antarctic phosphatase (Section 
2.2) to dephosphorylate residual dNTPs and primers, which would otherwise interfere 
with the sequencing reaction.  
2.1.10  Agarose Gel Electrophoresis 
All PCR and restriction digest reactions were analysed by Agarose gel electrophoresis. 
Gels were made by dissolving 1% (w/v) ultrapure agarose in 1× TAE (40 mM Tris, 0.1% 
Acetic acid, 1 mM EDTA) buffer by boiling. This mixture was cooled before adding 5 
μl/100 ml of SYBR Safe gel stain, to allow visualisation of DNA bands by UV exposure. 
The gel was poured and allowed to set. DNA samples were mixed with 6x DNA loading 
dye (10 mM Tris-HCl pH 7.6, 0.15% (w/v) orange G, 0.03% (w/v) xylene cyanol FF, 60% 
(v/v) Glycerol, 60 mM EDTA) before loading. Gels were run at 120 V for 30-45 min in 1× 
TAE running buffer and DNA Hyperladder I (Bioline) was used as size markers.  
2.1.11  Mutant elp1 Plasmids 
All elp1 mutant plasmids used in this study were synthesised by DNA2.0 
(https://www.dna20.com/) and the mutations made are listed elsewhere (Figure 3.1). 
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These were generated from YCplac111-ELP1-6HA  by replacing the relevant part of the 
gene with a synthesized elp1 mutant sequence. The original YCplac111 vector was 
used as an empty vector control (Gietz and Akio, 1988). 
2.1.12  Site Directed Mutagenesis by ‘delitto perfetto’ 
The ‘delitto perfetto’ method allows for ‘clean’ integrations as site directed mutations 
are introduced into a gene of interest without the need for marker selection (Storici 
and Resnick, 2006).  A region within the gene of interest is first replaced with a marker 
cassette, which in turn is replaced by a mutant sequence. This second event is 
identified by counterselection for the marker.  
A CORE knockout cassette containing the KlURA3 and KanMX6 markers was amplified 
using Taq DNA polymerase and pCORE (Storici and Resnick, 2006) as a template. The 
primers appended forward P1 (GAGCTCGTTTTCGACACTGG) and reverse P2 
(TCCTTACCATTAAGTTGATC) plasmid specific sequences onto ~50 bps ELP1 specific 
sequence. The cassette was transformed into appropriate stains to replace the region 
of ELP1 encoding amino acids 1164-1277. Positive elp1::CORE transformants were 
selected by growth on DOA -Ura and confirmed by growth on YPAD + G418 and colony 
PCR.   
Primers flanking the deleted region of ELP1 were used to amplify a replacement 
sequence from YCp-ELP1-6HA or the equivalent mutant vector using Phusion DNA 
polymerase. These were transformed into elp1::CORE strains to reconstitute the 
deleted region with the wild type or mutant ELP1 sequence. Transformants were 
grown on YPAD at 30°C overnight and then replica plated twice over 2 days on 5-FOA 
medium to select for loss of the KlURA3 marker. Positive transformants were further 
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confirmed by lack of growth on YPAD + G418, colony PCR and sequencing across the 
replaced region. 
2.1.13  Elongator “switch off” strain construction and analysis 
To generate strains in which Elp1 levels were controlled through fusion to an Auxin 
inducible degron (Nishimura et al., 2009) , a strain that expressed TIR1-9myc under the 
control of the ADH1 promoter was made. The pNHK53 plasmid (kind gift from Tomo 
Tanaka) containing the OsTIR1-9myc gene under control of the ADH1 promoter was 
linearised by restriction digest using SphI. This unique restriction site is within the 
ADH1 promoter sequence and generates a cassette that can be integrated at the 
endogenous ADH1 promoter. This cassette was transformed into a strain expressing C-
terminal 3HA tagged Elp1 and selected for by growth on DOA -Ura. Colony PCR was 
used to distinguish single and multiple integration at the ADH1 locus. Primers were 
then designed for C-terminal tagging of Elp1-3HA with an auxin inducible degron 
sequence (AIDD17) using pT1450 as a template (kind gift from Tomo Tanaka). The 
tagging cassette was transformed into a single integrant TIR1-9myc strain to replace 
ELP1-3HA-HIS3MX with ELP1-3HA-AID-NatRMX.  Transformants were selected for by 
growth on YPAD+ ClonNAT, checked for lack of growth on DOA-His and verified by 
colony PCR.  
For inducible inactivation of Elongator through in vivo C-terminal truncation of Elp1, a 
previously made strain containing a pGAL-TEV-3myc-HIS3MX cassette integrated in 
multicopy at the TRP1 locus (Charlotte Lloyd, unpublished) was used. This was crossed 
with a MATα strain to generate pGAL-TEV-3myc-HIS3MX containing haploids of the 
opposite mating type. These were crossed with a strain containing ELP1-3HA disrupted 
with a pCORE cassette (elp1::CORE-3HA).  Haploids containing both the pGAL-TEV-
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3myc-HIS3MX and elp1::CORE-3HA loci in the MATa mating type were selected for and 
verified by colony PCR. The CORE cassette in these strains was reconstituted by ‘delitto 
perfetto’ using a version of ELP1 encoding a TEV protease cleavage site (ENLYFQGDDV) 
immediately before Ser-1202 in Elp1 using the YCp-Elp1::TEV-6HA plasmid as template. 
Thus induction of TEV protease expression by growth on galactose results in cleavage 
of the last 147 amino acids of Elp1.  Strains were verified using colony PCR and 
sequencing across the replaced region of Elp1.  
Cleavage/degradation of Elp1 in our strains was analysed by time course experiments. 
TEV cleavage strains were grown overnight in YPAR (2% raffinose), inoculated into 
fresh YPAR medium at an OD600= 0.2 and grown at 30°C for two doublings. A sample of 
cells equivalent to 10 OD600 units was harvested, washed with 1x Phosphate buffered 
saline (PBS) and the pellets snap frozen in liquid nitrogen and stored at -80°C (‘Pre’ 
sample).  Cultures were harvested at 3000 rpm for 1 min and resuspended at OD600= 
0.5 in YPARG (2% raffinose, 2% galactose). Additional 10 OD600 samples were taken at 
0, 30, 60, 90, 120, 150, 180, 210 min after switching to YPARG medium. As a control a 
small scale glucose switch culture was also grown and samples were taken 0 and 210 
min after inoculating into YPAD (2% glucose).  
Auxin inducible degron strains were inoculated from overnight cultures into fresh 
YPAD (2% glucose) media at an OD600= 0.1 and grown at 30°C for around two 
doublings. A 10 OD600 unit sample was processed as above (‘Pre’ sample) and then 0.5 
mM of 1-naphthalene acetic acid (NAA), an auxin related compound, was added to 
cultures. Additional 10 OD600  unit samples were taken at 0, 15, 30, 60, 90, 120, 150, 
180, 360 min after NAA addition to the medium.  
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The pelleted samples from each experiment were all processed in parallel by the 
NaOH/TCA protein extraction method and analysed by western blotting (Sections 2.4.1 
and 2.4.7).  
2.2 Molecular Cloning 
Cloning was carried out using standard methods (Sambrook and Russell, 2001) and all 
kits and reagents were used according to manufacturer’s instructions unless otherwise 
stated. Restriction enzymes were supplied by New England Biolabs (NEB) or 
Fermentas.  
For restriction digests, typically up to 0.5-1 μg of plasmid DNA or insert was digested in 
a final reaction volume of 25 μl, containing 1× reaction buffer and 10 units of each 
restriction enzyme. Reactions were incubated at the appropriate temperature for 1-1.5 
hours and either heat inactivated or immediately separated by agarose gel 
electrophoresis. For fast digest enzymes (Fermentas), reactions were incubated for 20 
min only. 
Plasmid vectors and inserts digested with the appropriate restriction enzymes and 
purified using a Gel extraction kit (QIAGEN) after separation by agarose gel 
electrophoresis.  Briefly, bands were visualised and cut from the gel. The appropriate 
volume of QG buffer (20 mM Tris HCl pH 6.6, 5.5 M GuSCN) was added to the gel piece 
and this was incubated at 50°C until the agarose dissolved. DNA was bound to a silica 
column by spinning at 10,000 × g for 1 min and then washed with QG buffer and PE 
buffer (10 mM Tris-HCl pH 7.5, 80% ethanol). The DNA was eluted in 10 mM Tris-HCl 
pH 8.5 or mQH20. 
 65 
 
To reduce background from self-ligation of single cut vectors, plasmid digests were 
treated with 5 Units of Antarctic phosphatase (NEB) in 1× Antarctic phosphatase buffer 
(5 mM Bis-Tris-Propane-HCl , 0.1 mM MgCl2, 10 μM ZnCl2 pH 6.0) for 30 min-1 hour at 
37°C and then reactions were heat inactivated at 75°C.  
Ligations were carried out using the Rapid DNA ligation kit (Roche) in general using 1:3 
or 1:5 molar ratio of vector to insert. The insert and vector were mixed and added to 
an equal volume of 2× T4 DNA ligase buffer (usually to a final volume of 20 μl) and 5 U 
of T4 DNA ligase. Reactions were left at room temperature for 30 min - 2 hours and 
transformed directly into competent DH5 alpha E. coli (Section 2.2.5). Usually no more 
than 1/20th of the ligation reaction was used for bacterial transformation and reactions 
omitting DNA ligase were used as negative controls.   
Plasmids were purified from E. coli with a Plasmid miniprep kit (Bioline) using 5 ml or 
10 ml overnight cultures for high copy and low copy plasmids respectively, with 
appropriate selection. In brief, cultures pellets were lysed in alkaline NaOH/SDS buffer 
for no more than 5 min.  Lysates were then neutralised in a high salt buffer and 
precleared by centrifugation at 20,000 × g for 10 mins. Lysates were passed through a 
silica column by spinning at 10,000 × g for 1 min and then DNA bound to the column 
was washed with an acidic/salt buffer and then an ethanol based buffer. Plasmid DNA 
was eluted from the column using 10 mM Tris-HCl pH 8.5 or mQH20. 
Details of plasmids used and/or generated in this study are provided in the Appendix. 
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2.2.1  Cloning part of the Elp1 C-terminal domain into the GFP tagging vector pUG34 
Sequences encoding part of the Elp1 C-terminal domain (amino acids 1181-1349) were 
amplified using Phusion DNA polymerase with primers containing built in SpeI 
(Forward primer) and XhoI (Reverse primer) restriction sites. The plasmid YCp-ELP1-
6HA (or the equivalent plasmid carrying mutations in the basic region) were used as 
templates. The amplified Elp1 C-terminal sequences were subcloned using blunt end 
ligation into the pJET1.2 vector (Thermo scientific) and verified by diagnostic 
restriction digests and sequencing across the insert. The C-terminal fragments were 
then digested out from pJET1.2 using SpeI and XhoI enzymes and cloned into 
complementary sites in the pUG34 N-terminal green fluorescence protein (GFP) 
tagging vector.  Diagnostic restriction digests were used to verify integration of the C 
terminal fragments.  
2.2.2  Cloning the NES from HIV Rev into pFa6a-GFP(S65T)-HIS3MX6 
Complementary primers encoding nuclear export sequence (NES) from HIV Rev were 
designed containing BamHI (forward) and PacI (reverse) overhangs. These primers 
were mixed in a 1:1 molar ratio (0.1 μM each), placed in boiling water and then 
allowed to cool slowly to room temperature for annealing to form a double stranded 
NES insert sequence. The annealed template was cloned between BamHI and PacI 
sites in frame with the GFP coding sequence in the Longtine pFa6a-GFP(S65T)-
HIS3MX6 plasmid to make pFa6a-NES-GFP(S65T)-HIS3MX6. Positive clones were 
verified by bacterial colony PCR and sequencing across the cloned sequence. The final 
cloned plasmid was used as a template for C-terminal tagging of ELP1 with an NES 
sequence. 
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2.2.3  Cloning the NLS from Cbp80 into pFa6a-GFP(S65T)-HIS3MX6 
A 462 bp dsDNA sequence (‘gBlock’; Integrated DNA technologies) was synthesised 
and used to replace the plasmid sequence between endogenous PacI and BsrGI sites in 
pFa6a-GFP(S65T)-HIS3MX6. The PacI and BsrGI restriction sites lie upstream and within 
the GFP gene respectively. The gBlock was designed to reinstate the plasmid sequence, 
but with the inclusion upstream of the GFP gene of a sequence encoding the first 30 
amino acids of the Cap binding protein 80 (Cbp80). This sequence contains a strong 
nuclear localisation sequence (NLS, Rahl et al., 2005). A mutant NLS version of this 
construct containing four alanine substitution mutations was also similarly generated.  
The ‘gBlocks’ (100 ng) were digested with PacI and BsrGI and cloned between the 
equivalent sites in pFa6a-GFP(S65T)-HIS3MX6, creating a plasmid with the Cbp80 NLS 
or mutant NLS encoded upstream of the GFP gene.  Positive clones were verified by 
diagnostic restriction digests and sequencing across the cloned sequence. The final 
cloned plasmids pFa6a-NLS(Cbp80)-GFP(S65T)-HIS3MX6 and pFa6a-NLS4A(Cbp80)- 
GFP(S65T)-HIS3MX6 plasmids were used as templates for C-terminal tagging of ELP1.  
2.2.4  Cloning the C-terminal domain of Elp1 into pGEX4T-1  
For recombinant expression of Elp1, primers were designed to amplify the region 
encoding the C-terminal half (amino acids 730-1349) with built in EcoRI (forward 
primer) and XhoI (reverse primer) restrictions sites. The reverse primer also included a 
His6 tag. This region of Elp1 is predicted to be mainly alpha helical. The C-terminus was 
amplified using Phusion DNA polymerase and genomic DNA preps from ELP1-GFP and 
elp1-KR9A-GFP strains as template. The amplified C-terminal sequence was cloned 
between EcoRI and XhoI sites in the Glutathione-S-transferase (GST) fusion expression 
vector pGEX4T-1 (kind gift from Angus Lamond).  Positive clones were verified by 
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diagnostic restriction digests and DNA sequencing across the cloned insert in both 
directions to ensure there were no PCR based mutations.  
2.2.5  Bacterial plasmid transformations  
Bacterial transformations were carried out in chemically competent DH5 alpha E. coli 
(F– Φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17 (rK
–, mK
+) phoA supE44 λ– 
thi-1 gyrA96 relA1) as previously described (Sambrook and Russell, 2006). Briefly, 
around 50-100 ng of plasmid DNA was added to competent E. coli cells and incubated 
for 30 min on ice with intermittent gentle swirling to mix. The cells were heat shocked 
for 90 sec at 42°C and immediately replaced on ice to recover for 2 min. Cells were 
allowed to recover in Super optimal broth (SOC) medium at 37°C with shaking for 45 
min before being plated on Luria broth (LB) agar with plasmid selection (normally 
Ampicillin, abbreviated Amp). Transformation plates were grown overnight at 37°C and 
single colonies were inoculated into liquid LB with selection. These were cultured at 
37°C overnight with shaking and plasmids isolated (Section 2.2).  
For transformation of expression plasmids into chemically competent BL21 (DE3) E. 
coli (Stratagene:  F– ompT gal dcm lon hsdSB(rB
– mB
–) λDE3 [lacI lacUV5-T7 gene 1 ind1 
sam7 nin5]). The manufacturer’s protocols were followed but differ from the above 
only in the time of heat shock at 42°C, which is reduced to 20 s. For long term storage 
of plasmid containing strains liquid overnights from single colonies were stored at -
80°C in 20% (v/v) glycerol. 
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2.3 Fluorescence Microscopy 
2.3.1  Checking yeast strains for fluorescent protein-tagged fusions 
To check strains for expression of fluorescent protein-tagged fusions, cells from 
overnight cultures were harvested by centrifugation at 3000 rpm for 2 min and washed 
once with sterile mQH20.  Cell pellets were resuspended in low fluorescence synthetic 
complete (SC) medium or the appropriate selective medium and a small volume was 
inoculated onto a microscope slide and compressed with a coverslip. Cells were 
visualised with a Delta Vision RT microscope (Applied Precision) connected to a CCD 
camera (CoolsnapHQ / ICX285) using the appropriate channel setting to assay for a 
particular fluorescent tag. 
2.3.2  Preparing fixed log phase yeast cells for fluorescence imaging 
For fixed cell imaging, strains from overnight cultures were subcultured to log-phase 
(OD600~ 1 ) at 30°C in the appropriate medium, allowing at least 2 doublings. Strains 
containing pUG34-ELP1-CTD plasmids were cultured in DOA -His -Met media to select 
for the plasmid and to induce the GFP tagged C-terminus. Strains containing genomic 
GFP tagged fusions were grown without selection in YPAD. The equivalent of 4.5 OD600 
units (4.5 ml culture at OD600=1) of each strain was fixed by adding formaldehyde at 
3.7% (v/v) for 30 min with gentle agitation.  Cells were harvested at 3000 rpm for 2 
min, washed three times with 1× PBS and pipetted onto 0.2% (w/v) Concanavalin A 
(Sigma) treated coverslips. After immobilising for ~3-5 min, coverslips were placed on 
microscope slides onto which a small spot of antifade solution (0.5% (w/v) p-
phenylenediamine, 20 mM Tris pH 8.8, 90% (v/v) glycerol) had been placed and then 
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sealed with nail varnish. Slides were allowed to dry for at least 2 hours, stored in the 
dark and imaged within 4 days. 
2.3.3  Acquisition of 2D fluorescent images 
Cells were visualised with a Delta Vision RT microscope (Applied Precision) connected 
to a CCD camera (CoolsnapHQ / ICX285) using an 100x lens (Olympus 1X-71) and 1.514 
immersion oil. 2D images (512 x 512) were captured with Bin 2 x 2 mode (0.132 μm 
pixel size) under the following standard conditions;  
Excitation/Emission Channel:  mCherry, Exposure: 0.5 sec, ND filter: 100% 
Excitation/Emission Channel: YFP-ET, Exposure: 1 sec, ND filter 100% 
Excitation/Emission Channel: OPEN, Exposure: 0.05 sec, ND filter 10%  
Flat field calibration was carried out before imaging for the YFP-ET channel using a 
fluorescent calibration slide (488-519 nm, Applied Precision) and applied during image 
acquisition. The mCherry exposure was sometimes altered within the range 0.35- 1 sec 
across experiments depending on factors such as bulb strength and age of slide. In any 
given experiment all settings were constant across samples and each field of view 
focused so the majority of cells were imaged through the middle of the cell. For 
quantification experiments at least 5-10 different fields of view were captured for each 
sample. Images were initially visualised using SoftWoRx (Applied Precision). 
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2.3.4  Quantification of 2D fluorescent images 
Raw images were visualised and processed for figures using OMERO insight v4.4.0 
(Allan et al., 2012). Quantification of raw images was performed using Volocity 6.0 
(Perkin Elmer) and data processed with Microsoft Excel (Office 2010).  Briefly, 
quantification protocols identified whole cell objects using YFP-ET channel and nuclear 
objects using the mCherry channel. The intensity values were calculated for each 
compartment and the GFP signal within the nucleus intersected with the whole cell 
object.  Thresholds for identification of whole cell objects were applied using strains 
without a GFP tag as a guide to identify intensities generated by autofluoresence. The 
intensity information for each object was exported to Microsoft Excel and averages 
were calculated for each set of images.  
 
2.4 Protein Biochemistry 
2.4.1  Protein extraction using NaOH/TCA method 
Strains were grown to log phase (OD600~ 1 ) and typically 5-10 OD600 units were 
harvested by centrifugation at 3000 rpm, 2 min. Yeast protein extracts were prepared 
using the NaOH-TCA method (Horvath and Riezman, 1994) as follows. Cell pellets were 
resuspended in 200 μl of NaOH buffer (1.85 mM NaOH, 7.4% (v/v) β-mercaptoethanol) 
by vortexing and incubated on ice for 10 min. An equal volume of 20% (v/v) TCA was 
added, mixed by inverting and incubated on ice for a further 10 min.  Protein pellets 
were harvested at 14,000 rpm for 2 min, washed with acetone and allowed to air dry 
briefly. Pellets were incubated with 200 μl of 2× Laemmli buffer (125 mM Tris-HCl pH 
6.8, 4% (w/v) SDS, 20% (v/v) glycerol, 0.01% (w/v) Bromophenol Blue, 5% (v/v) β-
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mercaptoethanol) for 10 min at room temperature then resuspended by disrupting the 
pellet with a pipette tip. Samples were incubated at 75 °C for 15 min and centrifuged 
at 14,000 rpm for 30 sec. The supernatant containing dissolved proteins was removed 
into a fresh tube and 5-10 μl used for SDS-PAGE analysis (Section 2.4.5).  
2.4.2  Yeast protein extraction by bead beating lysis 
Strains were grown to log phase (OD600~ 1 ) and typically 50-100 OD600 units (50-100 ml 
at an OD600=1) were harvested by centrifugation at 3000 rpm, 2 min. Cell pellets were 
snap frozen and stored at -80°C until use. Lysis by bead beating was used to prepare 
yeast protein extracts as described below. To minimise protein degradation all further 
steps are carried out at 4°C. 
Pellets were defrosted slowly on ice and resuspended in cold Lysis Buffer (50 mM 
HEPES pH 7.5, 2 mM MgCl2, 150 mM NaCl, 0.1% (v/v) Triton X-100, 50 mM NaF, 50 mM 
Na-β-glycerophosphate) supplemented with Complete EDTA free Protease inhibitor 
(Roche), PhosSTOP (Roche), 1 mM AEBSF and 2 mM Na3VO4 . Typically 10 μl /OD600 was 
added to pellet (i.e. 0.5 ml to 50 OD600 unit pellet).  The resuspended cell pellets were 
added to 1.5 ml screw cap tubes filled two thirds full with cold 0.5 mm glass beads 
(BioSpec products) so that liquid and beads completely filled the tube. If necessary 
multiple tubes were set up to accommodate each resuspended pellet and these were 
mixed well by vortexing. Cells were lysed using a bead beater (BioSpec products) at 
intervals of 4 × 30 sec with 1 min hold and then 2 × 1 min with 2 min hold. Cell 
suspensions were checked using a bright field microscope (Zeiss) and typically around 
70-90% cell lysis was achieved. Lysates were separated from the glass beads by 
pricking the bottom of the screw cap tubes with a microlance syringe needle and 
quickly placing into 1.5 ml microfuge tubes on ice, followed by centrifugation at 3000 
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rpm for 30 sec. Lysates were then cleared by centrifugation at 14,000 rpm for 10 min 
and the supernatant removed into a fresh tube. For larger cultures, above 100 OD600, 
resuspended cell pellets were added to 7 ml specimen tubes filled two thirds full with 
cold 0.5 mm glass beads. Cell lysis by bead beating was as described above but using 
the larger sized tube holder for the bead beater.  
Protein extracts were normalised using Bradford Coomassie reagent (Pierce) by 
standard methods. Briefly, a dilution of protein extract (typically 1 in 10) was added to 
Bradford reagent and then OD595 values were measured. Protein concentrations were 
estimated using the relationship Absorbance OD595 /(mg/ml) = 0.05.  
2.4.3  Expression, purification and coupling of GFP-Trap to Sepharose 
GFP-Trap is a single heavy chain antibody derived from Llama which recognises GFP 
(Rothbauer et al., 2008). GFP-Trap was expressed from a pGEX4T-1 plasmid in BL21 
(DE3) E. coli (kind gift from Angus Lamond), purified using standard GST affinity 
purification techniques (GE Healthcare, 2012) and coupled to cyanogen bromide 
(CNBr) activated Sepharose.  
For expression of GFP-Trap, starter cultures in LB-Amp were grown at 37°C with 
shaking for 8-12 hours and then inoculated 1 in 100 into Autoinduction medium 
containing Amp (i.e. 5 ml starter in 500 ml). Expression cultures were grown at 25°C 
with shaking for 72 hours and induction of GST tagged GFP-Trap occurred upon 
saturation of the culture. Cultures were harvested by centrifugation at 5250 × g, 4°C 
with slow deceleration and pellets were resuspended (25 ml/500 ml culture) in cold 1× 
PBS with Complete EDTA Protease inhibitors (Roche). The resuspended pellets were 
snap frozen and stored at -80°C. Unless stated otherwise all further steps were carried 
out at 4°C to minimise protein degradation. 
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For lysis, resuspended pellets were defrosted slowly and then treated with Lysozyme 
(1 mg/ml, Sigma) for 30 min with rotation. The lysates were supplemented with MgCl2 
to 10 mM and treated with DNase I (~4 μg/ml, Sigma) for a further 30 min.  Finally, 
Triton X-100 at 1% (v/v) was added and lysates were sonicated on ice with 10 sec 
bursts at 60% power until no longer cloudy (typically 40 sec total). Sonicated lysates 
were cleared by centrifugation at 20,000 × g for 30 min and the supernatant retained 
for affinity purification using the GST tag.  
Lysates were added to Glutathione-Sepharose Fast flow 4 resin (GE Healthcare) 
prewashed with 1× PBS (2 ml bead resin/ 500 ml culture) and incubated overnight with 
end-over rotation. The resin was harvested at 1000 rpm and washed twice with 1 x PBS 
before being added to a purification column (Pierce). The resin was further washed by 
gravity flow with 30 ml 1× PBS, 20 ml 1× Tris buffered Saline (TBS) and then 20 ml 1× 
Thrombin cleavage buffer (50 mM Tris HCl pH 8, 10 mM CaCl2
 ). The resin was 
incubated with 10 U of Thrombin in 1× Thrombin cleavage buffer at room temperature 
overnight for cleavage of the GST tag. The GFP-Trap protein was eluted from the 
column at room temperature using 10 ml 1× Thrombin cleavage buffer and fractions 
were collected and analysed by SDS-PAGE (Section 2.4.5). The concentration of GFP-
Trap was determined by absorbance at 280 nM using the calculated extinction 
coefficient. 
Fractions containing GFP-Trap were pooled and coupled to CNBr Sepharose (GE 
Healthcare) at a concentration of 5-10 mg/ml protein per ml of Sepharose, as follows. 
GFP-Trap was dialysed overnight using 6-8 kDa cut off dialysis tubing (SpectroPor) into 
CNBr Sepharose coupling buffer (0.1 M Na2CO3, 0.5 M NaCl pH 8.3) and concentrated 
using a 10 kDa cut off column (Amicon), if required. CNBr Sepharose was rehydrated in 
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10 mM HCl for 30 min at room temperature, pelleted by centrifugation at 1000 rpm 
and then washed three times with 10 mM HCl. Working quickly, the beads were 
washed in CNBr coupling buffer and then completely drained. Purified GFP-Trap was 
added to the beads to make a 50% slurry and then left to couple for 2-8 hours at room 
temperature with gentle rotation. The beads were pelleted and then blocked with 10 
bead volumes of 100 mM Tris-HCl pH 7.4 for 8 hours at room temperature with gentle 
rotation. The GFP-Trap Sepharose was stored at 4°C as 50% slurry in TBS with 0.02% 
(v/v) sodium azide.  
2.4.4  GFP tagged protein pulldowns using GFP-Trap Sepharose 
Protein extracts from GFP tagged strains, made by bead beating lysis, were normalised 
typically to ~8 mg/ml in cold Lysis Buffer (50 mM HEPES pH 7.5, 2 mM MgCl2, 150 mM 
NaCl, 0.1% (v/v) Triton X-100, 50 mM NaF, 50 mM Na-β-glycerophosphate) 
supplemented with Complete Protease Inhibitors (Roche), PhosSTOP (Roche), 1 mM 
AEBSF and 2mM Na3VO4.  To minimise protein degradation extracts were kept on ice 
or at 4°C throughout. A small sample (1/10th volume) of each normalised extract was 
added to an equal volume of 2× Laemmli buffer and incubated at 75°C for 15 min; this 
served as the input sample.  
Protein extracts were precleared with Sepharose-4B beads (Sigma) for 30 min with 
end-over rotation. In general 0.5 μl of bead slurry was used per 1 OD600 unit of extract 
(i.e. 25 μl was used for 50 OD600 units of cells).  Precleared extracts were harvested by 
centrifugation at 1000 rpm for 1 min and added to GFP-Trap slurry for 2 hours with 
end-over rotation. In general 1 μl of GFP-Trap slurry was used per 1 OD600 unit of 
extract (i.e. 50 μl was used for 50 OD600 units of cells). GFP-Trap pulldowns were 
harvested by centrifugation at 1000 rpm for 1 min. A small sample (1/10th volume) of 
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the supernatant was added to an equal volume of 2× Laemmli buffer and incubated at 
75°C for 15 min, this served as the flow through sample.  GFP-Trap pulldown beads 
were washed three times with Lysis buffer and proteins were eluted from the beads by 
adding 50 μl 2× Laemmli buffer and incubating at 75°C for 15 min. This elution step 
was repeated twice and the two sequential eluates were pooled.  
In general, for GFP pulldowns to assay complex assembly the equivalent of 50 OD600 
units of cells were used and for pulldowns coupled to mass spectrometry 250 OD600 
units were used.  
2.4.5  Separation of proteins by SDS-PAGE 
Precast 4-12% NuPage Bis-Tris Gels  were used to separate protein samples in 1× 
MOPS SDS running buffer (50 mM MOPS, 50 mM Tris Base, 0.1% SDS, 1 mM EDTA, pH 
7.7, LifeTech) supplemented with NuPage Antioxidant (Proprietary). Gels were run in 
an XCell Surelock electrophoresis tank at 200V for 60-80 min and then either stained or 
used for western blotting. All equipment and reagents were supplied by Novex.   
2.4.6  Protein Gel staining 
Gels were added to Instant Blue stain (Expedeon) in petri dishes with gentle agitation 
for 1 hour-overnight and protein bands visualised with a light box. For SYPRO Ruby 
staining (Molecular probes) gels were first fixed with 50% methanol, 7% acetic acid for 
60 min and then stained overnight with SYPRO Ruby in foil wrapped petri dishes with 
gentle agitation. Gels were then washed once with 10% methanol, 7% acetic acid for 
30 min , rinsed with mQH20 and then scanned using a fluorescent image analyser (FLA-
5100 Fujifilm) using the LPB setting (473 nm).  
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2.4.7  Western Blotting 
Protein samples separated by SDS-PAGE were electrotransferred to a PVDF membrane 
(Immobilon) in 1× Towbin buffer (25 mM Tris, 192 mM glycine, 10% methanol).  
Briefly, the membrane was activated using Methanol before being placed over the 
SDS-PAGE gel and sandwiched between two filter papers and two foam sponges, 
rolling out all air bubbles between layers. This was sealed inside a transfer cassette and 
placed into a Mini Trans Blot tank (Bio-Rad) with the gel side nearest the cathode. 
Transfer was carried out at 100 V for 60-80 min with an ice pack for cooling. 
Membranes were then blocked with gentle agitation for 1 hour in TBS-T (Tris buffered 
saline, 0.02% (v/v) Tween) with 5% (w/v) dried non-fat milk. When using 
phosphospecific antibodies milk was substituted with 4% (w/v) Bovine serum albumin 
(BSA). Primary antibodies were diluted in the equivalent blocking solution and added 
to membranes overnight at 4°C with rotation. After incubation with primary antibody 
membranes were washed three times for 10 min with TBS-T before being incubated 
with the appropriate secondary antibody conjugated to horse radish peroxidase (HRP). 
All secondary antibodies were diluted 1 in 10,000 in 5% (w/v) dried non-fat milk TBS-T 
and incubated with blots for 1 hour with rotation. The blots were washed three times 
for 10 min with TBS-T before being developed using Enhanced Chemiluminescent HRP 
Substrate (Immobilon) and visualised using the LAS-4000 chemiluminescence imager 
(Fujifilm).  Details of all antibodies used in this study are shown in Table 2.2. Analysis 
by densitometry of bands was carried out using Aida Image Analyzer v.3.27 and values 
exported to Microsoft Excel (Office 2010). Statistical analyses were carried out using 
SigmaPlot 12.0 (Systat Software, Inc). 
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Table 2.2. Antibodies used in this study 
Antibody Dilution Host Source Code 
Anti-GFP 1 in 1000 Mouse Roche 11814460001 
Anti-HA 1 in 3000 Mouse Santa Cruz sc-7392 
Anti-Cdc28 1 in 10,000 Goat Santa Cruz sc-6709 
Anti-Myc 1 in 10,000 Rabbit Santa Cruz sc-789 
Anti-His 1 in 5000 Rabbit Santa Cruz sc-803 
Anti-GST 1 in 5000 Mouse Sigma G1160 
Anti-pSer 1 in 1000 Rabbit ImmunoK 220-15-1PSER 
Anti-1209p-Elp1 1 in 3000 Rabbit This Study - 
Anti-Non phospho-Elp1 1 in 3000 Rabbit This Study - 
Anti-Mouse IgG 1 in 10,000 Donkey GE Healthcare NA931V 
Anti-Rabbit IgG 1 in 10,000 Donkey Santa Cruz sc-2004 
Anti-Goat IgG 1 in 10,000 Donkey Santa Cruz sc-2020 
 
2.4.8  Antibody Production 
An anti-phospho-1209S Elp1 antibody was generated for use in this study using a 
peptide antigen and Rabbit hosts. The peptide sequence used for immunisation was 
H2N-CTSTQE-pS-FFTRY-CONH2 where pS indicates phosphoserine. The antipeptide 
antibody was produced and purified by Biogenes using standard procedures as 
indicated on their website (http://www.biogenes-antibodies.com). Briefly, the 
phosphospecific fraction of the final bleed was purified by serum depletion using 
immobilised non-phosphorylated peptide (H2N-CTSTQESFFTRY-CONH2). The 
phosphospecific antibodies were then isolated from the depleted serum using the 
immobilised phosphopeptide. This procedure also generated a non-phosphospecific 
fraction from the first step. The purified antibody was tested for phosphospecificity by 
loss of signal against protein extracts prepared from an elp1-1209A mutant and by 
competition with the phosphopeptide. The antibody was stored at -20°C in 50% (v/v) 
glycerol and the conditions for use are described (Table 2.2). A small excess of the non-
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phosphorylated peptide was normally added to the primary dilution before use to 
prevent any cross-reaction with the non-phosphorylated epitope.  
2.4.9  Expression and purification of the Elp1 C-terminal domain 
The C-terminal domains of Elp1 and Elp1-KR9A were expressed from a pGEX4T-1 
plasmid transformed into BL21 (DE3) E. coli (Stratagene). The constructs express these 
proteins with an N-terminal GST tag and C-terminal His6 tag for dual affinity 
purification. A GST-His6 plasmid was expressed and purified alongside these as a 
control (kind gift from Tom Owen Hughes).  
For expression of the Elp1 and Elp1-KR9A fusion proteins, starter cultures in LB-Amp 
were grown at 37°C with shaking for 8-12 hours and then inoculated 1 in 50 into 
Autoinduction medium with Amp (i.e. 10 ml starter into 500 ml). Expression cultures 
were grown at 30°C with shaking for 4-5 hours and then the temperature was reduced 
to 25°C overnight. Expression was induced upon saturation of cultures and was tested 
by taking a small sample of culture and boiling in an equal volume of 2× Laemmli 
buffer for western blotting against affinity tags.  
Cultures were harvested by centrifugation at 5250 × g, 4 °C with slow deceleration and 
pellets were resuspended (25 ml/500 ml culture) in cold Lysis buffer (20 mM Tris HCl 
pH 7.5, 300 mM NaCl) supplemented with Complete EDTA free Protease inhibitors 
(Roche). The resuspended pellets were snap frozen and stored at -80°C. All further 
steps are carried out at 4°C to prevent protein degradation.  
For lysis, resuspended pellets were defrosted slowly and then treated with Lysozyme 
(1 mg/ml, Sigma) for 30 min with rotation. The lysates were supplemented with MgCl2 
to 10 mM and treated with DNAse I (~4 μg/ml, Sigma) for a further 30 min. Lysates 
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were sonicated on ice with 10 sec bursts at 60% power until no longer cloudy (typically 
40 sec total) and lysis was checked by bright field microscopy. Sonicated lysates were 
cleared by centrifugation at 20,000 × g for 30 min and the supernatant used for affinity 
purification.  
Lysates were added to HisPur Cobalt resin (Thermo scientific) prewashed with Lysis 
Buffer (1 ml bead resin/500 ml culture) and incubated for 2 hours at 4°C with rotation. 
The resin was harvested at 1000 rpm and added to a purification column (Pierce). The 
resin was further washed by gravity flow with 20 ml of Lysis Buffer and then His6 
tagged proteins were eluted using 1 ml, 2 ml and 3 ml of HisPur Elution Buffer (20 mM 
Tris HCl pH 7.5, 300 mM NaCl, 300 mM Imidazole). For each elution step the resin was 
incubated in HisPur Elution Buffer for 10 min with rotation before the eluate was 
collected by gravity flow.  
Eluates from the HisPur resin were pooled and Dithiothreitol (DTT) to 10 mM was 
added. The HisPur eluate was added to Glutathione-Sepharose Fast Flow 4 resin (GE 
Healthcare), prewashed with HisPur Elution buffer (2 ml bead resin/500 ml culture) 
and incubated for 3 hours with rotation. The resin was harvested at 1000 rpm and 
washed with 10 ml HisPur elution buffer before being added to a purification column 
(Pierce). The resin was further washed by gravity flow with 20 ml Lysis Buffer and then 
GST tagged proteins eluted with 2 ml then twice with 3 ml of GST elution buffer (50 
mM Tris HCL pH 8, 50 mM reduced Glutathione). For each elution step the resin was 
incubated in GST elution buffer for 10 min at 4°C with rotation before the eluate was 
collected by gravity flow.  
Eluates from the Glutathione resin were pooled and diafiltered into Protein Binding 
Buffer (20 mM Tris HCl pH 7.5, 150 mM NaCl, 2 mM MgCl2) using a 10 kDa cut off 
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column (Amicon) according to manufacturer’s instructions. Briefly, the pooled eluates 
were added to the column, made up to 10 ml with Protein binding buffer and 
concentrated 10-20 fold by centrifugation at 14,000 rpm for 10-15 min. This step was 
repeated twice and then the concentrated eluate was collected.  
The recombinant protein preps were stored at -20°C in 50% glycerol until use when 
they were diafiltered back into Protein Binding Buffer as above. Recombinant proteins 
were normalised by absorbance at 280 nM using the extinction coefficient of the full 
length tagged proteins. Throughout the purification, samples of inputs, bound, 
flowthroughs, eluates and post elution bound were boiled in 2× Laemmli buffer for 
SDS-PAGE analysis. Recombinant protein preps were checked by western blotting for 
affinity tags and by peptide mass fingerprinting. 
2.4.10  Mass spectrometry analysis of protein samples 
Preparation of samples by in-gel trypsin digest was carried out by Kelly Hodge and 
processed by the University of Dundee Mass spectrometry facility 
(http://proteomics.lifesci.dundee.ac.uk/). Briefly, each band was incubated in 100 mM 
NH4HCO3 ,100% (v/v) acetonitrile (ACN) and incubated at room temperature for 10 min 
with shaking. This step was repeated and liquid removed before sequential addition of 
100% (v/v) ACN then 100 mM NH4HCO3 and incubation for 30 min at 37°C with 
shaking. Gel pieces were dried and then incubated in 10 mM DTT for 45 min at 55°C. 
Liquid was again removed and gel pieces incubated in 55 mM iodoacetamide for 30 
min in the dark. Gel pieces were washed twice, as above, with 100 mM NH4HCO3 , 
100% (v/v) ACN and then dried. For digestion, 20 ng/μl of trypsin was added in 50 mM 
NH4HCO3 and left overnight at 37°C. To the digests a roughly equivalent volume of 
0.1% (v/v) trifluoroacetic acid (TFA) followed by 100% (v/v) ACN was added and the gel 
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pieces were sonicated on ice for 15 min. The supernatant containing tryptic peptides 
was removed into a new tube and sonication of the gel pieces was repeated with 0.1% 
(v/v) TFA, 30% (v/v) ACN and then 0.1%  (v/v) TFA, 50% (v/v) ACN. The supernatants 
from all sonication steps were pooled, concentrated in a vacuum centrifuge at 60°C 
and then cleaned on a C18 column.  
For pulldown experiments, samples were analysed on a Velos Pro (Thermo Scientific 
Fisher, Boston) Orbitrap mass spectrometer coupled to an Ultimate 3000 RSLC 
nanoflow HPLC system (Dionex, Sunnyvale California). Sample volumes of 5 μl were 
eluted over a 100 min run on a 50 cm C18 column (75 μm × 50 cm nanoviper column, 
Thermo Scientific Boston). Samples were injected using the EasySpray source and run 
gradient was a 2–40% linear gradient of solvent A (0.1% formic acid): solvent B (80% 
ACN with 0.8% formic acid) at a flow rate of 0.3 μl/min. For recombinant protein 
fingerprinting samples were run on the XL Orbitrap mass spectrometer coupled to the 
HPLC system described above. The run gradient was as described above except that 
samples were eluted over a 40 min run on a 15 cm C18 column (15cm × 75μm pepmap 
column, Thermo Scientific Boston). Raw data was analysed using Maxquant version 
1.3.0.5 run against the appropriate protein databases. Microsoft Excel (Office 2010) 
was used for further analysis. For pulldown experiments, the intensity values of 
proteins detected in the pulldowns was normalised by the total intensity value 
(intensity in sample plus intensity in bead control) of the corresponding protein to give 
an enrichment value. Population statistics were used to check the distribution of the 
data. In general, a ratio lower than 0.75-0.8 was classed as non-significant enrichment. 
A ratio of 1 for a protein indicates that there was no protein detected in the bead 
control sample. Posterior error probability (PEP) values act as a p value for probability 
of correct protein identification.  
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2.5 RNA Analysis and binding 
2.5.1 GFP tagged protein pulldowns for analysis for associated RNAs 
Typically around 100 OD600 units of cells were used for each GFP-Trap pulldown. These 
were carried out essentially as described previously (Sections 2.4.2 and 2.4.4), up to 
the point of elution from the GFP-Trap beads, with minor changes as follows. Separate 
RNase free reagents, tubes and pipettors were used throughout and gloves were 
changed frequently. Lysis buffer was also supplemented with 100 U/ml of Ribolock 
RNase inhibitor (Fermentas) and the concentration of normalised protein extract was 
higher, typically around 10-12 mg/ml. As the RNA input sample 1/10th the volume of 
normalised extract was added to 300 μl Tripure Reagent (Roche), snap frozen and 
stored at -80°C.  
After the final wash step, elution was carried out by adding to the beads 100 μl of TE 
buffer (10 mM Tris-Cl, pH 7.5. 1 mM EDTA, Ambion) supplemented with 1% (v/v) SDS 
and 2.5% (v/v) β-Mercaptoethanol.  These were incubated at 75°C for 15 min and the 
supernatant removed to a new RNase free tube. This elution step was repeated and 
the supernatants pooled. To check GFP pulldown efficiency, 50 μl of eluate was added 
to an equal volume of 2× Laemmli buffer for western blot analysis. The remaining 150 
μl of eluate was added to 300 μl Tripure Reagent (Roche), snap frozen and stored at -
80°C. RNA extractions were carried out as described in Section 2.5.2.  
2.5.2 RNA Extraction 
RNA was extracted from samples in Tripure reagent (a mixture of phenol and 
guanidine thiocyanate, pH 4, Roche) following the manufacturer’s protocols. Briefly, 
chloroform was added to the samples (0.3 ml/ml of Tripure) and shaken for 15 sec. 
 84 
 
Once mixed these were left at room temperature for 15 min to allow phases to 
separate. Samples were centrifuged at 12,000 × g, 4°C for 15 min and the aqueous 
phase containing RNA was carefully removed into a new tube. RNA was precipitated at 
-20°C using 2.5 volumes of 100% ethanol, 0.3 M sodium acetate pH 5.5, 10 mM MgCl2 
and 20 μg of glycogen. The RNA pellet was harvested by centrifugation at 20,000 × g, 
4°C for 30 min and then washed once using 75% cold ethanol. The pellet was air dried 
and resuspended in an appropriate volume of RNase free water (10-100 μl). To remove 
any small contamination with genomic DNA, the resuspended RNA was treated with 
RNase free DNase I (Fermentas). RNA was mixed with 1 × DNase I buffer (10 mM Tris-
HCl pH 7.6, 2.5 mM MgCl2, 0.5 mM CaCl2) and 2 Units of DNase I and incubated at 37°C 
for 15 min. The enzyme was inactivated by the addition of EDTA to 5 mM and heating 
to 75°C. The yield of RNA was calculated by absorbance at 260 nm and samples were 
snap frozen and stored at -80 °C. Small RNA extractions were carried out as described 
above except after obtaining the aqueous phase a subtractive precipitation using ~2.5 
M LiCl was carried out at -20 °C for 3 hours to remove RNAs larger than ~200 bp. The 
supernatant was then precipitated and processed as above. 
 
2.5.3 Radiolabelling of DNA oligonucleotide probes 
Radiolabelling of oligonucelotide (oligo) DNA probes for northern blot analysis was 
carried out using T4 polynucleotide kinase (Fermentas) and [γ-32P]ATP (Perkin Elmer), 
under the following conditions. For each labelling reaction 10 pmol of oligo was heated 
at 95°C for 30 sec and then immediately placed on ice. The oligo was added to 1× 
Forward buffer A (50 mM Tris-HCl pH7.6, 10 mM MgCl2, 5 mM DTT, 0.1 mM 
spermidine), 10 units of T4 polynucleotide kinase and ~1 μM of [γ-32P]ATP (specific 
activity 6000 Ci/mmol). Reactions were incubated at 37°C for 1-2 hours and then 
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unincorporated nucleotides were removed using a G-25 microspin column (GE 
healthcare). For each northern blot, 10 pmol of 5’ end labelled oligo was used as a 
probe. The sequences of oligo probes used in this study are shown in the Appendix.  
2.5.4 Radiolabelling yeast tRNA 
Yeast tRNA (R9001, Sigma) was resuspended in RNase free water and the 
concentration determined using absorbance at 260 nm. The quality of tRNA was also 
checked by small RNA gel electrophoresis (Section 2.5.5).  Yeast tRNA was treated with 
Fast alkaline phosphatase (Fermentas) to remove the endogenous 5’ phosphate before 
radiolabelling.  For each reaction 4 pmol of yeast tRNA was mixed with 1× FAP buffer 
(10 mM Tris-HCl pH 8.0, 5 mM MgCl2, 0.1 M KCl, 0.02% (v/v) Triton X-100, and 
0.1 mg/ml BSA), 10 U of Ribolock RNase inhibitor and 2 U of Fast alkaline phosphatase. 
Reactions were incubated at 37°C for 1 hour and then heat inactivated. Radiolabelling 
was carried out using T4 polynucleotide kinase (Fermentas) and [γ-32P]ATP (Perkin 
Elmer), under the following conditions. The inactivated phosphatase reactions were 
made up with 1× Exchange buffer B (50 mM imidazole-HCl pH 6.4 , 18 mM MgCl2, 5 
mM DTT, 0.1 mM spermidine and 0.1 mM ADP), 8 units of Ribolock RNase inhibitor, 10 
U of T4 polynucleotide kinase and ~1 μM of [γ-32P]ATP (specific activity 6000 Ci/mmol). 
Reactions were incubated at 37°C for 2 hours and then the kinase was inactivated by 
addition of EDTA at 8 mM and heating. Unincorporated nucleotides were removed 
using a G-25 microspin column (GE healthcare) and radiolabelled tRNA was snap 
frozen and stored at -20°C.  
2.5.5  Small RNA gel electrophoresis 
Precast 10% TBE-Urea Gels were used to separate RNA samples in ultrapure 1× TBE 
running buffer (100 mM Tris-base pH 8.4, 90 mM boric acid, and 1 mM EDTA, LifeTech) 
 86 
 
made up in twice autoclaved mQH20. RNA samples were added to 2× TBE-Urea loading 
dye, incubated at 75°C for 5-10 min then immediately placed on ice, to denature 
secondary structure. Typically around 100-300 ng of RNA was loaded per lane.  Gels 
were run in an XCell Surelock electrophoresis tank at 180 V, 4°C for 60-80 mins, until 
the Bromophenol Blue dye front was near the bottom of the gel. All equipment and 
reagents were supplied by Novex (LifeTech).   
2.5.6  SYBR Gold nucleic acid staining 
RNA gels were added to SYBR Gold stain (Molecular probes), diluted 1 in 10,000 in 1× 
TBE.  Staining was carried out in sterile petri dishes, covered in foil, with gentle 
agitation for 30 min then rinsed briefly with sterile mQH20. To visualise bands, gels 
were scanned using a fluorescent image analyser (FLA-5100 Fujifilm) on the LPB setting 
(473 nm).  
2.5.7  Northern Blotting 
RNA samples were separated by RNA gel electrophoresis (Section 2.5.5) and then 
electrotransferred to a Hybond XL membrane in ultrapure 0.5× TBE (50 mM Tris, 45 
mM boric acid, and 0.5 mM EDTA, LifeTech). Briefly, the membrane was soaked in 
transfer buffer before being placed over the RNA gel and sandwiched between four 
filter papers and foam sponges, rolling out all air bubbles between layers. This was 
sealed inside the transfer module and placed into an X Cell Blotting tank (Novex) with 
the gel side nearest the cathode. Transfer was carried out at 30 V for 1-2 hours at 4°C.  
Membranes were auto crosslinked on both sides using a UV Stratalinker (254 nm) and 
blocked with Perfecthyb Plus hybridisation buffer (Sigma) for 2-3 hours at 42°C with 
rotation. For each blot 10 pmol radiolabelled oligo probe was added to the 
hybridisation buffer and allowed to bind at 42°C overnight with rotation. Membranes 
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were typically washed twice for 10 min at 42°C with 4× SSC (750 mM  NaCl and 75 mM 
sodium citrate pH 7.0) and then 2× SCC (375 mM  NaCl and 37.5 mM sodium citrate pH 
7.0). Between washes the counts on the membrane were monitored with a Geiger 
counter to determine when enough background radioactivity had been removed. 
Autoradiography was carried out by exposures to Phosphoimager film and bands 
visualised by scanning using the fluorescent image analyser (FLA-5100 Fujifilm) on the 
IP-S setting.  Analysis by densitometry of bands was carried out using Aida Image 
Analyzer v.3.27 and values exported to Microsoft Excel (Office 2010).  
2.5.8  Electrophoretic Mobility Shift Assays 
For Electrophoretic mobility shift assays (EMSAs), recombinant protein was mixed with 
tRNA in binding buffer (20 mM Tris HCl pH 7.5, 150 mM NaCl and 2 mM MgCl2) and 
allowed to equilibrate for 45 min at room temperature.  
For EMSAs with excess tRNA, each binding reaction consisted of 0.4 mM (~200 ng) of 
tRNA, 5% (v/v) glycerol and 20 U Ribolock RNase inhibitor mixed with the appropriate 
concentration of protein in a final volume of 20 μl. Binding reactions were separated 
on 6% polyacrylamide gels in ultrapure 0.5× TBE running buffer at 100 V for 1 hour. A 
small amount of 6× Gel Pilot loading dye (Qiagen) was run alongside reactions to 
monitor separation and gels were pre run for 15-30 min. Gels were stained with SYBR 
gold (Section 2.5.6) and scanned using a fluorescent image analyser (FLA-5100 Fujifilm) 
on the LPB filter (473 nm).  Immunoblot EMSAs were carried out the same way, except 
part of the gel was treated with 0.5% (v/v) SDS for 15 min before being transferred to 
PVDF membrane, as described (Section 2.4.7), using 1× Towbin buffer without 
methanol. The blots were then soaked in 10% acetic acid and air dried before western 
blotting to detect GST and His6 tags. 
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For EMSAs with radiolabelled tRNA, each binding reaction consisted of 1 nM 32P-tRNA, 
8% (v/v) glycerol and 10 U Ribolock RNase inhibitor mixed with the appropriate 
concentration of protein in a final volume of 12 μl. Binding reactions were typically 
separated on 4-20% polyacrylamide gels in ultrapure 0.25× TBE running buffer (25 mM 
Tris, 22.5 mM boric acid, 0.25 mM EDTA, LifeTech) at 100 V in an ice bucket. Reactions 
were run into the gel at 300 V for 10-15 min and then the voltage was reduced to 150 
V-180 V (to give a current of ~7 mA) for a total time of 90 min. For 5% polyacrylamide 
gels the running time was 45 min.  A small amount of 6× Gel pilot loading dye (Qiagen) 
was run alongside reactions to monitor separation and gels were pre run for 45 min. 
Gels were dried at 80°C for 90 min on a vacuum gel drier (Bio-Rad) before 
autoradiography was carried out by exposures to Phosphoimager film. Bands were 
visualised by scanning using the fluorescent image analyser (FLA-5100 Fujifilm) on the 
IP-S setting.  Analysis by densitometry of bands was carried out using Aida Image 
Analyzer v.3.27and values exported to Microsoft Cxcel (Office 2010).  For estimation of 
dissociation constant EMSA experiments the conditions were as described above 
except that 0.1 nM 32P-tRNA was used per binding reaction. Competitor EMSA 
experiments were as described above, except  binding reactions were allowed to 
proceed without competitor for 25 min and then the complexes were challenged by 
the addition of competitor for a further 25 min. Competitor binding reactions were 
also made up for a final volume of 15 μl.  
For EMSA separation on agarose gels, binding reactions were as described above 
except that these were separated on a 1.5% agarose gel in ultrapure 0.5× TBE running 
buffer at 120 V in an ice bucket. Reactions were run at 120 V for a total time of ~70 
min.  A small amount of 6× Gel pilot loading dye (Qiagen) was run alongside reactions 
to monitor separation and gels were pre run for 30 min. Gels were fixed for 5 min in 
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10% methanol, 10% acetic acid and dried at room temperature for 3 hours on a 
vacuum gel drier (Bio-Rad) before autoradiography as described above.  
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Chapter 3: A basic region in the Elp1 
subunit of Elongator is essential for tRNA 
modification but does not affect 
localisation of the complex 
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3.1 Introduction 
A putative nuclear localisation sequence (NLS) was previously annotated in the C-
terminal domain of the Elp1 subunit of Elongator (Fichtner et al., 2002b). Truncation of 
the C-terminus, including this lysine/arginine rich basic region results in resistance to 
Zymocin indicating that it may be essential to Elongator function (Fichtner et al., 2003). 
A high level of sequence conservation from yeast to humans also highlights its likely 
importance (Figure 3.1A).  The consensus sequence for a classical bipartite NLS is 
(K/R)(K/R)X10-12(K/R)3/5  (i.e. two basic residues followed by a spacer of 10 amino acids 
then 3/5 basic residues) and this would be expected to bind importin-α (Lange et al., 
2007, Kosugi et al., 2009a). The putative Elp1 NLS resembles this bipartite type NLS and 
is compared with a “classical” NLS sequence from X. laevis Nucleoplasmin in Figure 
3.1B.  The Elp1 putative NLS is not highlighted by the NLS prediction programme cNLS 
Mapper (Kosugi et al., 2009b) as a bipartite nuclear localisation sequence even at the 
lowest cut-off, but is identified using NLSstradumus (Nguyen Ba et al., 2009). The 
programs use different methods of prediction; cNLS Mapper marks each amino acid to 
give an NLS score based on known NLS sequences to predict nuclear import activity, 
whereas NLSstradumus relies on the frequency of lysine and arginine within a region. It 
should be noted that although the putative NLS of Elp1 does resemble the classical 
bipartite NLS, many annotated NLS sequences are non-functional in the context of the 
full protein. This is exemplified by the fact that the number of predicted NLS sequences 
in the yeast genome exceeds the number of nuclear localised proteins (Kosugi et al., 
2009a). Basic regions in proteins may therefore be required for other interactions and 
never see the cell’s nuclear import machinery. It is also worth noting that in the 
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alignments (Figure 3.1A) the general basicity of the region in Elp1 is conserved but the 
exact consensus of the putative bipartite NLS is not. 
 
 
Figure 3.1: A basic region in Elp1 is highly conserved and annotated as a putative NLS.            
A) Multiple sequence alignment of the Elp1 subunit of Elongator from various eukaryotic 
organisms. The basic region is displayed to highlight conservation, indicated by matching 
colours and the conservation bars.  Alignment was carried out using Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/) and Jalview v2.8 (Waterhouse et al., 2009) for 
display. B) For comparison the bipartite NLS consensus sequence, the S. cerevisiae Elp1 
putative NLS and the X.  laevis Nucleoplasmin NLS are shown. Basic residues are highlighted in 
purple.  
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Since tRNA anticodon modifications are thought to occur in the cytoplasm of cells 
(Hopper and Phizicky, 2003) and it is known that Elp1 is mainly cytoplasmic (Pokholok 
et al., 2002, Huh et al., 2003), it is interesting to hypothesise why the Elongator 
complex may require a nuclear import sequence.  It is possible that Elongator may 
have an evolutionary conserved NLS in order to undergo import and re-export 
alongside tRNAs, which have been shown to shuttle constitutively between the 
nucleus and cytoplasm in yeast (Takano et al., 2005). Certain nuclear factors may be 
required for the tRNA modification function of Elongator or nuclear-cytoplasmic 
shuttling may regulate the modification of tRNA. It is also possible that nuclear 
localised Elongator participates in other distinct functions such as transcription, though 
such functions are now disputed (Esberg et al., 2006).  A further possibility is that the 
basic region in Elp1 may never normally interact with the cell’s import machinery and 
could have a distinct function in the context of the Elongator complex.  
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3.2 Results (Part 1) 
3.2.1 Characterising the effects of mutations in the Elp1 basic region on   
Elongator function. 
In order to more extensively study the function of this conserved basic region in Elp1 a 
series of mutations were designed throughout its sequence (Figure 3.2).  A mutant 
allele, elp1-KR9A, with nine alanine substitutions in basic residues hypothesised to be 
important for nuclear import was created (Figure 3.2). To dissect this sequence more 
closely ‘proximal’ (first half) and ‘distal’ (second half) alanine substitutions in this 
sequence were also made creating elp1-KR5A and elp1-KR4A respectively (Figure 3.2).   
 
 
 
Figure 3.2: Summary of alanine substitutions created in the C-terminal domain of Elp1. 
Schematic of the Elp1 subunit of Elongator, including secondary structure predictions.  A part 
of the C-terminal domain is highlighted, indicating functionally important phosphorylation sites 
in blue and basic residues within the conserved basic region in purple.  Alanine substitutions in 
each mutant are highlighted in red. 
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Alanine substitution mutants were introduced into YCp-ELP1-6HA, a plasmid construct 
containing 6HA tagged Elp1 under the control of its endogenous promoter, which was 
then transformed into an elp1∆ strain.  Sensitivity to Zymocin is a convenient method 
of assessing Elongator function as loss of Elongator dependent tRNA modification 
results in resistance to this toxin. The ability of each of these mutant versions of Elp1 
to rescue the Zymocin resistance of elp1∆ was assayed by Eclipse assay (Figure 3.3).  
 
Wild-type ELP1 rescued the resistance of elp1∆ whereas elp1-KR9A did not indicating 
that the Elp1-KR9A protein does not support Elongator function. The elp1-KR5A 
mutant was resistant whereas the elp1-KR4A mutant was sensitive and so based on 
this assay it seemed that mutation of the distal region alone had a minimal effect on 
Elongator function compared with mutating the proximal region. To further dissect the 
region required for Elongator function, additional mutants that contained progressive 
Alanine substitutions within the proximal NLS region were made, elp1-1228A-1229A, 
elp1-1229A-1232A, elp1-1232A-1234A and elp1-1234A-1235A (Figure 3.2). These 
mutants all appeared Zymocin-sensitive by Eclipse assay (Figure 3.3), therefore based 
on these assays it appears that substituting just two basic residues within the proximal 
region does not lead to significant loss of function. 
 
To study the effects of these mutants on Elongator function more quantitatively a 
plasmid (pAE1) expressing the toxic gamma subunit of Zymocin under control of a 
galactose inducible promoter was used (Butler et al., 1994). The intracellular 
expression of the gamma subunit is induced by growth on galactose containing media 
allowing sensitivity or resistance to the toxin to be assayed by growth test.   
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Figure 3.3: Mutations in the Elp1 basic region disrupt Elongator function. Eclipse assay of 
elp1∆ (WAY034) strains containing plasmids carrying wild-type and mutant versions of ELP1 
(YCplac111-ELP1-6HA and derivatives; see Figure 3.2). Wild-type (WT, BY4741) and elp1∆ 
(WAY034) with empty vector (EV) served as controls for Zymocin sensitivity and resistance 
respectively.   
 
elp1∆ strains containing Elp1 mutant plasmids together with pAE1 were assayed for 
Zymocin resistance on galactose containing medium (Figure 3.4). The elp1-KR9A 
mutant was fully resistant compared with the empty vector control. The proximal elp1-
KR5A mutant was resistant but slightly less so than elp1-KR9A.  The distal elp1-KR4A 
mutant appeared sensitive by eclipse assay, but in this more quantitative assay of 
Zymocin sensitivity some level of resistance was seen, though less than that conferred 
by elp1-KR9A and elp1-KR5A.  
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In summary the proximal and distal mutants all displayed some level of Elongator 
dysfunction in this assay. Comparing the level of defect shown by these mutant alleles 
it appears that the elp1-KR5A and elp1-KR4A mutations are additive in the context of 
the elp1-KR9A allele. This suggests that both proximal and distal mutations contribute 
to the phenotype but with a greater contribution made by the proximal elp1-KR5A 
mutant. Since the elp1-KR9A is the most severe then the entire basic region is 
influencing Elongator function. 
 
 
Figure 3.4: The elp1-KR9A mutations result in a loss of Elongator function that is comparable 
to elp1∆.  Growth test of elp1∆ (WAY034) strains containing plasmids carrying wild-type and 
mutant versions of ELP1 (YCplac111-ELP1-6HA and derivatives; see Figure 3.2) together with 
pAE1. pAE1 contains the gamma toxin subunit of Zymocin under control of a galactose 
inducible promoter. Zymocin expression is induced by growth on galactose and repressed on 
glucose. elp1∆ (WAY034) containing empty vector (EV) and YCp-ELP1-6HA plasmids served as 
controls for Zymocin resistance and sensitivity respectively.   
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Our lab has created a SUP4 ochre suppressor system (Bandau and Stark, unpublished) 
that allows assay of Elongator dependent tRNA modification and its effect on 
translational efficiency. This SUP4 suppressor system monitors the efficiency of ochre 
stop codon suppression by the SUP4 tRNA that requires Elongator-dependent wobble 
uridine modification for activity. These SUP4 system strains carry a uraoc22 marker, 
containing a premature ochre stop codon within the coding region of the gene, as well 
as a SUP4 ochre suppressor tRNA gene (Figure 3.5A). The SUP4 gene encodes tRNATyrUΨA 
that can read through the ochre mutation in ura3oc22, supressing its stop codon 
function and allowing full translation of the marker protein. However, the SUP4 
tRNATyrUΨA requires an Elongator dependent wobble mcm
5U modification for efficient 
ochre suppression (Huang et al., 2005). Consequently only strains with functional 
Elongator can read-through ura3oc22 and grow on medium lacking uracil (Figure 3.5B). 
Strains that have compromised Elongator function show defective growth on media 
lacking uracil (DOA-Ura). 
elp1∆ SUP4 system strains containing ELP1 or elp1 mutant plasmids were assayed for 
Elongator dependent SUP4 ochre suppression by growth on DOA -Ura (Figure 3.6).     
Wild-type ELP1 ura3oc22 strains containing empty vector and elp1∆ ura3oc22 strains 
complemented by wild-type ELP1 on a plasmid each showed slightly defective growth 
on DOA-Ura compared with control strains that lacked the ochre mutation in URA3 
(note smaller colonies on the two highest dilutions). This is most likely due to the fact 
that the read through is probably not completely efficient even in the presence of the 
mcm5U modification. The difference in growth between elp1∆ SUP4 system strains 
with empty vector or complemented with a wild-type ELP1 plasmid indicate the 
extremes of phenotype against which the various mutant elp1 alleles can be compared 
(* in Figure 3.6).   
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Figure 3.5: A SUP4 ochre suppressor system to assay the levels of Elongator dependent tRNA 
modification. A) Schematic of the cassette system integrated at the his3∆1 locus. The ura3oc22 
gene has a premature stop codon that disrupts expression of the marker gene. SUP4 encodes 
tRNATyrUΨA and NatRMX is a marker gene for integration. B) Schematic of the Elongator 
dependent SUP4 ochre suppression system. The SUP4 encoded tRNA can read through the 
premature stop codon in ura3oc22 to allow expression of the marker.  However, this tRNA 
requires mcm5 modification at the wobble uridine position for its suppressor function.  Strains 
that lack Elongator function do not express the ura3oc22 marker and cannot grow on media 
lacking uridine.  
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The elp1-KR9A mutant showed a considerable growth defect on DOA-Ura that was 
comparable to that shown by the elp1∆ empty vector control.  The elp1-KR5A proximal 
mutant and elp1-KR4A distal mutants both looked similar to elp1∆ complemented with 
wild-type ELP1 in terms of growth (i.e. wild-type ELP1 from now on). The proximal 
mutant may show a very minor defect in comparison, having slightly smaller colonies 
in the last two dilutions. However, this suggests that there is some level of Elongator 
dependent tRNA modification in both the proximal and distal mutants that allows 
SUP4 ochre suppression levels comparable to wild-type ELP1. The elp1-KR9A mutant is 
more severe in terms of defective SUP4 ochre suppression, suggesting there is little to 
no Elongator dependent tRNA modification in this strain.   
The proximal basic region mutants elp1-1228A-1229A, elp1-1229A-1232A, elp1-1232A-
1234A and elp1-1234A-1235A  were also tested using the system but showed wild-type 
levels of SUP4 ochre suppression and this is in agreement with Eclipse assays (Figure 
3.7 and Figure 3.4).  
 
 101 
 
 
Figure 3.6: The elp1-KR9A mutant is defective in Elongator dependent SUP4 ochre 
suppression. Growth test of SUP4 system integrated strains (SBY128, 132, 134, 138) containing 
plasmids carrying wild-type and mutant versions of ELP1 (YCplac111-ELP1-6HA and derivatives; 
see Figure 3.2). Strains were assayed on DOA -Leu -Ura for SUP4 ochre suppression and 
subsequent expression of the ura3 marker.  The * indicates the effect of loss of Elongator 
function on SUP4 ochre suppression in ura3oc22 strains.  
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Figure 3.7: ‘Alanine scanning’ substitutions across the proximal part of the Elp1 basic region 
do not disrupt Elongator dependent SUP4 ochre suppression. Growth test of SUP4 system 
integrated strains (SBY128, 132, 134, 138) containing plasmids carrying wild-type and mutant 
versions of ELP1 (YCplac111-ELP1-6HA and derivatives; see Figure 3.2). Strains were assayed 
on DOA -Leu -Ura for SUP4 ochre suppression and subsequent expression of the ura3 marker.  
The * indicates the effect of loss of Elongator function on SUP4 ochre suppression in ura3oc22 
strains. 
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3.2.2 Genomic integration of elp1 mutants by ‘delitto perfetto’ 
In order to characterise the phenotypes of the basic region mutants further without 
plasmid selection these mutants were integrated into the yeast genome using a 
‘delitto perfetto’ approach (Figure 3.8A). This makes use of a counter selectable CORE 
cassette to allow for a small region of the endogenous copy of ELP1 to be replaced by 
the corresponding region containing specific mutations. This method has the 
advantage of giving a clean integration, since the mutants replace a region of the wild-
type gene locus without leaving a selectable marker integrated as well. This was 
carried out in the background of GFP tagged Elp1 to generate strains in which the 
endogenous ELP1 allele was replaced with elp1-KR9A, elp1-KR5A, elp1-KR4A and 
functionally important serine phosphorylation site mutants elp1-1209A and elp1-1198-
1202A. Expression of the GFP tagged integrants was checked by western blot and was 
equivalent to that of wild-type ELP1-GFP before integration, as shown for ‘delitto 
perfetto’ integrated wild-type ELP1 and elp1-KR9A (Figure 3.8B and C).  
Integrated GFP tagged versions of ELP1 were tested for Elongator function using 
Eclipse assays (Figure 3.9). The CORE cassette deletes part of the Elp1 C-terminal 
domain (amino acids 1164-1277) and as expected this resulted in non-functional 
Elongator as this strain was resistant to Zymocin. The elp-KR9A and elp1-KR5A mutants 
were resistant and the elp1-KR4A mutant was sensitive, in agreement with the Eclipse 
assays performed on strains expressing these elp1 alleles from a plasmid (Figure 3.3). 
The phosphorylation site mutants elp1-1209A and elp1-1198A-1202A were resistant, 
consistent with the previous finding that these alleles block Elongator activity (Abdel-
Fattah and Stark, unpublished). The ‘delitto perfetto’ integrated wild-type ELP1 is 
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sensitive to Zymocin as expected and is shown alongside wild-type and elp1∆ controls 
to validate the integration method. 
 
Figure 3.8: Precise replacement of the wild-type ELP1 locus with mutant alleles by ‘delitto 
perfetto’; See next page for figure legend. 
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Figure 3.8: Precise replacement of the wild-type ELP1 locus with mutant alleles by ‘delitto 
perfetto’. A) Schematic outlining the ‘delitto perfetto’ method of integration (Storici and 
Resnick, 2006). This allows for reconstitution of the wild-type ELP1 gene with mutant versions 
by counterselection. B) Eclipse assay of ‘delitto perfetto’ strains.  ELP1-GFP (starting strain, 
YRDS59) and elp1∆ (YRDS250) served as controls for Zymocin sensitivity and resistance 
respectively. C) Protein extracts from ‘delitto perfetto’ strains were analysed by western 
blotting with anti-GFP. The untagged (YRDS1) and ELP1-GFP (starting strain, YRDS59) samples 
served as controls. As a loading control blots were also analysed with anti-Cdc28. 
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Figure 3.9: The integrated elp-KR9A mutant disrupts Elongator function. Eclipse assay of 
strains containing chromosomal copies of ELP1 and elp1 mutants. Wild-type (WT, BY4741) and 
elp1∆ (YRDS250) served as controls for Zymocin sensitivity and resistance respectively. 
 
Mutant elp1 alleles were also assayed for Elongator function using the pAE1 Zymocin 
plasmid (Figure 3.10).  The elp1-KR9A mutant was resistant to galactose-induced 
intracellular Zymocin expression and this was comparable to elp1∆, as in the plasmid 
based assays (Figure 3.4). The proximal elp1-KR5A mutant was resistant but less so 
than elp1-KR9A, while the distal mutant elp1-KR4A appeared sensitive. The result with 
elp1-KR4A may indicate that the 6HA tag used in plasmid based assays could adversely 
affect Elongator function to a small degree when compared with the integrated GFP 
tagged versions, since elp1-KR4A showed more Zymocin resistance in the plasmid 
based assay (compare Figures 3.4 and 3.10).  The levels of Zymocin resistance shown 
by elp1-KR4A, elp1-KR5A and elp1-KR9A is progressively increased respectively, with 
elp1-KR9A having the most severe phenotype (Figure 3.10). Phosphorylation site 
mutants elp1-1209A and elp1-1198A-1202A also showed resistance comparable to 
that of the elp1∆ control.  
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Figure 3.10: The integrated elp1-KR9A mutant results in a loss of Elongator function that is 
comparable to elp1∆.  Growth test of strains containing chromosomal copies of ELP1 and elp1 
mutants. pAE1 contains the gamma toxin subunit of Zymocin under control of a galactose 
inducible promoter. Zymocin expression is induced by growth on galactose and repressed on 
glucose. * indicates the ELP1-GFP starting strain for ‘delitto perfetto’ integrations. *ELP1-GFP 
(YRDS59) and elp1∆ (YRDS250) served as controls for Zymocin sensitivity and resistance 
respectively. 
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Since elp1-KR9A showed a severe phenotype in the SUP4 ochre suppressor assay 
(Figure 3.6), this phenotype was retested with integrated wild-type ELP1 and elp1-
KR9A mutant in the SUP4 system strains (Figure 3.11).  As in the plasmid-based assays, 
the elp1-KR9A mutant showed defective growth on DOA-Ura, comparable to that of 
the elp1∆ control. Note that the first spot (OD600=1) for this mutant shows slightly 
better growth than elp1∆ in this case, whereas on the plasmid the elp1-KR9A mutant 
was just as compromised as the knockout. This is probably to do with the effects of the 
6HA tag as suggested above for elp1-KR4A. Nevertheless the elp1-KR9A mutant has a 
severe defect in Elongator dependent SUP4 ochre suppression, suggesting little to no 
Elongator dependent tRNA modification in this mutant. The integrated wild-type ELP1 
(denoted ELP1) showed equivalent growth on DOA-Ura as non-integrated wild-type 
ELP1 (denoted WT), which validates integration method. 
 
Figure 3.11: The integrated elp1-KR9A mutant is defective in Elongator dependent SUP4 
ochre suppression. Growth test of SUP4 system strains containing chromosomal copies of ELP1 
and elp1-KR9A. Wild-type (WT) denotes starting strains (SBY128, 132) and ELP1 denotes 
integrated wild-type ELP1. The lack of difference between these strains validates the ‘delitto 
perfetto’ method.  Strains were assayed on DOA-Ura for SUP4 ochre suppression and 
subsequent expression of the ura3 marker.  The * indicates the effect of loss of Elongator 
function on SUP4 ochre suppression in ura3oc22 strains. 
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In summary, the elp1-KR9A mutant was comparable to an elp1 knockout strain in 
terms of resistance to Zymocin and Elongator dependent SUP4 ochre suppressor 
function and was the most severe of all basic region mutants tested using each of the 
assays. The proximal mutant (elp1-KR5A) is also resistant to Zymocin but less so than 
elp1-KR9A and shows only a minor defect in Elongator dependent ochre suppression. 
The distal mutant (elp1-KR4A) showed some level of resistance to Zymocin in plasmid 
based assays, though marginally less than elp1-KR9A and elp1-KR5A, but was wild-type 
in terms of Elongator dependent SUP4 ochre suppression. Since elp1-KR9A is more 
severe than either elp1-KR5A or elp-KR4A alone then the entire basic region must 
contribute to the tRNA modification function of the complex. Taken together, these 
results show that the Elp1 basic region is essential for the tRNA modification function 
of Elongator. 
 
Strain Zymocin resistance 
SUP4 ochre suppressor 
defects 
Elongator function 
Wild-type - - Functional 
elp1-1228A-1229A - - Functional 
elp1-1229A-1232A - - Functional 
elp1-1232A-1234A - - Functional 
elp1-1234A-1235A - - Functional 
elp1-KR4A  +/- - Functional  
elp1-KR5A ++  +/- Partial 
elp1-KR9A +++ +++ Non Functional 
elp1Δ +++ +++ Non Functional 
Table 3.1: Summary of the effects of Elp1 basic region mutations on Elongator function. The 
effects of the various Elp1 basic region mutations on Elongator function, as assayed by 
Zymocin resistance and SUP4 ochre suppression are summarised. The extremes of phenotype 
are denoted by ‘+++’ as shown by elp1Δ strains and ‘-’ as shown by wild-type strains. The 
relative severity across mutants can be compared by the number of ‘+’s in comparison to these 
strains. A partial or minor phenotype in either assay is denoted by ‘+/-’. 
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3.2.3 Testing elp1 basic region mutants for other phenotypes associated 
with non-functional Elongator 
Deletion of Elongator subunits in yeast leads to pleiotropic phenotypes, including 
rapamycin hypersensitivity and temperature sensitivity (Frohloff et al., 2001, 
Schaffrath., personal communication, Otero et al., 1999). The temperature sensitivity 
of elp1 basic region and phosphorylation site mutants was assayed (Figure 3.12 and 
3.13). Apart from elp1∆ there was no obvious growth defect associated with any of 
these mutants when grown at high temperature (38°C). The rapamycin sensitivity of 
the elp1-KR9A mutant was also tested and it was found to be was rapamycin 
hypersensitive, although slightly less so than an elp1∆ (Figure 3.13).  
The differences in severity of these phenotypes compared with elp1∆ suggests that 
there is a greater defect associated with having no Elp1 (as in elp1∆) than having a 
mutant version of Elp1.  Although elp1-KR9A is equivalent to elp1∆ in terms of Zymocin 
sensitivity, this assays for the mcm5s2 modification on tRNAGluUUC and perhaps to a 
lesser extent tRNALysUUU and tRNA
Gln
UUC (Lu et al., 2005). The other phenotypes 
associated with Elongator dysfunction are likely to arise from secondary defects 
associated with accumulation of defective translation, occurring due to loss of 
modifications on multiple tRNAs. Any small level of tRNA modification may allow these 
secondary phenotypes to become less pronounced and the threshold of tRNA 
modifications that allow these to be assayed is likely to be different. This is exemplified 
by differences in the phenotypes for elp1-KR5A. In the SUP4 ochre suppression system 
some level of modification may support read through of the ura3oc22 gene to allow 
growth on DOA-Ura that is comparable to wild-type ELP1 despite this mutant showing 
considerable resistance to Zymocin (Figure 3.7 and Figure 3.3). 
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Figure 3.12: Mutations in the Elp1 basic region do not display a temperature sensitive 
phenotype.  Growth test of strains containing chromosomal copies of ELP1 and elp1 mutants 
at 30°C and 38°C. Two clones of each strain were assayed. * ELP1-GFP indicates the starting 
strain for ‘delitto perfetto’ integrations. *ELP1-GFP (YRDS59) and elp1∆ (YRDS250) served as 
controls for extremes of phenotype.  
 
It can be argued that many of the described phenotypes associated with Elongator 
dysfunction may result from other functions of the complex. However, it has been 
demonstrated that most of these phenotypes are rescued by multicopy expression of 
hypomodified tRNAGlnUUG and tRNA
Lys
UUU, which normally receive mcm
5s2 wobble 
uridine modifications (Esberg et al., 2006). This suggests that these all arise from a 
common translational defect that is countered by the approximately two-fold excess in 
the pool of these tRNAs when expressed from a high copy plasmid (Bjork et al., 2007).  
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Since a temperature sensitive phenotype in elp1-KR9A was not detected a test of tRNA 
rescue in this strain could not be attempted. However, the expression of these tRNAs 
from a high copy plasmid rescued the temperature sensitivity of elp1∆ (Figure 3.14A), 
which confirms previous work (Esberg et al., 2006). The rapamycin hypersensitivity 
phenotype of elp1∆ was not rescued in our hands by tRNA overexpression (Figure 
3.14B). More extensive work would be required to test whether other tRNAs may 
rescue this phenotype. It is possible that this phenotype may arise due the 
combination of lack of tRNA modifications and the more general decrease in 
translation initiation caused by inactivation of the mTOR pathway that may worsen 
existing defects.  
 
Figure 3.13: The elp1-KR9A mutant is rapamycin hypersensitive. Growth test of strains 
containing chromosomal copies of ELP1 and elp1 mutants at 30°C, 38°C and at 30°C on 
medium containing 1 μg/μl of Rapamycin. *ELP1-GFP indicates the starting strain for ‘delitto 
perfetto’ integration. Wild-type (WT, BY4741),*ELP1-GFP (YRDS59) and elp1∆ (YRDS250) 
served as controls for extremes of phenotype.  
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Figure 3.14: Multicopy expression of tRNAGlnUUG and tRNA
Lys
UUU rescues the temperature 
sensitivity of elp1∆ but not rapamycin hypersensitivity. Growth tests of wild-type (WT, 
BY4741) and elp1∆ (YRDS250) strains containing empty vector (EV) or a multicopy tRNA vector 
(pRS425-tK(UUU)-tQ(UUG)). Two clones of each strain were tested A) at 30°C and 38°C and B) 
on medium containing 1 μg/μl of Rapamycin.  
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3.3 Results (Part 2) 
3.3.1 The Elp1 C-terminal domain can drive nuclear import 
The basic region in the Elp1 subunit is essential for tRNA wobble uridine modification 
and this was previously annotated as a putative NLS. Since most of the Elp1 pool is 
cytoplasmic rather than nuclear (Pokholok et al., 2002, Rahl et al., 2005) it was unclear 
why the complex would require a nuclear import sequence for this function.  
To investigate whether the Elp1 putative NLS was capable of driving nuclear import 
and whether this was affected by basic region mutations, the region of ELP1 encoding 
part of the Elp1 C-terminus (amino acids 1181-1349) was cloned from plasmids 
carrying wild-type ELP1, elp1-KR9A, elp1-KR5A and elp1-KR4A into an N-terminal GFP 
tagging vector (pUG34) to enable expression of the corresponding GFP-Elp1 fusions. 
These constructs are regulated by a MET25 promoter that allows conditional 
expression of the fusion proteins in DOA-Met media. The effect of the Elp1 C-terminus 
on the distribution of GFP between the nucleus and cytoplasm can be assayed using a 
strain where the nuclear boundary is defined by fusion of a 4mCherry tag to Nic96, a 
nuclear pore complex protein.  
The localisation of GFP tagged constructs was visualised in unsynchronised fixed cells 
grown to log phase in DOA-Met-His medium (Figure 3.15). The GFP tagged wild-type 
Elp1 C-terminus was concentrated in the nucleus of the cell and this is in agreement 
with previous work (Fichtner et al., 2003).  In contrast, all of the elp1-KR mutants had a 
diffuse localisation comparable to the empty vector control, suggesting that the C-
terminus can no longer influence GFP localisation. The presence of GFP in both the 
nucleus and cytoplasm in the empty vector and elp1-KR mutant strains is most likely a 
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result of diffusion throughout the compartments. In general globular proteins of up to 
50-60 kDa can enter the nucleus by diffusion (Macara, 2001, Dingwall and Laskey, 
1986) and our GFP-Elp1 fusions have a molecular weight of ~47 kDa. However, based 
on these experiments we cannot rule out that elp1-KR9A, elp1-KR5A or elp1-KR4A may 
retain some level of nuclear import function. The C-terminus of Elp1 in isolation can 
therefore function to drive nuclear import and mutation of basic residues in this region 
disrupts this property. 
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Figure 3.15: The Elp1 C-terminal domain can drive nuclear import of GFP and this is disrupted 
by basic region mutations. Representative images of Nic96-4mCherry nuclear boundary 
tagged strains containing pUG34 plasmids expressing N-terminal GFP tagged wild-type and 
mutant Elp1 sequences (C-terminal residues 1181-1349). The pUG34 empty vector served as a 
GFP only control. The nuclear boundary (red) and GFP signals (green) were visualised by 
mCherry and YFP-ET channels respectively.  
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3.3.2 Basic region mutations do not disrupt the localisation of Elp1 
Although it is known that Elongator is mainly cytoplasmic rather than nuclear 
(Pokholok et al., 2002), the relative levels of Elp1 present in these compartments has 
not yet been quantified. We wanted to determine the relative pools of Elp1 in these 
compartments and examine how mutations in the Elp1 basic region might affect this. 
The localisation of Elp1-1209A, in which a serine to alanine substitution at an in vivo 
phosphorylation site leads to loss of Elongator function, was also assayed to see 
whether phosphorylation might regulate the distribution of Elp1.  
A strain was constructed in which Elp1 was C-terminally tagged with GFP and which 
had the nuclear boundary labelled by Nic96-4mCherry. This allowed the distribution of 
Elp1 between the nucleus and cytoplasm to be visualised and quantified. As described 
above (Figure 3.9), we introduced the required elp1 mutations into the wild-type ELP1-
GFP construct in this strain using ‘delitto perfetto’.  The localisation of Elp1-GFP in 
unsynchronised fixed log phase cells was analysed by taking 2D images of multiple 
fields of view. An untagged strain was used as a control to remove intensities caused 
by autofluorescence.  
The wild-type Elp1-GFP was mainly cytoplasmic (Figure 3.16A) with this compartment 
having a bright and granular distribution of GFP. This is in agreement with other 
reports, including that of the Yeast GFP collection (Huh et al., 2003, Tkach et al., 2012, 
Pokholok et al., 2002). The nucleus appeared darker compared with the cytoplasm 
indicating little to no nuclear localisation. None of the elp1-KR mutants showed any 
obvious defects in the distribution of Elp1, it is again mainly cytoplasmic in each case 
and any small nuclear pool of Elp1 appeared unchanged. It would be expected that if 
Elp1 was no longer being imported into the nucleus that a more obvious change 
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compared to wild-type Elp1 would be visible under steady state conditions. The elp1-
1209A mutant also showed no observable defect in its nucleo-cytoplasmic distribution, 
suggesting that phosphorylation at this functionally important site does not regulate 
Elongator localisation.   
 
The relative nuclear and cytoplasmic pools of Elp1-GFP were quantified in order to 
assay any more subtle changes that may not be visualised (Figure 3.16B). The GFP 
tagged wild-type or mutant Elp1 proteins were all mainly cytoplasmic as calculated 
from summed GFP intensities for each strain. A small nuclear pool could be quantified, 
but notably there were no major changes in this despite mutation of the basic region.  
The averages measured vary slightly but the standard deviations overlap. These small 
differences in the average could be due to small differences in the maximum 
intensities measured in each set of images or minor sampling differences. It is also 
possible that the basic residues affect the uptake of low levels of unassembled or 
unfolded Elp1 into the nucleus and this results in the small differences in the average 
pools (i.e. ~3% increase in cytoplasmic pool) when mutated. Since there are no clear 
differences in Elp1 distribution, any substantial role of the basic region as a 
determinant of the nucleo-cytoplasmic localisation of Elp1 is very unlikely. The effects 
of basic region mutations on Elongator function cannot be attributed to mutation of a 
functionally important nuclear localisation sequence. 
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Figure 3.16: Elp1 has a cytoplasmic localisation that is not disrupted by mutations in the 
basic region; See next page for figure legend 
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Figure 3.16: Elp1 has a cytoplasmic localisation that is not disrupted by mutations in the 
basic region. A) Representative images of strains expressing GFP tagged wild-type and mutant 
Elp1 with a Nic96-4mCherry nuclear boundary tag. The nuclear boundary (red) and GFP signals 
(green) were visualised by mCherry and YFP-ET channels respectively.  B) Quantification of the 
average % nuclear and cytoplasmic pools of wild-type and mutant Elp1. Percentages were 
calculated using the summed intensity of GFP and the number of cells (n) analysed for each 
strain is shown. The error bars represent the standard deviation of the averages.  
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A small nuclear localisation of Elp1 has been reported in the literature (Collum et al., 
2000, Fichtner et al., 2003, Kim et al., 2002, Rahl et al., 2005) and the results presented 
here agree that there support the presence of a nuclear pool, apparent upon 
quantification of images. The functional significance of any Elp1 nuclear pool is not 
immediately clear since tRNA modifications at the anticodon loop generally occur in 
the cytoplasm (Hopper and Phizicky, 2003). It is possible that the intensities present in 
the nucleus could represent some form of unaccounted for background or a degraded 
version of Elp1-GFP, small enough to enter the nucleus, although the latter is not 
obvious from western blotting (data not shown).  It should be noted that use of 2D 
images will overestimate the pool of GFP in the nucleus, since the smaller volume of 
this compartment cannot be taken into account in a single image section. 
Unfortunately, quantification of images in 3D cannot be carried out due to technical 
issues to do with photobleaching. It appears that a small nuclear pool of Elp1 is present 
but whether this could represent some form of background is impossible to rule out 
based on these data alone, but could be further addressed in the future by 
fractionation of the cells and analysis of Elp1 distribution by western blotting.  
Importantly, it is clear that the wild-type distribution of Elp1 is not disrupted by any of 
the mutations so far assayed under our conditions. Although the basic region of Elp1 
can drive nuclear import in isolation, in the context of the whole polypeptide this 
property does not appear to be functionally relevant. Mutation of the basic region 
does not alter the steady state distribution of Elp1 between the nucleus and 
cytoplasm. Under our conditions this basic region is not required for nuclear import of 
Elp1, although it is important for Elongator function. 
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Like Elp1, the other subunits of Elongator, Elp2-6 have been reported to be mainly 
cytoplasmic and this is in agreement with their assembly into a multiprotein complex 
(Tkach et al., 2012, Huh et al., 2003, Kim et al., 2002, Breker et al., 2013). The 
localisation of the accessory protein Kti12 has not been extensively investigated, and 
though reported cytoplasmic it does not appear to be excluded from the nucleus (Huh 
et al., 2003). Kti12 is a binding partner of Elp1 but has also been shown to interact with 
Chromatin independently of Elongator, which may suggest that it has other functions 
(Fichtner et al., 2002b, Petrakis et al., 2005).  
In order to assay its distribution throughout the nucleus and the cytoplasm Kti12 was 
GFP tagged at its C-terminus and the GFP tag was shown by eclipse assay not to disrupt 
Kti12 function (data not shown). Kti12-GFP had lower overall GFP intensities compared 
with Elp1-GFP but a higher relative nuclear pool (Figure 3.17). The Kti12-GFP fusion 
protein is ~67kDa so this construct should be too large to freely diffuse across 
compartments, suggesting another means of nuclear import. It should be noted that 
no obvious nuclear import or export sequences in the Kti12 protein sequence can be 
identified. It is not yet known whether Kti12 may play a role in other distinct functions 
in either the nucleus or the cytoplasm, but other work indicates that not all of it is 
associated with Elongator (Fichtner et al., 2002a). Since deletion of KTI12 results in loss 
of Elongator function it was possible that it might influence the distribution of the Elp1 
subunit. To test this, KTI12 was knocked out in strains containing ELP1-GFP or elp1-
KR9A-GFP and the localisation of Elp1 assayed. The distribution of Elp1 was largely 
unchanged when compared with wild-type KTI12 strains and so Kti12 does not appear 
to influence the distribution of Elp1 (Figure 3.18).  
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Figure 3.17: Kti12 has a different nucleo-cytoplasmic distribution than Elp1. A) 
Representative images of strains expressing GFP tagged Elp1 and Kti12 with a Nic96-4mCherry 
nuclear boundary tag. The nuclear boundary (red) and GFP signals (green) were visualised by 
mCherry and YFP-ET channels respectively. B) Quantification of the average % nuclear and 
cytoplasmic pools of Elp1 and Kti12. Percentages were calculated using the summed intensity 
of GFP and the number (n) of cells analysed for each strain is shown. The error bars represent 
the standard deviation of the average. 
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Figure 3.18: Kti12 does not influence the localisation of Elp1. A) Representative images of 
strains expressing GFP tagged Elp1 and elp1 mutants with a Nic96-4mCherry nuclear boundary 
tag. These are in the context of either wild-type KTI12 or kti12∆. The nuclear boundary (Red) 
and GFP signals (Green) were visualised by mCherry and YFP-ET channels respectively. B) 
Quantification of the average % nuclear and cytoplasmic pools of Elp1 and elp1-KR9A mutants. 
Percentages were calculated using the summed intensity of GFP and the number (n) of cells 
analysed for each strain is shown. The error bars represent the standard deviation of the 
average. 
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3.3.3 Fusing a nuclear export sequence onto Elp1 does not affect 
Elongator function 
It was clear from our data that the putative NLS of Elp1 was not driving nuclear import 
under steady state conditions. However, since a small nuclear pool of Elongator was 
quantified in the above work it was tested whether this nuclear pool of Elp1 could be 
important for tRNA modification. To this end the classical nuclear export sequence 
(NES) of the HIV Rev protein (Fischer et al., 1995, Pollard and Malim, 1998) was cloned 
downstream of the Elp1 C-terminus (Figure 3.19). This is a well-annotated Leucine Rich 
type 2-2-1 export sequence that is transported out of the nucleus by Crm1 (Fornerod 
et al., 1997).  The HIV Rev NES has been shown to function when fused to yeast 
proteins and should deplete any nuclear localised Elp1 to create a strain in which Elp1 
is completely cytoplasmic (Ohira and Suzuki, 2011, Fritz and Green, 1996).  
The localisation of Elp1-NES(Rev)-GFP was assayed and strikingly it showed that there 
were no visible or major quantifiable difference in the distribution of Elp1 (Figure 
3.20). Like wild-type Elp1, the nucleus of the cell appeared darkened with a mainly 
cytoplasmic distribution of GFP.  This lack of clear difference in the nuclear pool of Elp1 
with or without the NES may suggest that there is very little Elp1 in the nucleus and so 
a strong export sequence cannot drastically affect its distribution. However, it is also 
possible that in context of Elp1 this export sequence might be masked from the export 
machinery.  
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Figure 3.19: A nuclear export sequence from HIV Rev built into Elp1-GFP. Schematic showing 
the nuclear export sequence (NES) of HIV Rev fused downstream of the Elp1 C-terminus. The 
NES predictor programme NetNES1.1 annotation of this sequence is also shown 
(http://www.cbs.dtu.dk/services/NetNES-1.1/). The ‘Yes’ annotation denotes that the 
programme has predicted a score for the amino acid that suggests it is part of a putative NES. 
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Figure 3.20: The distribution of Elp1 fused to the NES of HIV Rev is not altered. A) 
Representative images of strains expressing GFP tagged Elp1 and Elp1-NES (Rev) with a Nic96-
4mCherry nuclear boundary tag. The nuclear boundary (red) and GFP signals (green) were 
visualised by mCherry and YFP-ET channels respectively.  B) Quantification of the average % 
nuclear and cytoplasmic pools of Elp1 and Elp1-NES(Rev). Percentages were calculated using 
the summed intensity of GFP and the number (n) of cells analysed for each strain is shown.  
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The Zymocin sensitivity of ELP1-NES(Rev)-GFP strains was tested by Eclipse assay 
(Figure 3.21A) and showed sensitivity comparable to that of wild-type ELP1, indicating 
that there was no obvious defect in Elongator function. Other phenotypes associated 
with Elongator dysfunction such as temperature and rapamycin sensitivity were also 
assayed but again there were no obvious defects (Figure 3.21B). The NES(Rev) 
sequence fused onto Elp1-GFP does not disrupt the tRNA wobble uridine modification 
function of Elongator.  
Assuming that the export sequence is functional this means that the Elp1 nuclear pool 
is not required for tRNA modification. By extension, the addition of the nuclear export 
sequence may have no effect on Elp1 function because it does not alter the wild-type 
distribution, namely there is no physiologically relevant Elp1 nuclear pool. This is in 
agreement with the fact that the distribution of Elp1-NES(Rev)-GFP is not drastically 
altered compared to wild-type Elp1-GFP. Taking into account the fact that analysis of 
images in 2D would be expected to overestimate the nuclear pool, since it does not 
account for compartment volumes, then it is possible that the apparent nuclear pool 
quantified in both images may be an artefact of this. We cannot say for sure that the 
nuclear export sequence can work in the context of Elp1-GFP but it has been used in 
other work to deplete yeast proteins from the nucleus (Ohira and Suzuki, 2011).   
It is also possible that independently of the basic region tested in this work, Elp1 could 
undergo nucleo-cytoplasmic shuttling so that in the context of this strong NES 
sequence no localisation defect can be assayed. There are no leucine rich NES 
sequences detectable in any Elongator subunits so it is not clear how any shuttling 
between the nucleus and cytoplasm could be facilitated. Previous work supports the 
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idea that Elp1 does not shuttle since sequential deletion of all known export pathways 
in yeast failed to cause accumulation of Elp1 in the nucleus (Rahl et al., 2005).  
 
 
Figure 3.21: Elp1 fused to the NES of HIV Rev is functional. A) Eclipse assay of ELP1-NES(Rev)-
GFP strains. Two ELP1-NES(Rev)-GFP clones were assayed alongside ELP1-GFP (YRDS59). WT 
(wild-type, BY4741) and elp1∆ (YRDS250) served as controls for Zymocin sensitivity and 
resistance respectively.  B) Growth tests of two ELP1-NES(Rev)-GFP clones alongside ELP1-GFP 
(YRDS59), elp1∆ (YRDS250) at 30 °C, 38°C and on media containing 1 μg/μl of Rapamycin.  
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3.3.4 Fusing a nuclear localisation sequence onto Elp1 disrupts 
Elongator function 
In previous work a nuclear localisation sequence (NLS) from the protein Cbp80 was 
fused onto Elp1 and shown to disrupt Elongator function (as assayed by caffiene 
sensitivity, Rahl et al., 2005). To confirm this result the NLS of Cbp80 was also inserted 
into our Elp1-GFP construct (Figure 3.22).  Unlike the basic region of Elp1, the Cpb80 
NLS is annotated by the program cNLS mapper but not by NLSstradeum, despite being 
a bona fide NLS (Huh et al., 2003).  This illustrates the potential issues with prediction 
of these types of sequences.  
The distribution of Elp1-NLS(Cbp80)-GFP was assayed and was found to be localised in 
the nucleus of the cell, indicating that this NLS can drive efficient nuclear import 
(Figure 3.23A). In contrast, mutating four basic amino acids in this sequence to create 
Elp1-NLS4A(Cbp80)-GFP resulted in a distribution that was mainly cytoplasmic. These 
strains were quantified alongside wild-type Elp1-GFP and Elp1-KR9A-GFP and this 
confirmed that Elp1-NLS(Cbp80) was mainly nuclear whereas Elp1-GFP, Elp1-KR9A-GFP 
and Elp1-NLS4A(Cbp80)-GFP were all cytoplasmic (Figure 3.23B). The fact that a 
functional NLS sequence inserted at this region can be recognised by the import 
machinery indicates that there is unlikely to be masking of sequences in this region 
due the conformation of the Elp1-GFP construct. This suggests that the NES sequence 
inserted at the same position should also be recognised by export machinery, though 
we acknowledge that masking affects could be sequence specific.  
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Figure 3.22: A nuclear localisation sequence from Cbp80 built into the Elp1 GFP.  Schematic 
showing the nuclear localisation sequence (NLS) from Cbp80 fused downstream of the Elp1 C-
terminus. A mutant version with four alanine substitutions was also cloned. The Cbp80 NLS 
sequence has basic residues highlighted in purple and alanine substitutions in red. The NLS 
predictor programme cNLS annotations of the Cbp80 NLS and NLS4A mutant sequences are 
also shown.  
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Figure 3.23: Elp1 fused to the NLS of Cbp80 is nuclear localised. A) Representative images of 
strains expressing GFP tagged Elp1, Elp1-KR9A, Elp1-NLS(Cbp80)-GFP, Elp1-NLS4A(Cbp80)-GFP 
with a Nic96-4mCherry nuclear boundary tag. The nuclear boundary (red) and GFP signals 
(green) were visualised by mCherry and YFP-ET channels respectively.  B) Quantification of the 
average % nuclear and cytoplasmic pools of Elp1. Percentages were calculated using the 
summed intensity of GFP and the number (n) of cells analysed for each strain is shown.  
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The Zymocin sensitivity of ELP1-NLS(Cbp80)-GFP and ELP1-NLS4A(Cbp80)-GFP strains 
was checked by Eclipse assay and by using the pAE1 Zymocin expression plasmid 
(Figure 3.23). The ELP1-NLS(Cbp80)-GFP strain was resistant to Zymocin whereas the 
ELP1-NLS4A(Cbp80)-GFP strain was sensitive. The ELP1-NES(Rev)-GFP strain showed 
slight resistance compared to wild-type ELP1-GFP in the pAE1 assay. This suggests it 
may have a minor effect on Elp1 function, the conformation of the NES or increased 
length of the linker between GFP and the Elp1 C-terminus could cause this small 
defect. Nevertheless the tRNA wobble uridine modification function of Elongator, as 
monitored using Zymocin sensitivity, is abolished when Elp1 is trapped in the nucleus.  
Taken together this data supports a role for Elongator that involves cytoplasmic rather 
than nuclear localisation. We have tried to deplete the nuclear pool of Elp1 using a 
strong nuclear export sequence (HIV Rev) and though we cannot be certain how well 
this works, the Elp1 protein is still functional in terms of tRNA modification. 
Conversely, when Elp1 is trapped in the nucleus using a strong nuclear import 
sequence (Cbp80) this inactivates Elongator. Coupled with the fact that the Elp1-KR9A 
mutant shows no defect in Elp1 localisation this would suggest that Elp1 is a bona fide 
cytoplasmic protein and that its cytoplasmic distribution is required for its tRNA 
modification.   
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Figure 3.24: Elp1 fused to the NLS of Cbp80 is non-functional.  A) Eclipse assay of various ELP1 
strains. Two clones of each strain were tested. Wild-type (WT, BY4741), ELP1-GFP (YRDS253) 
were controls for sensitivity and elp1∆ (YRDS250) for resistance to zymocin. B) Growth tests of 
various ELP1 strains containing the pAE1 plasmid. pAE1 contains the gamma toxin subunit of 
Zymocin under control of a galactose inducible promoter. Zymocin expression was induced by 
growth on galactose and repressed on glucose. ELP1-GFP (YRDS59) and elp1∆ (YRDS250) 
served as controls for Zymocin sensitivity and resistance respectively. 
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Chapter 4: The Elp1 basic region does not 
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terminal phosphorylation 
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4.1 Introduction 
The Elongator holocomplex consists of two copies of a heterotrimeric subcomplex 
containing Elp1, Elp2, and Elp3 (Otero et al., 1999) together with a more salt labile 
subcomplex containing two copies each of Elp4, Elp5 and Elp6 (Krogan and Greenblatt, 
2001, Winkler et al., 2001, Glatt et al., 2012).  The Elp1 subunit has been shown to be 
essential for assembly of Elongator and acts as a core scaffold (Frohloff et al., 2003, 
Fichtner et al., 2002b). The Elp3 subunit relies on Elp1 for stability and is also required 
for Elongator to be assembled. In contrast, Elp2 is dispensable for core Elongator 
assembly but is required for binding of accessory factor Kti12 (Frohloff et al., 2003, 
Fichtner et al., 2002b). The Elp4-6 subunits all contain a common RecA-like NTPase fold 
and assemble into a heterohexameric ring structure (Glatt et al., 2012). The 
dodecamer holocomplex of Elongator is suggested to be assembled such that the 
heterohexameric ring of Elp4-6 bridges two sub-complexes of Elp1-Elp3 (see Figure 1.3, 
Glatt et al., 2012).  
Kti12 is an accessory factor that binds to the preassembled Elongator complex and is 
essential for its function (Frohloff et al., 2001, Fichtner et al., 2002a, Butler et al., 
1994). It is not known why Kti12 is important for the tRNA modification function of 
Elongator but deletion or overexpression results in Zymocin resistance, suggesting that 
a balance of Kti12 is required (Butler et al., 1994).  
The Elp1 subunit of Elongator is also regulated by phosphorylation and it has been 
shown that the balance of phospho-isoforms is important for Elongator function 
(Mehlgarten et al., 2009, Jablonowski et al., 2004, Jablonowski et al., 2001a, 
Jablonowski et al., 2009). Deletion of the phosphatase SIT4 or multicopy KTI12 results 
in Elp1 ‘hyper’ phosphorylation and inactivation of Elongator (Jablonowski et al., 
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2001a, Butler et al., 1994, Frohloff et al., 2001, Fichtner et al., 2002a).  Conversely, 
mutation of the casein kinase HRR25 or deletion of KTI12 results in Elp1 ‘hypo’ 
phosphorylation but also inactivation (Mehlgarten et al., 2009, Jablonowski et al., 
2009, Jablonowski et al., 2004, Jablonowski et al., 2001a).  It has been suggested that 
both Kti12 and Hrr25 act together to negatively regulate Sit4 dependent Elp1 
dephosphorylation. Some evidence to support this is that the Elp1 ‘hypo’ 
phosphorylated form in kti12 deletion strains persists when combined with multicopy 
HRR25, suggesting promotion of phosphorylation requires both Hrr25 and Kti12. 
Multicopy KTI12 and SIT4 in combination also restored normal phosphorylation levels 
(Jablonowski et al., 2004, Mehlgarten et al., 2009) suggesting these proteins may 
antagonise each other. Further to this Hrr25 is known to associate with Kti12 and Elp1 
and the latter interaction is reduced with excess Kti12 (Mehlgarten et al., 2009). There 
is a clear interplay between different phospho-forms of Elp1 that is dependent on 
Kti12, Hrr25 and Sit4 and as of yet this is not well understood (see Figure 1.10).   
Many interlinking factors may influence the tRNA wobble uridine modification function 
of the Elongator complex, including correct assembly of the holocomplex, interaction 
with accessory factors and its modification status. It was therefore important to 
address whether there were any differences in these properties that may be 
associated with or perhaps be responsible for the loss of Elongator function observed 
in our basic region mutant elp1-KR9A.  
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4.2 Results 
4.2.1 Elongator complex assembly in Elp1-KR9A 
It was possible that the Elp1 basic region could be required for the proper assembly of 
the Elongator holocomplex. In order to check that the Elongator complex was still 
assembled in the presence of the basic region mutations, Elp1-GFP and Elp1-KR9A-GFP 
were pulled down with GFP-Trap and interacting proteins stained with SYPRO Ruby. As 
a negative control GFP tagged argininosuccinate lyase (Arg4), a protein involved in 
arginine biosynthesis that should not interact with Elongator subunits was pulled down 
in parallel. This controls for non-specific interactions with the beads and the GFP tag. 
There were no obvious differences in the overall assembly of the Elp1-3 subcomplex 
when comparing Elp1 and Elp1-KR9A and no major protein bands missing in the 
mutant (Figure 4.1).  This implies that the interaction profile of Elp1-KR9A may not be 
drastically altered compared to wild-type Elp1 and that this subcomplex is still 
assembled. Protein bands corresponding to Elp4-6 cannot be easily assigned but are 
reportedly less stable interactors and could also be obscured by the large number of 
other small protein bands in the pulldown. It should also be noted that a faster 
migrating N-terminal truncated form of Elp1 is also observed in both wild-type Elp1 
and Elp1-KR9A samples, this may be a degradation product or serve an as of yet 
unknown function (Fichtner et al., 2003).  
 
 141 
 
 
Figure 4.1: The Elp1-3 subcomplex of Elongator is assembled in the Elp1-KR9A mutant. GFP-
Trap pulldowns of Arg4-GFP, Elp1-GFP and Elp1-KR9A-GFP were analysed by SDS-PAGE on a 4-
12% Bis-Tris polyacrylamide gel and stained with SYPRO Ruby. The arrows indicate Elp1 
associated bands and where possible the predicted identity of each band based on previous 
work. The faster migrating form of Elp1 is an N-terminal truncation. There are no obvious 
differences in the pattern of bands between Elp1 and Elp1-KR9A. The right panel shows the 
predicted molecular weights of each of the Elongator subunits and Kti12.  
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To further determine the effects of the basic region mutation in terms of complex 
assembly, the interaction of GFP tagged Elp1 and Elp1-KR9A with other HA tagged 
Elongator complex members was tested. Representative members of the two sub-
complexes of Elongator, Elp3 and Elp5 respectively, together with Kti12, were HA 
tagged in the context of GFP tagged Elp1 or Elp1-KR9A.  
Pulldowns of Elp1-GFP and Elp1-KR9A-GFP were assayed for associated HA tagged 
Kti12, Elp3 and Elp5 and these were each present as co-precipitants under 
physiological salt conditions (Fig 4.2A and E). This confirms both that the Elp1-3 
subcomplex is intact and that interactions with Elp5 and Kti12 are largely unaffected by 
the basic region mutation. As with the previous pulldowns, Arg4-GFP was used as a 
negative control to show that these proteins are not associated with this nonspecific 
protein or with the GFP tag (Fig 4.2C). 
When these interactions were analysed by densitometry, Elp1-KR9A-GFP was 
consistently found associated with ~30% less Elp5-3HA and ~40% less Kti12-3HA than 
the wild-type Elp1-GFP protein (Fig 4.3A and B). These minor defects in interaction are 
highly consistent and statistically significant. In contrast, the interaction between Elp1-
KR9A-GFP and Elp3-3HA appears unchanged (Figure 4.3C), consistent with the previous 
experiment (Figure 4.1). As a positive control Elp1-1209A-GFP was also pulled down in 
the context of HA tagged Kti12, since this mutant was previously shown to have 
increased Kti12 binding (Abdel-Fattah and Stark, unpublished). As expected this 
phosphorylation site mutant had ~2 fold more interacting Kti12-3HA than wild-type 
Elp1-GFP (Figure 4.2 and 4.3A).   
It is difficult to explain why such defects in Kti12 and Elp5 interactions with the Elp1-
KR9A mutant were observed but it may reflect the fact that Elongator is no longer 
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modifying tRNA. If the complex needs to shuttle between multiple forms and is stuck 
due to the basic region mutations, then this may lead to reduced complex stability 
and/or interaction with particular subunits. It cannot be ruled out that the 
conformation of Elp1-KR9A may also be altered and that has subtle effects on these 
interactions. The differences in Kti12 association between Elp1-KR9A and Elp1-1209A 
mutants suggests that although both are non-functional in terms of tRNA modification 
(Chapter 3), the defect causing this loss of function may be distinct in both cases. 
These mutants may represent distinct forms of Elongator, whereas wild-type Elp1 may 
cycle between the two for its tRNA modification function. It is likely that Elp4 and 6 
would show similar defects in their interaction with Elp1-KR9A since these subunits are 
assembled into a hexameric ring complex alongside Elp5 (Glatt et al., 2012). We might 
also expect to see no defect in Elp2 interaction based on the results for Elp3 and our 
previous initial assay of total complex assembly (Figure 4.1).  
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Figure 4.2: Elp1 and Elp1-KR9A show differences in Elp5 and Kti12 association; See overleaf 
for figure legend. 
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Figure 4.2: Elp1 and Elp1-KR9A show differences in Elp5 and Kti12 association; See next page 
for figure legend. 
 146 
 
 
Figure 4.2: Elp1 and Elp1-KR9A show differences in Elp5 and Kti12 association. All samples 
were analysed by western blotting with anti-GFP and anti-HA. A) GFP-Trap pulldowns and B) 
inputs of Elp1-GFP and Elp1-KR9A-GFP in the context of HA tagged Kti12, Elp3 and Elp5. C) 
GFP-Trap pulldowns and D) inputs of Elp1-GFP and Elp1-KR9A-GFP in the context of HA tagged 
Kti12 and Elp5. E) GFP-Trap pulldowns and F) inputs of Arg4-GFP in the context of HA tagged 
Kti12, Elp3 and Elp5 as a negative control.  As a loading control input blots were also analysed 
with anti-Cdc28. The Elp1-1209A-GFP mutant is known to bind excess Kti12 and was used as a 
positive control. Pulldown blots were quantified relative to wild-type Elp1 by densitometry of 
HA tag signals normalised by GFP tag signals. 
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Figure 4.3: Elp1 and Elp1-KR9A show highly consistent differences in Kti12 and Elp5 
association. The average relative quantification of pulldown experiments by densitometry of 
HA tag signals normalised by GFP tagged signals. GFP-Trap pulldowns of Elp1-GFP and Elp1-
KR9A-GFP in the context of A) HA tagged Kti12 B) HA tagged Elp5 C) HA tagged Elp3. The Elp1-
1209A-GFP mutant is known to bind excess Kti12 and was used as a positive control. The 
number (n) of independent experiments is indicated and the error bars represent the standard 
deviation of the average.  * indicates a p value of < 0.05 (significant), *** indicates a p value < 
0.001 (very highly significant). Differences in Elp3 association were not statistically significant. 
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It was possible that since there was a reduced interaction between Kti12 and Elp1-
KR9A that the Elp1-KR9A mutant phenotype might be rescued by introducing extra 
copies of KTI12. Deletion or multicopy expression of Kti12 causes Elongator 
dysfunction (Butler et al., 1994) suggesting there is a balance that must be maintained 
for Elongator functionality. Extra copies of KTI12 were therefore introduced on a high 
copy plasmid (pJHW27) and the effect on Elongator function tested by eclipse assay 
(Figure 4.4A).  
Wild-type Elp1 strains with elevated KTI12 gene copy became resistant to Zymocin, in 
agreement with previous work (Butler et al., 1994, Mehlgarten et al., 2009). The Elp1-
KR9A mutant was Zymocin resistant as expected, and elevation of KTI12 copy number 
did not alter this. Extra Kti12 protein cannot suppress the Elp1-KR9A defect and this is 
consistent with defects in Kti12 association not being the primary cause of Elongator 
dysfunction in this mutant. The phosphorylation site mutant Elp1-1209A also remained 
Zymocin resistant with extra copies of KTI12. The effects of kti12∆ in the context of 
these mutants were also assayed (Figure 4.4B). The wild-type Elp1 became resistant to 
Zymocin when KTI12 was deleted but Elp1-KR9A and Elp1-1209A remained resistant. 
The balance of Kti12 is essential for Elongator function and disrupting this in the 
context of Elp1-KR9A does not rescue the strain’s Zymocin resistant phenotype.  
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Figure 4.4: Altering the balance between Elongator and Kti12 does not rescue the Zymocin 
resistance of elp1 mutants. A) Eclipse assay of WT (wild-type), ELP1-GFP, elp1-KR9A-GFP and 
elp1-1209A-GFP strains with either empty vector (EV) or a multicopy KTI12 vector (pJHW27). B) 
Eclipse assay of ELP1-GFP, elp1-KR9A-GFP and elp1-1209A-GFP strains with or without kti12∆. 
WT (YRDS1) and elp1∆ (WAY034) served as controls for Zymocin sensitivity and resistance 
respectively.   
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4.2.2 Elp1 and Elp1-KR9A can associate within Elongator 
Since it is now known that Elongator forms a dodecamer made up of two copies of its 
six subunits, it seemed possible that Elp1-KR9A could be defective in assembly into this 
higher order complex.  To test this YCp-ELP1-6HA and YCp-elp1-KR9A-6HA plasmids 
were transformed into ELP1-GFP and elp1-KR9A-GFP strains to generate cells 
expressing two differentially tagged copies of Elp1.   
Wild-type Elp1-GFP and Elp1-KR9A-GFP were pulled down using GFP-Trap and assayed 
for co-precipitation of the 6HA tagged versions of Elp1 (Figure 4.5).  The GFP tagged 
wild-type Elp1 co-precipitated with Elp1-6HA as was previously reported (Glatt et al., 
2012) and could also associate with Elp1-KR9A-6HA to the same degree. The GFP 
tagged Elp1-KR9A also co-precipitated with Elp1-6HA and Elp1-KR9A-6HA and no 
obvious defects in the interaction between any of the combinations were observed. 
There is therefore no apparent defect in Elp1 association within the Elongator complex 
due to the Elp1 basic region mutation.  
It is interesting that there are no observable defects in Elp1 association in Elp1-KR9A, 
despite the fact this mutant shows a minor defect in Elp5 association. It should also be 
noted that Elp3 association is apparently unaffected in this mutant (Figure 4.2A). This 
suggests that Elp1 could associate across Elp1-3 subcomplexes independently of the 
Elp4-6 hexamer.  To test this, these differentially tagged Elp1 pulldowns could be 
repeated in the context of an elp5 deletion strain. If wild-type Elp1 shows no defect in 
association with a different tagged version of itself, despite the hexamer being 
disrupted by loss of Elp5, then this interaction is independent of bridging by the Elp4-6 
subcomplex.  
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Figure 4.5: Elp1 and Elp1-KR9A can both associate as part of Elongator. All samples were 
analysed by western blotting with anti-GFP and anti-HA. A) GFP-Trap pulldowns and B) inputs 
from ELP1-GFP (YRDS253) and elp1-KR9A-GFP (YRDS255) strains containing YCp-ELP1-6HA or 
YCp-elp1-KR9A-6HA plasmids. As a loading control, input blots were also analysed with anti-
Cdc28. Pulldown blots were quantified relative to wild-type Elp1 by densitometry of HA tag 
signals normalised to the GFP tag signals.  
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The Zymocin sensitivity of these doubly tagged Elp1 strains was tested by Eclipse assay 
to check that Elongator dysfunction was not caused by an excess of Elp1 expression 
(Figure 4.6).  As shown previously, wild-type ELP1 strains were sensitive whereas elp1-
KR9A strains resistant to Zymocin.  ELP1-GFP strains remain sensitive in the context of 
YCp-ELP1-6HA, so increased ELP1 copy number is not causing any obvious defects. 
Interestingly, elp1-KR9A-GFP strains, though still largely Zymocin resistant, showed 
some subtle evidence of rescue by wild-type YCp-ELP1-6HA. When ELP1-GFP was 
combined with YCp-elp1-KR9A-6HA, the strain remained sensitive, but slightly less so 
than when combined with the wild-type YCp-ELP1-6HA plasmid. Strains expressing the 
two differentially tagged copies of Elp1-KR9A were completely resistant. The fact that 
the combination of Elp1-GFP with Elp1-KR9A-6HA is more functional than Elp1-KR9A-
GFP with Elp1-6HA implies adding the 6HA tag to the Elp1 C-terminus leads to slightly 
less functionality than the GFP tagged version, as was observed previously (Chapter 1).  
Although these effects are quite subtle, it is nonetheless clear from these experiments 
that both wild-type Elp1 and Elp1-KR9A compete for incorporation into Elongator 
despite the fact this leads to the formation of non-functional complexes. This is further 
evidence that there is no defect in the overall assembly of Elongator due to the Elp1 
basic region mutant.   
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Figure 4.6: Elp1 and Elp1-KR9A compete for assembly into Elongator. Eclipse assay of ELP1-
GFP (YRDS253) and elp1-KR9A-GFP (YRDS255) strains containing either empty vector (EV), YCp-
ELP1-6HA or YCp-elp1-KR9A-6HA plasmids. Two replicate spots of each strain are shown.  
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4.2.3 The Elp1-KR9A mutant leads to increased phosphorylation at the 
functionally important serine-1209 site 
The Elp1 subunit of Elongator is regulated by phosphorylation and the balance 
between phosphorylated forms is important for Elongator function (Mehlgarten et al., 
2009, Jablonowski et al., 2004, Jablonowski et al., 2001a, Jablonowski et al., 2009). 
Further to this our lab has shown that the C-terminus of Elp1 contains functionally 
important phosphorylation sites by phosphopeptide mapping and mutational analysis 
(Abdel-Fattah and Stark, unpublished). The mutation of Elp1 C-terminal serine 1209 to 
alanine results in Elongator inactivation, suggesting this site is functionally essential. 
Mutation of this site to a phosphomimic residue (aspartic acid) partially rescues this 
defect (Abdel-Fattah and Stark, unpublished).  
An anti-peptide antibody was raised against the 1209 phosphorylation site in order to 
begin investigating the possible relationship between the Elp1 basic region and 
phosphorylation. As expected, this antibody cannot recognise the Elp1-1209A mutant 
protein in which residue 1209 cannot be phosphorylated (Figure 4.7).  
To test whether the Elp1-KR9A mutant was still phosphorylated at this functionally 
important site, Elp1-GFP and Elp1-KR9A-GFP were pulled down with GFP-Trap and 
probed for ser-1209 phosphorylation (Figure 4.8A). The elp1-KR9A mutant showed a 
three-fold increased phosphorylation at this site compared to wild-type Elp1-GFP. This 
increase in ser-1209 phosphorylation was also detected in total protein extracts of 
Elp1-GFP and elp1-KR9A-GFP (Figure 4.8C).  
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Figure 4.7: The 1209p-Elp1 antibody does not recognise the Elp1-1209A mutant protein. 
Protein extracts from an elp1∆ strain (WAY034) containing YCp-ELP1-6HA or YCp-elp1-1209A-
6HA plasmids were analysed by western blotting with phosphospecific anti-phosphoserine-
1209 (anti-1209p-Elp1) antibody and anti-HA. As a loading control blots were also analysed 
with anti-Cdc28.  
 
Elp1-GFP and Elp1-KR9A-GFP pulldowns were also checked for general levels of 
phosphorylated serine as well as for ser-1209 phosphorylation (Figure 4.9).  Alongside 
the observed increase in ser-1209 phosphorylation there was also an increase in the 
phospho-serine signal in Elp1-KR9A-GFP compared to wild-type Elp1. The Elp1-1209A 
mutant showed wild-type levels of phospho-serine. The increase in the generic anti-
phospho-serine signal observed in Elp1-KR9A may be generated by recognition of ser-
1209 phosphate only, since this is lost in the Elp1-1209A mutant, but it is also possible 
that phosphorylation of Elp1 at other sites is increased. The interplay between 
different specific phosphorylation sites on Elp1 is not well understood and this requires 
more thorough investigation, perhaps with other phosphospecific antibodies. Such 
work is currently ongoing in our lab.  
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Figure 4.8: The Elp1-KR9A mutant shows increased phosphorylation at ser-1209.  All samples 
were analysed by western blotting with anti-GFP and anti-1209p-Elp1. A) Duplicate GFP-Trap 
pulldowns and B) inputs of Elp1-GFP and Elp1-KR9A-GFP. C) Protein extracts from strain 
expressing Elp1-GFP, Elp1-KR9A-GFP and Elp1-1209A-GFP. As a loading control, input and 
extract blots were also analysed with anti-Cdc28. Pulldown blots were quantified relative to 
wild-type Elp1 by densitometry of 1209p-Elp1 signals normalised by GFP tag signals.  
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In Elp1-KR9A, Kti12 association was slightly defective but phosphorylation was 
increased compared to wild-type Elp1. In contrast, Elp1-1209A results in increased 
Kti12 association. This apparent inverse relationship between serine 1209 
phosphorylation and Kti12 binding might suggest that phosphorylation governs Kti12 
binding and release. In support of this, Hrr25 kinase dead mutants lead to ‘hypo’ 
phosphorylated Elp1 and this also results in increased binding of Kti12 to Elp1, similar 
to the Elp1-1209A mutant (Mehlgarten et al., 2009).  
The increased phosphorylation at ser-1209 in Elp1-KR9A could be in line with the 
hypothesis that this mutant is trapped in a specific form that prevents tRNA 
modification. It is not yet clear why phosphorylation at this site is functionally relevant 
but it may be required to activate the complex or be involved in the mechanism of 
tRNA modification. The accumulation of this phosphorylated site in Elp-KR9A could 
indicate that this mutant is being misregulated, or could occur as a compensatory 
mechanism to lack of function. The basic region may also bind to phosphorylated 
residues in the Elp1 C-terminus and this could result in conformational changes 
involved in complex function. However, regardless of the mechanism, it is clear that 
mutation of the Elp1 basic region has some interplay with the functionally essential 
serine-1209 phosphorylation site.  
 158 
 
 
Figure 4.9:  The Elp1-KR9A mutant shows increased serine phosphorylation. All samples were 
analysed by western blotting with anti -GFP, anti -1209p-Elp1 and anti-pSer. A) GFP-Trap 
pulldowns and B) inputs of Elp1-GFP, Elp1-KR9A-GFP and Elp1-1209A-GFP. As a loading control 
input and lysate blots were also analysed with anti-Cdc28. Pulldown blots were quantified 
relative to wild-type Elp1 by densitometry of 1209p-Elp1 or pSer signals normalised by GFP tag 
signals.  
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4.2.4 Analysis of Elp1 and Elp1-KR9A associated proteins 
To attempt to identify any other differences between the binding profiles of Elp1-GFP 
and Elp1-KR9A-GFP these were affinity purified by virtue of their GFP tag and analysed 
by mass spectrometry for label-free quantification of associated proteins. As a control, 
pulldowns from untagged strains were processed in parallel. This method is qualitative 
rather than quantitative but would give an idea of any major differences in the 
interaction profile of the wild-type and mutant Elp1 proteins, especially in terms of 
known interactors.  Any candidate binding interactions drastically altered in Elp1-KR9A 
relative to wild-type Elp1 could then be confirmed by further pulldowns and western 
blotting. A huge difference in the binding profiles of these proteins was not expected 
based on the fact that there were no obvious protein band changes when GFP-Trap 
pulldowns of Elp1-GFP and Elp1-KR9A-GFP were compared (Figure 4.1).  
Using this approach, all subunits of the Elongator complex were identified associated 
with both Elp1-GFP and Elp1-KR9A-GFP (Table 4.1). The Elp1-3 subunits were all 
identified with a similar number of peptides between samples and were by far the best 
identified in terms of peptide number. The subunits Elp4-6 were also all identified but 
in most cases with only one peptide being detected. Since they are known and verified 
interactors this was acceptable and indicates that this subcomplex is present in the 
Elp1 associated fraction. However, peptides corresponding to Kti12 were not observed 
in any of the pulldown samples, despite associated Kti12 being readily identified by 
western blotting under the same pulldown conditions (Figure 4.2), this may suggest a 
technical issue in the identification of associated proteins.  
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Table 4.1: All Elongator subunits were detected in Elp1 and Elp1-KR9A pulldowns by mass 
spectrometry. Elp1-GFP and Elp1-KR9A-GFP were pulled down using GFP-Trap and precipitates 
analysed by mass spectrometry. The Elongator subunits were significantly enriched in 
pulldowns compared to untagged controls and are summarised. Enrichment is calculated by 
intensity in sample relative to total intensity (sample+bead control). PEP is the posterior error 
probability and acts as a p value for protein identification. Values shown here are 
representative of 2 independent replicates.  
 
All the subunits of the Elongator complex were identified associated with Elp1 and 
Elp1-KR9A by mass spectrometry, which when taken together with the previous data 
confirms that there is no major defect in assembly of the holocomplex. Since Kti12 was 
absent and the small complex subunits were only identified with a small number of 
peptides, caution is needed in interpreting any other interactors identified in this 
analysis.  Given that caveat, other interacting proteins that were identified by at least 
two peptides and that were enriched in the Elp1 and Elp1-KR9A pulldown samples 
relative to the bead control are summarised in Tables 4.2 and 4.3. In general there 
were less interacting proteins, meeting these criteria in Elp1-KR9A than wild-type Elp1 
pulldown, this may suggest the mutant is defective in some interactions, though this 
would require more work to confirm. 
Gene 
Name
Protein 
Name Description
Enrichment 
relative to beads
Number of 
peptides PEP Coverage %
YLR384C Elp1 Elongator subunit 1 0.999 75 0 64.6
YGR200C Elp2 Elongator subunit 2 1.000 46 0 67.6
YPL086C Elp3 Elongator subunit 3 0.997 34 0 60.9
YPL101W Elp4 Elongator subunit 4 1.000 1 2.18E-44 15.4
YHR187W Elp5 Elongator subunit 5 1.000 1 1.36E-15 3.9
YMR312W Elp6 Elongator subunit 6 1.000 1 0.000422 3.7
YLR384C Elp1 Elongator subunit 1 0.999 72 0 64.4
YGR200C Elp2 Elongator subunit 2 1.000 44 0 65.5
YPL086C Elp3 Elongator subunit 3 0.997 35 0 61.4
YPL101W Elp4 Elongator subunit 4 1.000 4 2.18E-44 10.3
YHR187W Elp5 Elongator subunit 5 1.000 1 1.36E-15 3.9
YMR312W Elp6 Elongator subunit 6 1.000 1 0.000422 3.7
Elp1-KR9A-GFP
Elp1-GFP
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Gene 
Name
Protein 
Name Description
Enrichment 
relative to 
beads
Number 
of 
peptides PEP Coverage %
Also in 
Elp1-
KR9A?
YJR009C TDH2
Glyceraldehyde-3-phosphate dehydrogenase, 
isozyme 2 0.825 19 8.6E-145 63.3 Yes
YKL081W TEF4
Gamma subunit of translational elongation factor 
eEF1B 0.824 9 0 25.5 No
YLR441C RPS1A
Ribosomal protein 10 (rp10) of the small (40S) 
subunit 0.793 9 1.23E-150 48.6 No
YBR196C PGI1 Glycolytic enzyme phosphoglucose isomerase 0.853 8 2.37E-124 17.5 No
YDR023W SES1 Cytosolic seryl-tRNA synthetase 1.000 7 2.03E-60 25.5 Yes
YER074W;
YIL069C
RPS24A/ 
RPS24A 
Protein component of the small (40S) ribosomal 
subunit 0.920 7 2.91E-30 37.8 No
YER110C KAP123 
Karyopherin beta, mediates nuclear import of 
ribosomal proteins prior to assembly into 
ribosomes 0.834 6 1.9E-167 14.5 Yes
YHR064C SSZ1
Hsp70 protein that interacts with Zuo1p (a DnaJ 
homolog) to form a ribosome-associated 
complex 0.987 6 2.47E-46 16.7 No
YGL245W GUS1 Glutamyl-tRNA synthetase (GluRS) 1.000 5 5.69E-17 7.9 No
YPL061W ALD6 Cytosolic aldehyde dehydrogenase 0.914 5 5.59E-39 11.8 No
YKL152C GPM1 Tetrameric phosphoglycerate mutase 0.832 5 2.42E-41 49 No
YMR108W ILV2 
Acetolactate synthase, catalyses the first 
common step in isoleucine and valine 
biosynthesis 1.000 4 1.66E-15 7 Yes
YCL050C APA1
AP4A phosphorylase; bifunctional diadenosine 
5',5'''-P1,P4-tetraphosphate phosphorylase 1.000 4 1.36E-11 11.8 Yes
YGL253W HXK2 Hexokinase isoenzyme 2 1.000 3 7.93E-37 12.1 No
YJL136C; 
YKR057W
RPS21B/ 
RPS21A 
Protein component of the small (40S) ribosomal 
subunit 1.000 3 2.18E-05 25.3 No
YDR050C TPI1 Triose phosphate isomerase 0.908 3 1.55E-105 46.8 No
YJL138C; 
YKR059W TIF2/TIF1 Translation initiation factor eIF4A 0.900 3 1.24E-44 18.7 No
YML028W TSA1 
Thioredoxin peroxidase; acts as both a ribosome-
associated and free cytoplasmic antioxidant 0.820 3 7.93E-84 60.2 No
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Table 4.2: Proteins enriched in wild-type Elp1 pulldowns. Elp1-GFP was pulled down using 
GFP-Trap and precipitates were analysed by mass spectrometry. The proteins identified that 
were significantly enriched in pulldowns compared to untagged controls are summarised. 
Enrichment is calculated by intensity in sample relative to total intensity (sample+bead 
control). PEP is the posterior error probability and acts as a p value for protein identification. 
Values shown here are representative of 2 independent replicates. 
YHR183W;
YGR256W
GND1 
/GND2
6-phosphogluconate dehydrogenase; part of the 
pentose phosphate pathway 0.793 3 4.50E-32 8.6 No
YER043C SAH1 S-adenosyl-L-homocysteine hydrolase 1.000 2 3.16E-14 4.5 No
YGR162W;
YGL049C
TIF4631/TI
F4632
Translation initiation factor eIF4G, subunit of the 
mRNA cap-binding protein complex 1.000 2 8.08E-16 6 No
YNL055C POR1 
Mitochondrial porin (voltage-dependent anion 
channel) 1.000 2 7.92E-09 7.4 Yes
YAL051W OAF1 Oleate-activated transcription factor 1.000 2 0.000204 5.7 No
YLR180W;
YDR502C
SAM1 
/SAM2 S-adenosylmethionine synthetase 1.000 2 6.91E-07 5.2 Yes
YKL080W VMA5
Subunit C of the eight-subunit V1 peripheral 
membrane domain of vacuolar H+-ATPase 1.000 2 6.65E-22 11.7 Yes
YAL003W EFB1 Translation elongation factor 1 beta 1.000 2 1.78E-05 9.7 No
YLR447C VMA6 
Subunit d of the five-subunit V0 integral 
membrane domain of vacuolar H+-ATPase 1.000 2 3.66E-05 8.4 No
YGR061C ADE6 
Formylglycinamidine-ribonucleotide (FGAM)-
synthetase 1.000 2 7.01E-09 3.1 No
YGL234W ADE5,7
Bifunctional enzyme of the 'de novo' purine 
nucleotide biosynthetic pathway 0.873 2 1.03E-91 5.5 Yes
YLR029C RPL15A 
Ribosomal 60S subunit protein L15A; binds to 5.8 
S rRNA 0.821 2 5.23E-23 24 No
YNL064C YDJ1 Type I HSP40 co-chaperone 0.804 2 4.25E-31 18.3 Yes
YPR181C SEC23 GTPase-activating protein 1.000 2 1.25E-11 4.8 No
YIL053W; 
YER062C
RHR2/ 
HOR2 Constitutively expressed glycerol-1-phosphatase 1.000 2 1.83E-14 14.4 No
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Table 4.3: Proteins enriched in Elp1-KR9A pulldowns. Elp1-KR9A-GFP was pulled down using 
GFP-Trap and precipitates were analysed by mass spectrometry. The peptides identified that 
were significantly enriched in pulldowns compared to untagged controls are summarised. 
Enrichment is calculated by intensity in sample relative to total intensity (sample+bead 
control). PEP is the posterior error probability and acts as a p value for protein identification. 
Values shown here are representative of 2 independent replicates. 
 
In the wild-type Elp1 pulldown a number of proteins involved in Energy metabolism, 
tRNA metabolism and translation were identified but the significance of these hits in 
terms of Elongator function is not yet obvious. Two S-adenosyl methione metabolising 
enzymes were identified; S-adenosyl-L-homocysteine hydrolase and S-
adenosylmethionine synthetase, which may warrant further investigation. These could 
work alongside the Radical SAM domain in Elp3 for the chemistry of the mcm5 and 
ncm5 modifications. Another interesting hit is Kap123, an importin implicated in 
ribosome transport. This was also found in Elp1-KR9A pulldowns with a similar number 
of peptides but only in one replicate, which is why it is not listed in the top hits for the 
mutant. While it is possible this importin could be responsible for nuclear import of 
Elongator, our data have shown this is not mediated by the Elp1 basic region and the 
fact that Kap123 was also found associated with Elp1-KR9A-GFP is consistent with this. 
Gene 
Name
Protein 
Name Description
Enrichment 
relative to 
beads
Number 
of 
peptides PEP Coverage %
Also in 
Elp1?
YJR009C TDH2
Glyceraldehyde-3-phosphate dehydrogenase, 
isozyme 2 1.000 11 8.6E-145 34 Yes
YOL039W RPP2A
Ribosomal protein P2 alpha, a component of the 
ribosomal stalk 0.818 5 1.98E-52 52.8 No
YLR180W;
YDR502C
SAM1 
/SAM2 S-adenosylmethionine synthetase 1.000 2 6.91E-07 5 Yes
YOL080C REX4 Putative RNA exonuclease 1.000 2 0.003745 9.7 Yes
YGL060W YBP2 Central kinetochore associated protein 1.000 2 0.000204 3.4 Yes
YNL222W SSU72
Phosphatase and transcription/RNA-processing 
factor 1.000 2 0.00022 8.7 Yes
YMR004W MVP1 
Protein required for sorting proteins to the 
vacuole 0.758 2 0.002658 6.3 Yes
 164 
 
Although speculative, it is tempting based on wild-type Elp1 results to hypothesise that 
Elongator may associate with enzymes involved in energy metabolism in order to 
‘sense’ changes in nutrients. It is also possible that the complex may accumulate 
around areas of active translation for its tRNA modification function or interact with 
ribosomal proteins to influence translation under certain conditions. The Elongator 
associated factor Kti11 has been shown to associate with ribosomal proteins (Fichtner 
et al., 2003), although it was not identified here. Since other known Elongator 
associated factors have not been identified then other techniques and/or conditions 
are required to more fully address its interacting partners.  In order to quantitatively 
assess the differences in the interaction profile of wild-type Elp1 and Elp1-KR9A a 
SILAC labelling approach could be employed (Ong et al., 2002) to enable a true 
quantitative comparison to be made. 
Although it is difficult to interpret the results for other unverified interacting proteins 
present in the pulldowns, the reduced number of hits in the Elp-KR9A mutant would 
support the idea that the complex could be trapped in a distinct form from wild-type 
Elp1 and that this excludes it from certain interactions. Our label free analysis of wild-
type Elp1 and Elp1-KR9A associated proteins does, however, support the conclusion 
that the Elongator complex is assembled in the basic region mutant.  
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4.2.5 Creating and testing conditional Elongator “switch off” strains 
The C-terminal domain of Elp1 and sites therein are functionally important for tRNA 
wobble uridine modification (Fichtner et al., 2003, Mehlgarten et al., 2009). This 
finding was exploited to create a system whereby the functionality of Elongator could 
be conditionally regulated in real time. This would allow investigation into the 
timescale for turnover of Elongator dependent tRNA modifications under Elongator 
“switch off” conditions. In the future this could be used to investigate the acute effects 
of loss Elongator function on a timescale that may reflect more accurately the type of 
change that might be seen if Elongator activity is subject to phosphoregulation. 
Proteins whose levels change or that show reduced translation when Elongator 
function is lost could be analysed using SILAC mass spectrometry and/or ribosome 
profiling (Ong et al., 2002, Ingolia et al., 2009). This could be useful since changes that 
result solely due to translational dysfunction may be masked in chronically adapted 
Elongator knockout strains where defects are likely to arise from secondary issues with 
long term translational defects.  
A version of Elp1 in which the C-terminus is disrupted by a Tobacco Etch Virus (TEV) 
protease cleavage site was designed (Figure 4.10A). This was introduced by ‘delitto 
perfetto’ into a strain that expresses TEV protease from the galactose-inducible GAL1 
promoter. The introduction of the TEV site did not interfere with Elongator function, as 
monitored by eclipse assays on glucose containing medium (Figure 4.10C, right panel).  
The TEV cleavage system was tested by switching cells growing in log phase from 
raffinose to galactose-containing media. This resulted in expression of TEV protease 
and specific cleavage of the Elp1 C-terminus, detectable by a dramatic reduction in the 
C-terminal HA tag signal, within 30 min of galactose switching. The Elp1-TEV-3HA signal 
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was undetectable by 90 min and this persisted for the full time course (Figure 4.10B). 
There was no cleavage of wild-type Elp1-3HA upon induction of TEV protease and no 
TEV expression or Elp1-TEV cleavage in glucose containing media.  
The consequences of TEV protease cleavage of Elp1 was assayed by eclipse assay on 
galactose containing medium (Figure 4.10C, left panel) and resulted in loss of 
Elongator function. The function of Elongator can therefore be disrupted by growth on 
galactose with this system.  
 
 
 
Figure 4.10: A galactose inducible TEV protease cleavage system to conditionally disrupt 
Elongator function; See overleaf for figure legend. 
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Figure 4.10: A galactose inducible TEV protease cleavage system to conditionally disrupt 
Elongator function; See next page for figure legend. 
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Figure 4.10: A galactose inducible TEV protease cleavage system to conditionally disrupt 
Elongator function. A) Schematic summary of the TEV protease cleavage system. Strains 
express TEV-3myc from a galactose inducible promoter as well as Elp1-3HA with a TEV 
cleavage site built into the C-terminus. B) Protein extracts from a galactose switching time 
course were analysed by western blotting with anti-Myc and anti-HA. After galactose induction 
TEV protease expression was detected and specific cleavage of Elp1::TEV-3HA was assayed by 
loss of the 3HA signal. Strains that express Elp1-3HA do not show any degradation. As a loading 
control blots were also analysed with anti-Cdc28. C) Eclipse assays of ELP1-3HA and ELP1::TEV-
3HA strains containing inducible TEV protease on galactose (TEV on) and glucose (TEV off) 
containing media. Each panel shows two replicate spot and multiple clones. ELP1-3HA 
(YRDS261) and elp1Δ (YRDS250) strains served as controls for Zymocin sensitivity and 
resistance, respectively.  
 
As an alternative means of conditional Elongator ‘switch off’ the Auxin inducible 
degron system was used (Nishimura et al., 2009). This method takes advantage of the 
fact that in plants there is a means by which certain transcription factors are degraded 
by the SCF- Ubiquitin pathway but only in the presence of the plant hormone Auxin.  
Substrates of this Auxin-degron system contain an Auxin inducible degron sequence 
(AID) which is specifically bound by this hormone. This Auxin-AID complex then binds a 
plant specific F-box transport inhibitor response 1 protein (Tir1) that forms a complex 
with the E3 ligase SCF machinery.  This ultimately results in recruitment of other 
factors for polyubiquitation and proteasome mediated degradation of the AID 
containing substrate (Quint and Gray, 2006).  
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In other eukaryotes, including S. cerevisiae, the components of the SCF E3 ubiqutin 
ligase machinery are conserved whereas the auxin regulated components, auxin, AID 
and the F-box protein Tir1 are not. The existing SCF machinery in other eukaryotes can 
by hijacked to replicate this plant system by expression of plant Tir1 and addition of 
exogenous auxin. Fusing the AID sequence to a protein of interest allows it to be 
degraded by the endogenous proteasome in an auxin-dependant manner.  
A strain was created where the Oryza sativa (Os) TIR1 gene with a C-terminal 9-myc 
tag was integrated at the ADH1 locus, under the control of the ADH1 promoter. Into 
this strain the AID sequence at the C-terminus of Elp1-3HA was introduced. This should 
allow conditional, proteasome mediated degradation of Elp1 in the presence of auxin 
or related compounds (Figure 4.11A).  
The presence of Elp1-3HA-AID was assayed in medium in which 0.5 mM 1-Naphthalene 
acetic acid (NAA), an auxin related compound, was added (Figure 4.11B).  A reduction 
in Elp1-3HA-AID could be seen after 30 min whereas Elp1-3HA was unchanged. Elp1-
3HA-AID was further reduced after 90 mins but was still visible until the 360 min time 
point, when it can no longer be seen by western blot. The consequences of NAA-
triggered loss of Elp1 on Elongator function were assessed by Eclipse assay (Figure 
4.11C).  When assayed on NAA containing agar at 0.25 mM and 0.5 mM, strains 
expressing Elp1-3HA-AID became resistant to Zymocin whereas Elp1-3HA strains 
remained sensitive. This system can therefore conditionally degrade the Elp1 subunit 
of Elongator in the presence of NAA, resulting in loss of Elongator function. 
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Figure 4.11: An auxin inducible degron system to conditionally disrupt Elongator function; 
See overleaf for figure legend.   
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Figure 4.11: An auxin inducible degron system to conditionally disrupt Elongator function; 
See next page for figure legend.   
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Figure 4.11: An auxin inducible degron system to conditionally disrupt Elongator function.  A) 
Schematic summary of the auxin inducible degron system for Elp1. Strains express Tir1-9myc 
from the ADH1 promoter as well as Elp1-3HA with an AID sequence built into the C-terminus. 
B) Lysates from the 1-Naphthalene acetic acid (NAA) time-course were analysed by western 
blotting with anti-Myc and anti-HA and specific degradation of Elp1-3HA-AID was assayed by 
loss of the 3HA signal. Strains that express wild-type Elp1-3HA show no degradation. As a 
loading control, input blots were also analysed with anti-Cdc28. C) Eclipse assays of strains 
expressing Elp1-3HA-AID and Elp1-3HA on media containing no NAA (System off), 0.25 mM and 
0.5 mM NAA (System on). Each panel shows two replicate spots and multiple clones. Wild-type 
(WT, BY4741) and elp1Δ (YRDS250) strains served as controls for Zymocin sensitivity and 
resistance, respectively. 
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The timescale for degradation of Elp1 is slower than for cleavage with the TEV system 
(compare Figure 4.10B and Figure 4.11B).  This may reflect the fact that the AID system 
relies on assembly of the ubiquitin-proteasome factors for loss of Elp1 and the binding 
of NAA to the AID sequence in Elp1, which may not be completely efficient.  The 
cleavage of Elp1-TEV by TEV protease is probably more efficient because it only relies 
on the TEV protease recognising its sequence and cleaving it.   
Since Elp1 acts as a scaffold, it is expected that in the AID system there is no Elongator 
complex formation in the absence of Elp1. In the TEV cleavage system, whether or not 
loss of the Elp1 C-terminus abolishes complex integrity has not yet been directly 
tested.  However, preliminary data from our lab has implicated the N-terminus as 
being essential for complex assembly, since truncation causes loss of Elp3 protein 
stability.  A deletion of the C-terminal portion, encompassing the same region as the 
TEV cleaved Elp1, can still bind to Elp3 suggesting that complex assembly may not be 
disrupted (Kozyrska and Stark, unpublished).  
The two conditionally functional Elp1 systems can both be used for acute down-
regulation of Elongator function to assess the turnover of the tRNA wobble uridine 
modifications. Once a timescale for loss of modification is established, the defects that 
arise from this down-regulation of Elongator function can be assessed without the 
complication of effects of chronic adaptation.  
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Chapter 5: The basic region in Elp1 is 
required for tRNA binding 
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5.1 Introduction 
The conserved basic region in Elp1 is essential for the tRNA wobble uridine 
modification function of Elongator, but although this sequence was annotated as a 
putative NLS it does not appear to play a role in regulating the distribution of the Elp1 
between the nucleus and cytoplasm. The Elp1 basic region is also not required for 
overall complex assembly but is linked to phosphorylation of the C-terminus of Elp1 at 
serine-1209. 
Elongator was previously described as a factor required for RNA polymerase II 
mediated transcription (Otero et al., 1999, Wittschieben et al., 1999) and in line with 
this the Elongator complex was shown to interact with naked DNA and nucleosomal 
DNA by electromobility shift assays (EMSAs, Winkler et al., 2002). However, the 
functional significance of this interaction in vivo is now disputed since Elongator is 
mainly cytoplasmic and could not be found interacting with any tested genes in yeast 
(Pokholok et al., 2002). It was then shown that Elongator bound RNA in vitro with a 
greater specificity than DNA (Gilbert et al., 2004, Greenwood et al., 2009). The Elp3 
subunit was also crosslinked to mRNAs and pre-mRNAs in vivo and was suggested to 
be in close proximity to elongating RNA transcripts despite its steady state cytoplasmic 
distribution (Gilbert et al., 2004, Petrakis et al., 2004). These studies implicated 
Elongator in nucleic acid binding but the in vivo function of this was remained unclear.  
When it was first reported that Elongator was required for tRNA wobble uridine 
modifications, it was shown that the Elp1 and Elp3 subunits could be crosslinked to 
radiolabelled tRNAGluUUC but not tRNA
Met
i  (Huang et al., 2005). More recently, it was 
demonstrated that the Elp4-6 subcomplex of Elongator binds tRNAGluUUC by EMSA and 
that this binding may be regulated by ATP hydrolysis (Glatt et al., 2012). This suggests 
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that Elongator may play a direct role in tRNA binding and subsequent modification, 
though the domains required and the molecular mechanisms involved are not known.  
Since the basic region in Elp1 was clearly important for Elongator function, we 
hypothesised that it may be involved in binding tRNA molecules to the complex for 
modification. Elp1 was analysed for potential RNA binding sites using the RNA/DNA 
binding prediction program BindN (Figure 5.1). This program attempts to predict RNA 
binding regions from primary sequence based on the properties of RNA binding 
residues from known structures (Wang and Brown, 2006). BindN highlighted the C-
terminal basic region in Elp1 as being likely to bind RNA. The human Elp1 subunit was 
also analysed in this way and a similar putative RNA binding region was highlighted, 
within the conserved basic region.  Arg4, a protein not known to bind RNA did not 
have any particular regions highlighted by BindN (data not shown). This is consistent 
with the hypothesis that this basic region may be required for tRNA binding. 
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Figure 5.1. The basic region in Elp1 is annotated as a putative RNA binding domain. A) The 
results from a search on BindN+ (http://bioinfo.ggc.org/bindn+/) for RNA binding regions with 
the entire protein sequence of S. cerevisiae Elp1 and H. sapiens Elp1. This highlights (red) the 
basic region as putative RNA binding with several residues scoring with high confidence. B) The 
putative RNA binding region is compared to the putative nuclear localisation sequence (NLS) 
predicted by NLStradamus (http://www.moseslab.csb.utoronto.ca/NLStradamus/). The S. 
cerevisiae Elp1 putative RNA binding resides (1223-1247) overlap exactly with the putative NLS 
and several basic residues (purple) that are mutated (red) in the elp1-KR9A mutant may 
therefore influence RNA binding if it occurs. The H. sapiens Elp1 RNA binding residues (1181-
1207) overlap partially with a predicted NLS.  
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5.2 Results 
5.2.1 Expression and purification of the Elp1 C-terminal domain 
We hypothesised that Elp1 may be able to bind to tRNA and that elp1-KR9A mutants 
may lose this ability due to mutation of the putative RNA binding region. To begin to 
address this hypothesis, recombinant Elp1 and Elp1-KR9A were required for in vitro 
binding assays. Since Elp1 is a large protein, made up of 1349 amino acids, it seemed 
possible that recombinant expression of the full-length protein could be problematic. 
Therefore the C-terminus of Elp1 (residues 730-1349), which is predicted to consist of 
largely alpha helices, was expressed as a GST fusion protein (Figure 5.2).  
Primers were designed with built in restriction sites to amplify the region encoding the 
C-terminal domain of Elp1 and Elp1-KR9A from plasmid constructs for cloning into an 
inducible expression vector pGEX-4T-1. A sequence encoding 6 histidine residues was 
included in the Elp1 reverse primer to add a C-terminal His6 tag.  The pGEX-4T-1 vector 
contains an N-terminal Glutathione-S-transferase (GST) sequence for in frame fusion to 
cloned genes as well as an intervening Thrombin cleavage site for tag removal after 
purification.  The final cloned ELP1 and elp1-KR9A constructs therefore contained an N-
terminal GST tag and a C-terminal His6 tag for tandem affinity purification (GST-ELP1-
CTD-His6 and GST-elp1-KR9A-CTD-His6).  These fusion genes are under the control of 
the tac promoter, which is repressed by plasmid encoded lac repressor in the absence 
of lactose or other analogues (Smith and Johnson, 1988, Amann et al., 1983, GE 
Healthcare, 2012).  E. coli strains grown in the presence of lactose or analogues such as 
IPTG direct  high levels of recombinant protein expression from pGEX vectors (Studier 
and Moffatt, 1986).   
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Figure 5.2: The C-terminal domain of Elp1 is predicted to be alpha-helical. The entire protein 
sequence of Elp1 was analysed using PSI-PRED v3.3 (http://bioinf.cs.ucl.ac.uk/psipred/) to 
predict its secondary structure. The C-terminal half of Elp1 was predicted to consist of alpha-
helices and residues 731-1349, starting ATRG were utilised for protein expression.  
 180 
 
Elp1 and Elp1-KR9A expression vectors were transformed into E. coli BL21 (DE3) and 
expression of the recombinant C-terminal domain was induced using auto induction 
medium (Studier, 2005).  Auto induction medium contains a mixture of glucose, 
lactose and glycerol as carbon sources.  Strains utilise glucose until late log phase and 
upon saturation begin to take up and metabolise lactose. This induces high-level 
expression of the tac promoter driven constructs upon saturation of the culture.  
Strains were grown at 30°C for 4-5 hours to allow for sufficient cell density and then 
the temperature was lowered to 25°C overnight to minimise degradation of expressed 
recombinant proteins.  
A small sample of culture by SDS-PAGE was assayed for expression of Elp1 and Elp1-
KR9A C terminal domains (Figure 5.3) and these were compared against a control GST- 
His6 expressing culture. Bands of around the expected size (~ 98 kDa) for GST-Elp1-
CTD-His6 and GST- Elp1-KR9A-CTD-His6 (from now on these will be referred to as Elp1 
CTDs or fusion proteins) that were absent from the GST- His6 lysate were observed. 
These samples were also checked for the presence of both tags by western blot (data 
not shown).  
Since relatively high levels of the recombinant Elp1 fusion proteins were detectable in 
our strains, these were used for tandem affinity purification alongside the GST-His6 
control.  Lysates were made from these strains and assayed for the presence of the 
Elp1 and Elp1-KR9A fusion proteins in the soluble fraction (SN) and the insoluble 
fraction (Pellet). The majority of the recombinant Elp1 fusion proteins appeared in the 
soluble fraction (Figure 5.4A) and so this was incubated with HisPur Cobalt resin for 
affinity purification using the C-terminal His6 tag (Figure 5.4B).  
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Figure 5.3: GST and His6 tagged Elp1 and Elp1-KR9A C-terminal domains were detectable 
upon induction of expression in E. coli. A small (20 μl) sample of saturated cultures in auto 
induction medium was boiled in an equal volume of 2× Laemmli Buffer. The samples were 
analysed by SDS-PAGE on a 4-12% Bis-Tris polyacrylamide gel and stained with Instant Blue. 
Many high abundance proteins can be stained in all samples. A unique band of around the 
predicted size (~ 98 kDa) of the Elp1 fusion proteins is highlighted in Elp1 and Elp1-KR9A 
samples along with possible degraded or truncated products. The GST-His6 control band is also 
highlighted and this is known to be well expressed under these conditions.  
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The His6 tag was used to purify full length Elp1 as the first step, since the GST affinity 
purification would isolate both full length and C-terminally truncated versions of Elp1. 
Small scale testing confirmed that this order of purification was the most efficient 
(data not shown). Binding of the Elp1 CTDs to the HisPur resin (Bead) was visualised 
despite there being a significant proportion remaining in the flow-through (FT). This 
was also the case for the GST- His6 control, indicating that the resin was likely 
saturated.  Other contaminating proteins were also present in the bound samples, 
some of which may be degraded versions of the Elp1 fusions.  Excess imidazole was 
used to elute the His6 tagged proteins off the resin by competition, as assayed by the 
‘Post Bead’ samples compared to the Bead samples (Figure 5.4B).  
The pooled eluates were added to glutathione resin for purification using the N-
terminal GST tag (Figure 5.4C).  A contaminating band was present in the bound 
sample between 64 and 51 kDa alongside the Elp1 and Elp1-KR9A fusion proteins. This 
band also appeared in the HisPur bead samples (Figure 5.4B) where it was 
hypothesised to be a degradation product of the fusion proteins. However, since it was 
also present in the glutathione bound sample it would need to have both affinity tags, 
so it seemed likely that it could be a bacterial chaperone as these can co-purify with 
recombinant proteins (GE Healthcare, 2012). Excess glutathione was used to elute the 
GST tagged proteins from the resin by competition and the eluates were pooled and 
concentrated (Figure 5.4D and Figure 5.5).  
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Figure 5.4: Purification scheme of Elp1 and Elp1-KR9A fusion proteins; See next page for 
figure legend.  
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Figure 5.4: Purification scheme of Elp1 and Elp1-KR9A fusion proteins. Samples from different 
stages of purification were boiled in an equal volume of 2× Laemmli Buffer. The samples were 
analysed by SDS-PAGE on 4-12% Bis-Tris polyacrylamide gels and stained with Instant Blue. 
Highlighted are the Elp1 fusion proteins, putative degradation products and GST-His6.  A) 
Samples before lysis (Pre), supernatants of cleared lysates (SN) and insoluble proteins and 
debris (Pellet) were analysed. B) Lysates were added to HisPur resin for affinity purification of 
the His6 tag. C) Pooled eluates from the HisPur resin were added to glutathione resin for 
purification of the GST tag. Samples of Inputs (IN), flow-through (FT) and Bound (Bead) 
fractions were analysed in both B) and C). D) Glutathione elution fractions, all three elution 
fractions for each sample were pooled.  
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The C-terminal domains of Elp1 and Elp1-KR9A were successfully purified using N-
terminal GST and C-terminal His6 tags (Figure 5.5A).  In order to find out the identity of 
the lower molecular weight band in the Elp1 and Elp1-KR9A fusion protein samples, 
both full length and contaminating bands (Band 2) were sent for peptide fingerprinting 
by mass spectrometry. Peptides identified were matched against the recombinant 
protein sequence (including tags) as well as the BL21 (DE3) E. coli proteome. 
Surprisingly, there were no significant peptide matches against E. coli proteins in any of 
the samples, indicating that the contaminating band was not a chaperone as 
hypothesised. Instead in all samples the vast majority of peptides identified matched 
Elp1 (Figure 5.5B) and this suggests that the small molecular weight band is a 
degradation product of Elp1.  An observation made was that peptides matching the 
GST tag were mainly found in the full length Elp1 band and a peptide corresponding to 
the first 8 residues in the GST tag was not identified in the smaller band. This suggests 
that this could be an Elp1 degradation product that has lost all or at least part of the 
GST tag but that it may interact with the full-length fusion protein and hence co-purify 
with it. 
To test this hypothesis further these samples were analysed by western blotting for 
presence of the GST and His6 tags (Figure 5.6). Interestingly, a His6 tagged protein at 
around the molecular weight of the contaminating band was detected. Although we 
could detect many smaller, lower intensity bands apart from full length with anti-GST 
antibody, no major GST band was detected at the molecular weight of the 
contaminating band. This supports the mass spectrometry data, making it very likely 
that the contaminating band is a degradation product of Elp1 that has lost all or part of 
the N-terminal GST tag.  
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Figure 5.5: Final purified Elp1 and Elp1-KR9A fusion proteins contain a lower molecular 
weight contaminating band that is likely to be a degraded version of Elp1. A) Two samples of 
pooled and concentrated recombinant proteins were boiled in an equal volume of 2× Laemmli 
Buffer, then analysed by SDS-PAGE on 4-12% Bis-Tris polyacrylamide gels and stained with 
Instant Blue. Highlighted are the Elp1 fusion proteins, a potential degradation product 
between 64 -51 kDa (Band 2) and the GST-His6 control. B) Table summarising the results for 
peptide mass fingerprinting. The majority of peptides detected in all samples matched the Elp1 
fusion protein sequence. The Elp1-KR9A fusion has a unique peptide that was only detected in 
this sample.  A peptide corresponding to the first 8 residues of the GST tag was missing in Band 
2 samples but in all samples a peptide corresponding to the C-terminal His tag was detected.   
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Figure 5.6: Western blotting recombinant Elp1 fusion proteins for GST and His6 tags. The 
samples shown in Figures 5.4 and 5.5 were analysed by western blotting for anti-His6 (top 
panel) and anti-GST (bottom Panel). The control GST-His6 bands are indicated as controls. 
Major bands corresponding to Elp1 fusion proteins (where both tags were recognised) were 
detected as indicated. A candidate for the contaminating band was detected in anti- His6 blots, 
appearing around 64-51 kDa. In the GST blot, multiple bands of lower size and intensity than 
the full-length fusion were detected and are likely to be other truncations or degradation 
products.  
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To further corroborate this, the samples were analysed with a non-phospho-Elp1 
antibody alongside both GST and His6 antibodies and the band pattern carefully 
matched across blots (Figure 5.7). A smaller molecular weight band was recognised by 
both the His6 and Elp1 specific antibodies but not the GST antibody. Therefore this is a 
degradation product of the Elp1 fusion protein which has lost all or part of the GST tag 
and that is stably associated throughout tandem affinity purification. This implies that 
full length Elp1 fusion protein may bind to a degradation product of itself and this 
complex is stable through the affinity purification, despite having lost at least part of 
one affinity tag, most likely the N-terminal GST.  We (Chapter 3) and others (Glatt et 
al., 2012) have shown that two copies of Elp1 can associate within Elongator and these 
results would indicate that the C-terminus is directly involved in this interaction.  This 
suggests that the Elp1 subunits may directly interact with one another within 
Elongator.  
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Figure 5.7: Western blotting recombinant Elp1 fusion proteins with Non-phospho-Elp1 
antibody. The samples shown in Figure 5.5 were analysed by western blotting for anti-Non-
phospho-Elp1 (left), anti-GST (middle) and anti-His6 (right). Major bands corresponding to Elp1 
fusion proteins (where both tags were recognised) were detected as indicated. The 
contaminating band, appearing around 64-51 kDa was detected by both anti-Non-phospho-
Elp1 and anti- His6 antibodies but not by the anti-GST antibody.  
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5.2.2 Electrophoretic mobility shift assays with Elp1 and excess tRNA 
If the Elp1 basic region is a tRNA binding domain then the recombinant Elp1 C-terminal 
domain should bind to tRNA and the Elp1-KR9A mutation would be expected to disrupt 
this. Binding reactions using either recombinant GST, Elp1 or Elp1-KR9A fusion proteins 
and an excess of yeast tRNA were set up and analysed by native gel electrophoresis 
and SYBR Gold staining (Figure 5.8A). If tRNA forms a complex with any of the 
recombinant proteins then we would expect to see a shift in the mobility of SYBR Gold 
detected tRNA to a slower-migrating position on the gel compared with the free tRNA. 
This technique is referred to as an Electrophoretic mobility shift assay (EMSA, Hellman 
and Fried, 2007) 
A clear tRNA shift was detected in binding reactions with the wild-type Elp1-CTD but 
not with the Elp1-KR9A-CTD or GST alone, despite all proteins being present at 
equivalent concentrations (Figure 5.8B). The wild-type Elp1-CTD shows multiple tRNA 
band shifts with the most intense SYBR gold staining at the top of the gel. It is possible 
that the complex formed between Elp1 and tRNA may not be completely stable during 
electrophoresis or that heterogenous complexes may exist due to multimerisation. 
Thus the wild-type Elp1-CTD forms a complex with tRNA and mutation of the basic 
region, as in Elp1-KR9A, disrupts this. 
Normally, antibody against the protein of interest is added to binding reactions and if 
this protein is present in a shifted complex, the binding of the antibody will produce an 
even greater mobility shift – a ‘supershift’. This is used to confirm that a protein of 
interest is part of the shifted complex. However, since the majority of the Elp1-tRNA 
complex was detected near the top of the gel it may have been impossible to resolve a 
supershift under our conditions.  
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Figure 5.8: The wild-type Elp1 C-terminal domain forms a complex with tRNA but this is 
disrupted in Elp1-KR9A; See next page for figure legend.   
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Figure 5.8: The wild-type Elp1 C-terminal domain forms a complex with tRNA but this is 
disrupted in Elp1-KR9A. A) EMSA using excess unlabelled tRNA and recombinant GST, Elp1-
CTD and Elp1-KR9A-CTD proteins. Complexes were allowed to form between unlabelled tRNA 
at 0.3 μM and the indicated concentrations of recombinant proteins. Binding reactions were 
separated on a 6% polyacrylamide native gel and stained with SYBR Gold. B) Recombinant 
protein from each dilution was added to an equal volume of 2× Laemmli Buffer, boiled and 
analysed by SDS-PAGE on a 4-12% Bis-Tris polyacrylamide gel followed by SYPRO Ruby staining.  
  
Instead, binding reactions were set up as previously, separated by native gel 
electrophoresis and then proteins present in the shifted bands were detected using 
western blotting (Figure 5.9).  The native gel blot was probed with antibodies against 
the His6 tag and the GST tag and wherever there was a shifted tRNA band, the 
equivalent band was also detected by both antibodies. Therefore, the Elp1-CTD was 
present in these shifted complexes.  In the binding reactions with no tRNA, both His6 
and GST tags were observed as single bands at the top of the gel. This could be 
consistent with a native multimerisation of Elp1, since faster migrating bands cannot 
 193 
 
be detected corresponding to the smaller contaminating version of Elp1 assayed 
during purification, however, we cannot yet conclude this based on this experiment.  
 
 
Figure 5.9: The wild-type Elp1 C-terminal domain is detectable in shifted tRNA bands. EMSA 
using excess unlabelled tRNA and recombinant Elp1-CTD. Complexes were allowed to form 
between unlabelled tRNA at 0.3 μM and the indicated concentrations of recombinant Elp1-
CTD. Binding reactions were separated on a 6% polyacrylamide native gel and one part of the 
gel stained with SYBR Gold. The rest of the gel was treated with 0.5% SDS and transferred to 
nitrocellulose membrane for western blotting using anti -His6 and anti -GST antibodies.  
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5.2.3 Electrophoretic mobility shifts assays with Elp1 and 32P-tRNA 
A complex between the wild-type Elp1 C-terminal domain and tRNA was detectable by 
native gel electrophoresis and SYBR Gold staining in an electrophoretic mobility shift 
assay, but this was not formed with the Elp1-KR9A C-terminal domain. However, in 
order to detect shifted tRNA using SYBR Gold, an excess concentration (0.3 μM) of 
unlabelled tRNA was used in each binding reaction. This excess of tRNA may artificially 
force the formation of complexes under physiological salt conditions. To address this 
yeast tRNA was radiolabelled at the 5’ end with [32P]-Phosphate as this allows more 
sensitive detection of complexes formed in binding reactions with much lower tRNA 
concentrations (Hellman and Fried, 2007).  
Binding reactions between 32P -tRNA and the Elp1-CTD were analysed by native gel 
electrophoresis and autoradiography. As observed previously, an Elp1-tRNA complex 
was detected at the top of the gel (Figure 5.10). This indicates that the complex 
formed between Elp1 and tRNA is not simply due to an artificial interaction caused by 
excess tRNA. Although there is some smearing in the shifted band, compared to the 
previous experiments using excess tRNA, the binding pattern was a lot less 
heterogeneous (compare Figure 5.8 and 5.10). This suggests that excess tRNA may 
have caused heterogeneous complexes to form or that the large amount of negatively 
charged tRNA affected the stability of the complexes during separation.  
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Figure 5.10: The wild-type Elp1 C-terminal domain forms a complex with radiolabelled tRNA. 
EMSA using 32P-labelled tRNA and recombinant Elp1-CTD. Complexes were allowed to form 
between 32P-tRNA at 1 nM and the indicated concentrations of recombinant Elp1-CTD. Binding 
reactions were separated on a 5% polyacrylamide native gel and analysed by autoradiography 
(left panel). Recombinant protein from each dilution was added to an equal volume of 2× 
Laemmli Buffer, boiled and analysed by SDS-PAGE on a 4-12% Bis-Tris polyacrylamide gel 
followed by Instant Blue staining (right panel).  
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Since the Elp1-tRNA complex migrated at the very top of 5% and 6% polyacrylamide 
native gels, further binding reactions were resolved on 4-20% polyacrylamide native 
gels. The reasoning was that this would allow further separation of the shifted complex 
without loss of the free tRNA probe. Binding reactions between 32P-tRNA and GST, Elp1 
and Elp1-KR9A fusion proteins was assayed by separation on 4-20% native gels and 
autoradiography (Figure 5.11A).  A tRNA shift was resolved with wild-type Elp1-CTD 
binding reactions but this was absent in the GST and Elp1-KR9A-CTD binding reactions 
despite similar concentrations of fusion proteins being present (Figure 5.11B).  The 
Elp1-tRNA complex still appears at the top of the gradient gel, which suggests it may 
be quite large since it is also unable to migrate very far though the pores of the 4% 
polyacrylamide region.  
In order to estimate the dissociation constant (KD) of the Elp1-tRNA complex, binding 
reactions were set up with a negligibly low concentration of 32P-tRNA (0.1 nM) and 
increasing concentrations of wild-type Elp1 fusion protein ranging from 25 nM to 0.75 
μM. These were resolved by native gel electrophoresis and autoradiography (Figure 
5.12A and 5.12B) and the fraction of bound tRNA quantified by densitometry. The 
values of the % bound fraction were plotted against the protein concentration and this 
was fitted to a non-linear sigmoidal curve (Figure 5.12C). The calculated KD was 0.37 
μM and therefore the dissociation constant of the complex formed between Elp1 and 
tRNA was estimated to be in the low micromolar range.  However, for a more accurate 
dissociation constant measurement more replicates are required.  A potential issue 
with these calculated values is that the protein concentrations were determined based 
on the calculated extinction coefficient of GST-Elp1-His6, but this is not a completely 
pure preparation and this could lead to under estimation. 
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Figure 5.11: The wild-type Elp1 C-terminal domain forms a complex with radiolabelled tRNA 
that is disrupted in the Elp1-KR9A mutant. A) Electromobility shift assay using 32P-labelled 
tRNA and recombinant GST, Elp1 and Elp1-KR9A fusion proteins. Complexes were allowed to 
form between 32P-tRNA at 1 nM and the indicated concentrations of fusion proteins. Binding 
reactions were separated on a 4-20% polyacrylamide native gel and analysed by 
autoradiography. B) Recombinant protein from each dilution was added to an equal volume of 
2× Laemmli Buffer, boiled and analysed by SDS-PAGE on a 4-20% Bis-Tris polyacrylamide gel 
followed by SYPRO Ruby staining.  
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The spreading of the bound bands at higher protein concentrations also make accurate 
quantification by densitometry technically difficult. The stoichiometry of binding is also 
not yet known but in some cases the value of the hill coefficient (b) calculated from 
fitted binding curves can indicate the stoichiometry of binding (Weiss, 1997). This 
value was calculated to be ~2 in this experiment, suggesting that the Elp1 CTD could 
interact with tRNA as a dimer. This could be more accurately determined with 
stoichiometric binding reactions using a constant excess of unlabelled tRNA containing 
a small concentration of 32P-tRNA and increasing molar concentrations of protein. 
Plotting the fraction of bound tRNA against the concentration of protein/tRNA 
equivalents allows the stoichiometry to be determined based on fitting to saturation 
binding curves (Ryder et al., 2008).  
 
Binding reactions were set up using 32P-tRNA and either GST-His6, Elp1-CTD or Elp1-
KR9A-CTD but this time these were resolved on a 1.5% agarose gel, followed by 
autoradiography (Figure 5.13).  Using this format, a shifted Elp1-tRNA complex that 
migrated nearer the middle of the gel was resolved and as previously, this shift was 
absent in GST-His6 and Elp1-KR9A-CTD binding reactions. This format may therefore be 
more appropriate for further analysis of the complex since it can now be better 
resolved through the larger pores formed by agarose.   
Taken together, these data demonstrate that the C-terminal domain of Elp1 forms a 
complex with tRNA and that Elp1-KR9A, in which the basic region of Elp1 is mutated, 
has lost the ability to form this complex. We propose that this basic region in Elp1 is a 
well-conserved RNA binding domain. 
 199 
 
  
Figure 5.12: The wild-type Elp1 C-terminal domain and tRNA form a complex with a KD in the 
low micromolar range; See next page for figure legend 
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Figure 5.12: The wild-type Elp1 C-terminal domain and tRNA form a complex with a KD in the 
low micromolar range. A) EMSA using 32P-labelled tRNA and increasing concentrations of 
recombinant Elp1-CTD. Complexes were allowed to form between 32P-tRNA at 0.1 nM and the 
indicated concentrations of protein. Binding reactions were separated on a 4-20% 
polyacrylamide native gel and analysed by autoradiography. B) Recombinant protein from 
each dilution was added to an equal volume of 2× Laemmli Buffer, boiled and analysed by SDS-
PAGE on a 4-12% Bis-Tris polyacrylamide gel followed by SYPRO Ruby staining. C) % Bound 
fraction shifts in the mobility of 32P-tRNA were quantified by densitometry and plotted against 
the protein concentration (μM) of Elp1 C-terminal domain. A sigmoidal curve was fitted to the 
data (f = (a*b)b/cb+xb) as indicated by the dotted line and the r2 values and calculated KD are 
shown. The KD is estimated from the protein concentration at which binding is 50% of the 
maximal value.  
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Figure 5.13: The wild-type Elp1 C-terminal domain forms a complex with radiolabelled tRNA 
that can be resolved by 1.5% agarose electrophoresis. A) EMSA using 32P-labelled tRNA and 
recombinant GST-His6, Elp1 and Elp1-KR9A fusion proteins. Complexes were allowed to form 
between 32P-tRNA at 1 nM and the indicated concentrations of recombinant proteins. Binding 
reactions were separated on a 1.5 % native agarose gel and analysed by autoradiography. B) 
Recombinant protein from each dilution was added to an equal volume of 2× Laemmli Buffer, 
boiled and analysed by SDS-PAGE on a 4-12% Bis-Tris polyacrylamide gel followed by SYPRO 
Ruby staining.  
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5.2.4 Specificity of the Elp1-tRNA interaction 
Previous work has demonstrated interactions between the Elongator complex and 
nucleic acids, such DNA and mRNA. In order to test the specificity of the interaction 
between the Elp1 fusion proteins and tRNA, competition binding experiments were 
carried out to assay whether any other types of nucleic acid could compete effectively 
with tRNA for binding to Elp1.   
Binding reactions with the Elp1 C-terminal domain and 1 nM 32P-tRNA were set up as 
previously but this time the formation of complexes was challenged with a variety of 
competitors (Figure 5.14). Since it is known that non-specific competitors added to 
binding reactions can decrease even specific interactions if added at a sufficiently high 
concentration, especially when using purified proteins, competitors were carefully 
titrated at incremental concentrations.  
Heparin, a negatively charged polysaccharide that is often used to purify nucleic acid 
binding proteins and inhibit RNA polymerase binding to DNA (Wallin and Maenpaa, 
1979, Carey et al., 2012) was tested first as a competitor in the binding reaction. 
Heparin has the highest net negative charge of any known biological molecule, and yet 
it was unable to significantly compete the Elp1-tRNA interaction at 0.5 nM or 1 nM, 
although at a 5-fold molar excess (5 nM) it reduced the complex formation by around 
60%. The interaction between the Elp1 C-terminal domain and tRNA is resistant to 
heparin when present at similar molar concentrations but the tRNA binding by Elp1 
may be quite dependent on electrostatic charge interactions, which cause its 
disruption at higher molar excess of heparin. Given heparin’s high negative charge 
density and the fact it is known to be a strong interactor with nucleic acid binding 
proteins this is not entirely surprising.  Polyuridylic acid (poly(U)) was also used as a 
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competitor since contrary to tRNA, this is an RNA which should have no secondary 
structure. This was supplied as a potassium salt and the length of each poly(U) tract is 
not known but is expected to be very heterogeneous. Therefore, half, equivalent and 5 
times the gram concentration of tRNA was titrated in as competitor.  Poly(U) did not 
significantly compete the Elp1-tRNA complex at any of these concentrations. Since it 
was also shown in previous work that Elp1 could bind DNA, we also tested ssDNA 
(22bp oligonucleotide) as a competitor. No significant competition of the Elp1-tRNA 
complex by ssDNA was detected, although there may be some small loss of complex at 
a 5-fold molar excess when quantified by densitometry. These results demonstrate 
that the Elp1 C-terminal domain preferentially binds tRNA over unstructured RNA and 
ssDNA. 
These competition experiments are in agreement with previous work using the 
recombinant Elp4-6 hexamer, which formed a complex with tRNA but not poly(U) or 
ssDNA (Glatt et al., 2012). Taken together the complex between the Elp1 C-terminal 
domain and tRNA is stable to competition from the other nucleic acids tested, 
suggesting specificity for tRNA. Extra stability and specificity may be imparted within 
the context of the entire Elongator complex where other subunits, such as the 
hexameric subcomplex, may also make interactions with the tRNA molecule (Glatt et 
al., 2012).  
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Figure 5.14: The complex formed between the Elp1 C-terminal domain and tRNA is not 
competed by other types of nucleic acid. EMSA using 32P-labelled tRNA and recombinant Elp1-
CTD. Binding reactions were incubated with 32P-tRNA at 1 nM and the indicated concentrations 
of recombinant proteins but were challenged with increasing concentrations of unlabelled 
competitor. The competitor concentrations were; Heparin and ssDNA: 0.5, 1.0 and 5 nM; 
poly(U): 12.5, 25, 125 pg/μl. Binding reactions were separated on a 4-20% polyacrylamide 
native gel and analysed by autoradiography. Shifts in the mobility of 32P -tRNA were quantified 
relative to those seen the absence of competitor by densitometry.  
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5.2.5 Analysis of Elp1 association with endogenous tRNA 
The Elp1 basic region may be important for the binding of tRNA to the Elongator 
complex based on in vitro EMSA assays with the recombinant C-terminal domain. 
However, we also wanted to address whether a defect in tRNA binding to Elongator in 
vivo could be observed. Previous work has demonstrated that immunoprecipitated 
Elp1 and Elp3 subunits can be crosslinked to exogenous tRNA (Huang et al., 2005) but 
the association of the complex with endogenous tRNA has never been demonstrated.  
To test whether Elp1 was associated with endogenous tRNAs, Elp1-GFP was pulled 
down using GFP-Trap and then RNA extracted from the precipitate (Figure 5.15A). The 
associated RNAs were assayed by northern blotting using a probe against tRNAGlnUUG, 
which receives the Elongator dependent mcm5s2 modification (Figure 5.15B). To act as 
positive controls glutamine tRNA synthetase (Gln4), which is known to bind tRNAGln 
(Grant et al., 2013, Grant et al., 2012), and cytoplasmic export protein 1 (Cex1), which 
is involved in the tRNA nuclear export pathway (McGuire and Mangroo, 2007), were 
used.  
There was an enrichment of tRNAGlnUUG associated with the Elp1-GFP pulldown 
compared to the untagged control, indicating that this tRNA associates with Elongator 
in vivo. The Gln4-GFP control also shows enrichment of tRNAGlnUUG, this is one of its 
two substrate tRNAs in yeast. No association of tRNAGlnUUG with Cex1-GFP was seen 
despite it being annotated as a tRNA binding protein. It is possible that Cex1-GFP may 
bind tRNA too transiently to see enrichment under these conditions. There is more 
enrichment of tRNAGlnUUG in the Gln4-GFP pulldown compared with the Elp1-GFP 
pulldown, but this may be because Gln4 binds only two tRNA substrates whereas 
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Elongator may be associated with any one of up to eleven different substrate tRNAs, 
which could reduce the tRNAGlnUUG specific signal significantly. 
 
 
Figure 5.15: Elp1 associates with tRNAGlnUUG. A) GFP pulldowns (left panel) and inputs (right 
panel) from untagged, Elp1-GFP, Gln4-GFP and Cex1-GFP expressing strains were analysed by 
western blotting with anti-GFP. The relative GFP pulldown signal was quantified by 
densitometry. B) RNA was extracted from GFP pulldown (left panel) and input (right panel) 
samples and analysed by northern blotting using a probe against tRNAGlnUUG. The relative 
tRNAGlnUUG signal was quantified by densitometry and normalised by input signals. This PD/IN 
value was also divided by GFP signals to take into account the efficiency of GFP pulldown.  
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The Elp1-KR9A basic region mutant has a defect in tRNA wobble uridine modification 
(Chapter 3) and furthermore there was no detectable binding of tRNA to the 
recombinant C-terminal domain of Elp1 in this mutant (Sections 5.2.3 and 5.2.4). To 
assay whether there was an in vivo defect in the association of tRNAGlnUUG with the 
basic region mutant, Elp1-KR9A-GFP and Elp1-GFP were pulled down with GFP-Trap 
and RNA was extracted from the precipitates (Figure 5.16A). As a negative control, 
argininosuccinate lyase (Arg4) was used, this should not associate with tRNA and 
controls for the presence of the GFP tag. The association of tRNAGlnUUG with Elp1-GFP, 
Elp1-KR9A-GFP and Arg4-GFP was analysed by northern blotting (Figure 5.16B).  No 
enrichment of tRNAGlnUUG in Arg4-GFP was observed compared with the untagged 
control, but as previously we could see an enrichment in the wild-type Elp1-GFP 
precipitate. There was no enrichment of tRNAGlnUUG with Elp1-KR9A-GFP and this 
implies that the basic region mutation disrupts tRNA binding to the complex.  
To analyse the specificity of this interaction, northern blots were reprobed for 
tRNALysCUU, which is not modified in an Elongator dependent manner (Figure 5.16C).  
There was still enrichment of tRNALys CUU in wild-type Elp1-GFP samples and this 
suggests that the association is not specific for Elongator modified tRNAs under our 
conditions. This is consistent with previous work that showed association of the Elp4-6 
hexamer with tRNA was unchanged regardless of which base was present in the 
wobble position (Glatt et al., 2012). It was suggested based on this that Elongator does 
not discriminate between tRNAs it binds but rather has a proofreading mechanism that 
determines which ones are modified (Glatt et al., 2012). In contrast, other work has 
shown that Elp1 and Elp3 could only be crosslinked to tRNAGlu and not tRNAMeti, 
implying that there might be some specificity for wobble uridine-containing tRNAs 
(Huang et al., 2005). However, since the structure of initiator tRNAs is slightly different, 
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having for example an A-U base pair at the top of the acceptor stem, three G-C base 
pairs in the anticodon stem and the sequence -GAUC- in place of -GrTC- in the TC 
loop this may not have been the best control to use in the latter work (Basavappa and 
Sigler, 1991, Kapp et al., 2006).  
The total associated RNA from the above pulldowns was also run on a small RNA gel 
and visualised by SYBR Gold staining (Figure 5.16D).  In the wild-type Elp1 pulldown a 
clear enrichment in the tRNA band was seen compared with the other samples. 
However, we could also see enrichment for what we assume are the 28S RNA and 18S 
ribosomal RNA bands, as well as dark staining at the top of the gel implying that other 
larger RNAs are also present. It has been shown by crosslinking that Elongator 
associates with mRNAs and this cannot ruled out based on our data (Gilbert et al., 
2004). However, it is also possible that these RNAs are associated with other proteins 
that interact with Elongator, for example Elongator interacts with RNA Polymerase II in 
lysates (Otero et al., 1999, Wittschieben et al., 1999), although the true in vivo 
significance of this is disputed. Ribosomal proteins were also identified in our mass 
spectrometry pulldown analysis, which was carried out under the same conditions as 
these RNA pulldowns (Chapter 2).  This makes interpretation of the true specificity of 
Elongator in vivo quite difficult and other methods may be required to complement 
this work. However, these RNA pulldown experiments do provide preliminary evidence 
to support the idea that that Elp1 associates with endogenous tRNAs and that this 
association depends on the basic region of Elp1, since the Elp1-KR9A allele blocks tRNA 
enrichment in the GFP precipitates.  
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Figure 5.16: Elp1 association with tRNAGlnUUG is disrupted in the Elp1-KR9A mutant; See next 
page for figure legend.   
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Figure 5.16: Elp1 association with tRNAGlnUUG is disrupted in the Elp1-KR9A mutant.  A) GFP 
pulldowns (left panel) and inputs (right panel) from untagged, Elp1-GFP, Elp1-KR9A and Arg4-
GFP expressing strains were analysed by western blotting with anti-GFP. The relative GFP 
pulldown signal was quantified by densitometry. B) RNA was extracted from GFP pulldown 
(left panel) and input (right panel) samples and analysed by northern blotting with a probe for 
tRNAGlnUUG). C) Northern blots were reprobed with tRNA
Lys
CUU. In both B) and C) the relative 
tRNAGlnUUG and tRNA
Lys
CUU signals were quantified by densitometry and normalised by input 
signals. This PD/IN value was also divided by GFP signals to take into account the efficiency of 
GFP pulldown. D) Total associated RNA was analysed by separation on a 10% TBE-Urea gel and 
staining with SYBR Gold. The tRNA band is indicated and the relative signals were quantified by 
densitometry.  
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6.1 A basic region in the Elp1 subunit of Elongator is essential 
for wobble uridine tRNA modification 
The Elp1 subunit of the Elongator complex contains a lysine/arginine-rich basic region 
in the C-terminal domain that is highly conserved across eukaryotes and was 
previously annotated as a putative nuclear localisation sequence (Fichtner et al., 2003). 
Since it was originally thought that Elongator played a role in transcription, a nuclear 
function, this was in line with the proposed function of the complex. However, it was 
then shown that the Elongator subunits were all mainly localised in the cytoplasm of 
cells and that the major function of the complex was likely to be in tRNA wobble 
uridine modification, which is thought to occur in the cytoplasm (Pokholok et al., 2002, 
Huang et al., 2005, Hopper and Phizicky, 2003). It therefore became less clear why the 
Elp1 subunit would contain a highly conserved basic region if its role was indeed to 
direct nuclear import. It was still thought possible that nuclear import could be 
important to the tRNA modification function of Elongator, despite its steady state 
cytoplasmic localisation, because deletion of the gene encoding a karyopherin, 
Kap120, was found to confer Zymocin resistance (Fichtner et al., 2003). However, this 
mutant has since been shown to have normal levels of Elongator dependent tRNA 
modification and so must be defective in Zymocin uptake or activation (Huang et al., 
2008).  
In order to address the role of this basic region in Elp1 we created alanine mutations 
throughout this sequence. Mutation of nine basic residues in this region to alanine, as 
in elp1-KR9A, caused Zymocin resistance and loss of Elongator dependent SUP4 ochre 
suppressor function, both phenotypes of which were comparable in severity to those 
shown by an elp1 deletion strain.  This indicates that the levels of Elongator dependent 
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tRNA modification in this mutant are very low. Mutations of the proximal (first half) 
basic residues in this region, as in elp1-KR5A, caused Zymocin resistance but only a 
minor defect in Elongator dependent SUP4 ochre suppression. Mutations of the distal 
(second half) basic residues, as in elp1-KR4A, were wild-type in terms of Elongator 
dependent SUP4 ochre suppression but showed some level of Zymocin resistance, 
though less than elp1-KR9A and elp1-KR5A mutant strains. Since the elp1-KR9A 
mutations confer a more severe phenotype than mutations in either the proximal or 
distal sequence alone then the entire region must be important for the tRNA 
modification function of Elongator.  
Despite the elp1-KR9A mutations being of comparable severity to an elp1 knockout in 
terms of the above assays, other phenotypes associated with Elongator dysfunction do 
not appear to be as severe.  There was no obvious temperature sensitivity phenotype 
compared to an elp1 knockout in any of the basic region mutants or in functionally 
important phosphorylation site mutants, elp1-1209A or elp1-1198A-1202A. Therefore, 
the presence of non-functional Elp1 gives a less severe temperature sensitivity 
phenotype than deletion of this subunit. The assayed temperature sensitivity of elp1∆ 
is fairly subtle and so any small level of tRNA modification in point mutants compared 
with a complete ELP1 knockout may allow this phenotype to become less pronounced. 
In the absence of Elongator no mcm5U is detected and there is a reduction in the levels 
of the s2 modification on mcm5s2U receiving tRNAs (Huang et al., 2005). Urm1 is 
responsible for the incorporation of the s2 group and it is possible that there may be 
some interplay between Urm1 and Elongator, although this has never been fully 
investigated. Assembly of a non-functional Elongator complex may support higher 
levels of the Urm1 catalysed s2 modification, allowing for a slightly higher level of tRNA 
function, although this is speculative.  
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In agreement with previous work, multicopy expression of hypomodified tRNALysUUU 
and tRNAGlnUUG rescued the temperature sensitivity of the elp1∆ deletion strain (Esberg 
et al., 2006). This implies that this phenotype is caused by reduced translational 
function of these hypomodified tRNAs in particular.  Multicopy expression of the 
hypomodified tRNA is expected to rescue this defect by increasing the available pool of 
these tRNAs for decoding, thereby compensating for the effects of reduced binding of 
these tRNAs to the ribosome A-site.  
Hypersensitivity to rapamycin was assayed in elp1-KR9A mutants but this was less 
severe than that shown by an elp1 knockout strain. Unlike temperature sensitivity, 
rapamycin sensitivity in elp1 knockouts was not suppressed by increased expression of 
the hypomodified tRNAs. It is possible that other Elongator dependent tRNAs may 
rescue this defect, although this has not yet been tested. Hypersensitivity to rapamycin 
may occur due to a more severe translational defect caused by concurrent loss of 
Elongator dependent tRNA modifications and the rapamycin induced down-regulation 
of protein synthesis. It was also reported that rapamycin treatment causes nuclear 
accumulation of spliced tRNAs in yeast (Pierce et al., 2010), so it is possible that this 
may deplete the pool available for translation and worsen the effects of lack of tRNA 
modifications.  
Deletion of Urm1 has previously been shown to confer similar, though less severe 
phenotypes compared with Elongator dysfunction. This was proposed to be due to the 
fact that Elongator targets eleven wobble uridine containing tRNAs, whereas Urm1 
only targets three (see Figure 1.9). In urm1 deletion strains rapamycin hypersensitivity 
does show rescue by the hypomodified tRNAs (Leidel et al., 2009). Since the same 
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tRNAs failed to rescue the phenotype in elp1 deletion strains, this suggests that the 
Elongator phenotype could be more severe in terms of its effects on translation.  
There may also be another aspect to the phenotypes caused by Elongator dysfunction. 
In yeast elp3∆ and urm1∆ cells recent work has demonstrated a weak induction of the 
Gcn4 signalling pathway caused by increased translation of the GCN4 mRNA (Zinshteyn 
and Gilbert, 2013).  In brief, Gcn4 is a transcription factor that is translationally 
regulated by stress and nutrient availability. The GCN4 mRNA contains upstream open 
reading frames (uORFs) that repress Gcn4 ORF translation by preferential ribosome 
binding at these upstream regions. The major pathway of Gcn4 up-regulation occurs in 
low nutrient availability, when increased levels of uncharged tRNAs directly activate 
the protein kinase Gcn2, which in turn phosphorylates the initation factor eIF2. This 
prevents the reformation of eIF2 ternary complexes and leads to decreased efficiency 
of translation initiation. This results in a general decrease in protein synthesis, but 
causes a concurrent increase in Gcn4 translation due to the skipping of uORFs on its 
mRNA transcript. Increased levels of the Gcn4 transcription factor cause transcriptional 
induction of a number of genes required to maintain homeostasis during amino acid 
starvation (Hinnebusch, 2005).  
In elp3∆ and urm1∆ cells there is an increase in transcription and translation of certain 
Gcn4 targets but the major pathway of Gcn4 activation governed by increased eIF2 
phosphorylation is apparently unaffected. The authors of this work suggest that a 
distinct mechanism is increasing the efficiency of Gcn4 translation and this could be 
occurring due to signalling by the hypomodified tRNAs directly, although how this 
occurs is not yet understood (Zinshteyn and Gilbert, 2013). It is possible that lack of 
tRNA modification could be sensed by an unknown pathway that causes cellular 
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responses. In yeast, mutations that result in inappropriate nuclear accumulation of 
tRNAs are associated with upregulation of Gcn4 translation, independent of eIF2 
phosphorylation (Qiu et al., 2000). It is possible that hypomodification of tRNAs 
resulting from lack of Elongator function causes them to accumulate in the nucleus and 
that this contributes to aberrant signalling. It is also possible that alterations in 
metabolites occurring due to lack of tRNA modifications may cause perturbations in 
signalling pathways, though both these suggestions are highly speculative.  
A double deletion of GCN4 and ELP3 with concurrent multicopy expression of the 
hypomodified tRNALysUUU and tRNA
Gln
UUG gives partial rescue of the rapamycin 
hypersensitivity phenotype, suggesting that disruption of cellular signalling pathways 
may also contribute to certain Elongator phenotypes (Zinshteyn and Gilbert, 2013). 
Although preliminary, an analysis of Elp1-GFP associated proteins by mass 
spectrometry identified three ribosome proteins of the 40S subunit as well as the 
initiation factor eIF4A and elongation factors eEF1B and eEFB1.  If these interactions 
can be confirmed they may support the idea that Elongator function could be linked to 
translation in other ways that are independent of tRNA function, though for now this is 
speculative.  
Taken together, this illustrates that thresholds for the detection of a particular 
Elongator phenotype are distinct due to the potentially complex underlying causes 
resulting from lack of tRNA modification, which are not yet fully understood.  
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6.2 Mutations in the Elp1 basic region do not disrupt the 
nucleo-cytoplasmic distribution of Elp1 
The basic region of Elp1 was annotated as a bipartite type NLS sequence that in 
isolation could direct the nuclear import of GFP (Fichtner et al., 2003). We confirmed 
this NLS function using the Elp1 C-terminal domain and demonstrated that mutations 
in this basic region disrupt this nuclear import function. The fact that elp1-KR9A, elp1-
KR5A and elp1-KR4A alleles all showed similar GFP distributions in this assay is 
interesting since the severity of phenotypes displayed by these mutants are distinct. 
The distal elp1-KR4A mutant is the most functional of these mutant alleles conferring 
only a slight Zymocin resistance phenotype. This indicates that tRNA modification in 
this strain is less defective compared with the other basic region mutants. However, 
the defect in nuclear import appears to be comparably severe across these mutants. 
This is consistent with the tRNA modification defects resulting from mutations in the 
Elp1 basic region not being due to a defect in nuclear import in the context of the full 
length polypeptide.  
The distribution of Elp1-GFP between the nucleus and cytoplasm was assayed and as 
reported previously found to be mainly cytoplasmic (Pokholok et al., 2002, Huh et al., 
2003). If the basic region functioned to drive nuclear import then mutation of this 
region should cause a clear defect in the distribution of Elp1 at steady state. However, 
we could not detect any obvious defects in the distribution of the Elp1-KR9A, Elp1-
KR5A or Elp1-KR4A GFP fusion proteins compared to wild-type Elp1-GFP. 
Quantification of images allowed a small nuclear pool of Elp1 to be demonstrated, 
~25% of the total Elp1 in a wild-type strain, but this was not disrupted by any basic 
region mutations, which would be expected if the basic region was required for 
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nuclear import of the subunit. Therefore the basic region of Elp1 does not function as a 
nuclear localisation sequence in the context of the full-length protein.  
We also hypothesised that functionally important phosphorylation sites, which lie 
upstream of the Elp1 basic region, could potentially regulate the localisation of Elp1. It 
would be expected that if these sites regulated distribution of the complex then 
phosphorylation site mutations would disrupt this and cause an obvious defect in 
localisation. The effect of the elp1-1209A mutation on the distribution of Elp1 between 
the nucleus and cytoplasm was assayed but no obvious changes were observed to 
suggest this site regulates localisation.  
In yeast, the cytoplasmic localisation of Elongator subunits has been reported in a 
number of studies (Pokholok et al., 2002, Huh et al., 2003). However, the localisation 
of the accessory factor Kti12 is less well defined. The Yeast GFP collection annotates 
Kti12 as cytoplasmic but the distribution of Kti12-GFP in these images appears to be 
uniform throughout the cell, whereas cells expressing GFP tagged Elongator subunits 
have a weakly-fluorescent nucleus as in the images presented in this work (Huh et al., 
2003). The localisation of Kti12-GFP was therefore determined and although the 
majority was observed to be cytoplasmic there was a higher relative nuclear pool of 
Kti12 compared to that of Elp1. Since it was formally possible that Kti12 may influence 
the localisation of the Elongator, the distribution of Elp1-GFP and Elp1-KR9A-GFP 
between the nucleus and cytoplasm was assayed in a kti12 deletion background but no 
obvious changes were seen in comparison with KTI12 wild-type controls.  
The role(s) of phosphorylation sites in Elp1 and of the accessory factor Kti12 in terms 
of Elongator-dependent tRNA wobble uridine modification remain to be defined but 
these do not appear to function through affecting Elp1 localisation. Although the Elp1 
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basic region can direct nuclear import in isolation, in the context of the full length Elp1 
subunit this property does not appear to be functionally relevant. However, the basic 
region is nonetheless essential for wobble uridine tRNA modification.  
 
6.3 The cytoplasmic localisation of Elp1 is essential for 
Elongator’s tRNA modification function 
The Elongator subunits all share a cytoplasmic localisation but in agreement with our 
work a small nuclear pool has also been reported (Pokholok et al., 2002, Fichtner et al., 
2002b, Rahl et al., 2005). It is clear that mutations in the basic region of Elp1 do not 
disrupt this steady state nuclear pool. However, this small pool of nuclear localised 
Elp1 may nevertheless contribute to function. To test this, the classical NES sequence 
from HIV Rev was cloned between Elp1 and the GFP tag and this should actively 
deplete any nuclear localised Elp1 to give a cytoplasmic distribution at steady state. 
The distribution of Elp1-NES(Rev)-GFP showed no clear differences in distribution 
compared to wild-type Elp1-GFP. This could imply that there is little to no nuclear Elp1 
under steady state conditions, although we cannot rule out that this sequence may not 
function in the context of Elp1. The addition of the NES(Rev) sequence also did not 
cause any major defect in Elongator function as assayed by Zymocin sensitivity, 
consistent with the tRNA modification function of Elongator requiring a cytoplasmic 
localisation.   
To confirm this, a bona fide nuclear localisation sequence was cloned between Elp1 
and the GFP tag. As expected this Elp1-NLS(Cbp80)-GFP construct was localised to the 
nucleus and consequently resulted in Zymocin resistance comparable to that of an elp1 
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deletion mutant. Taken together, these results are in support of the cytoplasmic 
localisation of Elongator being required for its tRNA wobble uridine modification 
function. 
It is possible that the small nuclear pool of Elp1 quantified through analysis of our 
images represents some form of unaccountable background signal rather than a 
genuine nuclear pool. Images taken in 3D could not be quantified because of problems 
with GFP and mCherry photobleaching but we have observed that in these images the 
apparent GFP nuclear pool assayed in Elp1-GFP, Elp1-KR9A-GFP and Elp1-NES(Rev)-GFP 
expressing strains is visibly bleached after the first z-section resulting in a black hole in 
the image, whereas cytoplasmic GFP signals are still detectable throughout the image 
stack. The 2D analysis of cells will also overestimate the nuclear pool since it does not 
take into account compartment volume. It is possible that a low level of degraded or 
unfolded Elp1-GFP could account for this nuclear pool. 
In other work both fluorescent protein tagging and immunolocalisation with antibodies 
against endogenous Elongator subunits have been used to assay localisation (Rahl et 
al., 2005, Fichtner et al., 2002b, Pokholok et al., 2002, Holmberg et al., 2002).  We and 
others have also tested different methods of sample preparation, such as different 
fixation methods or using live cells (Rahl et al., 2005, Kim et al., 2002). Arguably since 
these separate experimental conditions all indicate low levels of nuclear Elongator 
then this may not a technical artefact.  
It is possible that other basic sequences in Elp1 could influence its distribution. The 
programme cNLS Mapper does not annotate the Elp1 basic region as a bipartite NLS, 
but it does pick up a possible monopartite NLS with a score of 7.5.  A score of 7-8 
indicates possible partial nuclear localisation of a protein, and can be compared with 
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the bona fide bipartite NLS of Cbp80 that is given a score of 9.5 by cNLS Mapper. 
However, this putative monopartite sequence occurs in the N-terminus of Elp1 within 
a region predicted to fold into a beta sheet and so it may not be accessible to the cell’s 
import machinery. For comparison, the tRNA binding protein Gln4 has a similar 
cytoplasmic localisation to Elp1 (Huh et al., 2003) and also has a monopartite NLS 
predicted by cNLS mapper with a score of 7. If these sequences could interact with the 
importin machinery in the context of the full length polypeptide they may allow a small 
nuclear pool of these enzymes to form.  Neither of the predicted monopartite NLS 
sequences in these proteins conform exactly to the monopartite NLS consensus 
sequence so it is unclear whether these could be functionally significant in the context 
of these proteins. However, it is formally possible that these short basic sequences 
could allow a small nuclear pool of these tRNA modification enzymes to exist in yeast. 
There are no other putative NLS sequences identified by cNLS mapper in any of the 
other Elongator subunits or accessory factors.  
In worms, mice and flies, Elongator subunits have also been reported to be 
cytoplasmic but the extent to which any nuclear Elongator is detectable is also unclear 
(Chen et al., 2009a, Lin et al., 2013, Creppe et al., 2009, Kim et al., 2002, Holmberg et 
al., 2002). In worms no apparent nuclear pool of Elp1 was detectable and there was no 
overlap between Elp1 and nuclear localised RNA Pol II in mice (Chen et al., 2009a, Lin 
et al., 2013). In human cells the consensus appears to be that the complex is 
predominantly cytoplasmic, although there may be a small nuclear pool of Elongator 
subunits as assayed by both immunolocalisation and fluorescent tagging of Elp 
subunits (Kim et al., 2002, Holmberg et al., 2002, Close et al., 2012b). Fractionation of 
HEK293 cell lysates followed by western blotting for Elp5 detected ~14% of the protein 
in the nuclear fraction (Close et al., 2012b). However, this would require further work 
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to confirm for the other larger Elongator subunits, since it is possible that this 
represents a pool of Elp5 that is not assembled into Elongator and that may be freely 
diffusible between the compartments due to its small size.  
We cannot completely rule out that Elp1 may undergo nucleo-cytoplasmic shuttling 
under steady state conditions and this could have masked the effect of the strong NES 
sequence. However, since addition of the HIV Rev NES did not affect the nucleo-
cytoplasmic distribution, this would require wild-type Elp1 nuclear export to occur at a 
similar rate as that which occurs in the Elp1-NES construct, implying that a strong 
nuclear export sequence would have to be present in either wild-type Elp1 or another 
Elp subunit. Nuclear import must also be occurring independently of the Elp1 basic 
region, since its mutation does not affect the steady state distribution. It is not 
immediately clear how shuttling would be mediated since the nuclear pool of Elp1 
would have to be maintained at low levels to support cytoplasmic wobble uridine tRNA 
modification and there are no obvious nuclear export sequences in Elp1 or any other 
Elongator subunits. Previous work has also shown that sequential deletion of known 
yeast nuclear export pathways, including the Crm1 export pathway, also does not 
disrupt the steady state distribution of Elp1 (Rahl et al., 2005). However, it is true that 
this does not take into account redundancy between these pathways or export by a 
yet unknown pathway. 
It is known that in yeast mature tRNAs constitutively shuttle between the nucleus and 
the cytoplasm and this may serve as a proofreading mechanism, preventing damaged 
or improperly folded tRNAs from being exported back into the cytoplasm for use in 
translation (Takano et al., 2005, Phizicky and Hopper, 2010b). It is formally possible 
that a small nuclear pool of Elongator may increase the efficiency of tRNA modification 
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by allowing modifications to occur in both compartments. In support of this, work 
unrelated to studies of Elongator assayed the modification status of a tRNA species 
that had apparently never been exported to the cytoplasm and the ncm5U 
modification was detected (Ohira and Suzuki, 2011). The re-export of mature yeast 
tRNAs is sensitive to nutrient status since amino acid, glucose and nitrogen starvation 
conditions cause nuclear accumulation of certain tRNA species. However, the 
localisation of Elongator subunits has been tested under various stress conditions, 
including nitrogen starvation (Rahl et al., 2005, Tkach et al., 2012, Breker et al., 2013). 
Under these conditions there were no apparent differences in the cytoplasmic 
distribution of Elongator subunits. Although further work may be required to confirm 
that there are not some more subtle changes occurring, it does suggest that if 
Elongator does shuttle then this may be independent of tRNA localisation, and so the 
immediate benefit of this to the yeast cell is not clear.  
It seems formally possible based on our data that there is a small pool of nuclear 
localised Elp1 but how this is maintained and its functional significance is not apparent. 
Whether or not a small nuclear pool of Elp1 does exist in vivo is ultimately out with the 
scope of this project. It is clear that localisation is not being disrupted by mutation of 
the Elp1 basic region and that the major Elongator pool involved in wobble uridine 
tRNA modification is cytoplasmic.  
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6.4 Elongator is still assembled in the Elp1-KR9A mutant 
In the context of the Elp1 basic region mutant Elp1-KR9A, the overall assembly of the 
Elongator complex was largely unaffected. The Elp1-3 subcomplex was detected in GFP 
tagged Elp1 and Elp1-KR9A pulldowns and all subunits were detected by mass 
spectrometry. HA-tagged Elp3, Elp5 and Kti12 proteins were also each present as co-
precipitants in GFP tagged Elp1 and Elp1-KR9A pulldowns. Since there were no 
apparent losses of any Elongator subunit interactions then the basic region of Elp1 is 
unlikely to encompass a binding domain involved in complex assembly.  However, 
there were subtle differences in the association of the Elp5 subunit and Kti12 with 
Elp1-KR9A binding ~30% and ~40% less of each, respectively. These defects could occur 
because the complex is non-functional and as a result the stability of certain 
interactions may be reduced.  
If Elongator cycles between multiple forms in order to bind, modify and release a tRNA 
molecule then a mutation that disrupts this mechanism could cause the complex to 
stall in a particular conformation. The Elp5 subunit has been shown to be an integral, 
though less stable component of the Elongator complex along with Elp4 and Elp6. 
These associate together into a hexameric ring complex and so any defect in the 
association of the Elp5 subunit with Elp1-KR9A should theoretically be shared with the 
Elp4 and Elp6 subunits (Glatt et al., 2012). Rather than forming a static structure it is 
expected that the hexameric ring complex would be involved in cycles of 
conformational changes, as in other members of the RecA-like NTPase superfamily, 
though this has not been confirmed (Lyubimov et al., 2011). Assuming this is the case, 
reduced association of Elp5 with Elp1-KR9A may occur due to an arrest in the 
mechanism of action of Elongator, resulting in reduced or stalled cycling of the 
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hexamer. It is also still possible that part of a binding domain for these subunits has 
been disrupted by the basic region mutations causing reduced association, since 
involvement of the Elp1 C-terminus in the interaction between the Elp1-3 subcomplex 
and the Elp4-6 hexamer has never been directly tested.  
Mutation of the essential serine phoshorylation site at position 1209 to alanine causes 
a similar level of defect in Elongator function as the Elp1-KR9A mutation. However, this 
Elp1-1209A mutant showed a ~2 fold increased Kti12 association compared to wild-
type Elp1. This is in contrast to reduced Kti12 association in the Elp1-KR9A mutant and 
suggests that the cause of Elongator dysfunction in these mutants is distinct. If 
Elongator does cycle between Kti12-associated and free forms, our data would be 
consistent with the basic region and phosphorylation site mutants having distinct 
effects on the balance of these different forms. It would be interesting to test whether 
the other Elongator accessory factor Kti11 and its binding partner Kti13 share the same 
pattern of association in these mutants.  
If defective Kti12 association was the primary defect in the Elp1 basic region mutant 
we reasoned that increasing the levels of Kti12 might rescue this defect and give a 
more functional Elongator complex. However, multicopy KTI12 did not rescue the 
Zymocin resistant phenotype of Elp1-KR9A and this is consistent with the minor 
defects in Kti12 association not being the major cause of dysfunctional Elongator in 
this mutant, rather this may occur as a secondary consequence. It is also possible that 
if the Elp1-KR9A mutation has disrupted part of the Kti12 binding domain then this 
might prevent rescue by extra copies of Kti12. However, since it was previously shown 
that truncation of the Elp1 C-terminus, including the basic region (deletion of residues 
1229-1349), still supported Kti12 association to the same degree as wild-type Elp1 
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(Fichtner et al., 2002b), it seems unlikely that the basic region is a major determinant 
of Kti12 interaction. 
The Elongator holocomplex has been proposed to be assembled using two copies of 
each of the six Elongator subunits to form a dodecamer (Figure 1.3, Glatt et al., 2012). 
It was possible that the Elp1 basic region may be important for integration into this 
higher order complex and so to test this, GFP pulldowns in strains with two 
differentially tagged versions of Elp1 and Elp1-KR9A were carried out. Both tagged 
versions of Elp1 and Elp1-KR9A could associate to a similar degree in various 
combinations, so that the Elp1-KR9A mutant was able to associate with a differentially 
tagged wild-type Elp1 and Elp1-KR9A protein. Concurrent expression of both wild-type 
Elp1 and Elp1-KR9A alleles in the same cell caused partial Zymocin resistance, 
indicating the formation of both functional and non-functional complexes. Therefore 
the basic region mutant could compete with the wild-type Elp1 for incorporation into 
Elongator.  
Interestingly, when purifying recombinant Elp1 and Elp1-KR9A C-terminal domains 
from E. coli a degraded version of the Elp1 fusion proteins was stably associated during 
both tandem affinity steps despite the apparent loss of an affinity tag in the shorter 
version, as judged by Western blotting. This suggests that the dimerization of Elp1 may 
occur directly via its C-terminal domain and provides further evidence that the basic 
region mutant does not disrupt this association. If this type of dimerisation occurs in 
the context of Elongator then our view of Elongator assembly would need to revised. 
Rather than two copies of Elp1-3 being bridged by an Elp4-6 hexamer, two copies of 
Elp1 may also directly associate with each other via the flexible C-terminal domain. 
This would be supported by the fact that there is no defect in Elp1-KR9A association 
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with a differentially tagged version of itself or Elp3, despite this mutant having a minor 
defect in Elp5 association. This is consistent with the Elp1 subunits associating 
independently of the Elp4-6 hexamer.  Previous data from our lab has shown that the 
N-terminal domain of Elp1 is essential for complex assembly, since the Elp3 interaction 
is lost when this domain is truncated. Conversely, deletion of the Elp1 C-terminal 
domain (deletion of amino acids 1198-1349) appears to be dispensable for this 
interaction (Kozyrska and Stark, unpublished). Our data may be consistent with the 
Elp1 C-terminal domain being essential in formation of the higher order dodecamer 
structure of Elongator and thus not completely dispensable for holocomplex assembly.  
Taken together, mutation of the Elp1 basic region does not disrupt the overall 
assembly of the Elongator holocomplex but does reduce the association of the Elp5 
subunit and of Kti12.  
 
6.5 The Elp1-KR9A mutant has increased ser-1209 
phosphorylation 
The Elp1 basic region mutant was assayed for phosphorylation at the functionally 
important ser-1209 site. Compared with wild-type Elp1, the Elp1-KR9A mutant had 
~three fold more phosphorylation at this site. A more modest increase in general 
phosphorylated serine was also detected in Elp1-KR9A mutant. The fact that the Elp1 
basic region mutant has an elevated pool of phospho-1209-Elp1 compared with wild-
type Elp1 is in line with the hypothesis that it could be trapped in a specific form.  
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The wild-type Elp1 showed a weak generic phosphorylated serine signal that was also 
detected in Elp1-1209A mutants. This is in agreement with other data from our lab in 
which other phosphorylation sites have also been mapped (Figure 1.11); Ser-1209 is 
not the sole phosphorylation site in Elp1. The increase in phosphorylated serine 
observed in Elp1-KR9A could be due to the increased phosphorylation at ser-1209 
alone but it also possible that other phosphorylation sites are affected. Mutation of 
ser-1209 to a phosphomimetic aspartic acid residue (Elp1-1209D) results in partial 
Zymocin sensitivity and so restores some functionality (Abdel-Fattah and Stark, 
unpublished). This suggests that this phosphorylation site could perhaps serve to 
activate the complex or prime phosphorylation at other surrounding sites. The 
increased phosphorylation at this site in Elp1-KR9A could therefore also be occurring 
as a compensatory mechanism for lack of Elongator function.  
In the Elp1-1209A mutant, Kti12 association with Elongator is increased and this may 
be a general trend that occurs when Elp1 is in a ‘hypo’ phosphorylated state, since 
deletion or mutation of the Hrr25 kinase also causes Elp1 ‘hypo’ phosphorylation and 
increased Kti12 association(Mehlgarten et al., 2009). Deletion of KTI12 results in Elp1 
‘hypo’ phosphorylation and disrupts the ability of Hrr25 to associate with Elongator. In 
contrast Elp1-KR9A shows increased phosphorylation and a reduced Kti12 association.  
It is not yet understood which kinases may act on the Elp1 C-terminus but previous 
work suggests that although both Kti12 and Hrr25 influence this there must also be 
other factors that impinge on Elp1 phosphorylation. When KTI12 and SIT4 are both 
expressed in multicopy, a wild-type balance of Elp1 phospho-forms is observed and 
this is also the case in strains with a simultaneous Hrr25 kinase dead allele and SIT4 
deletion. To fit with these observations it was therefore suggested that Kti12 and 
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Hrr25 may act to down-regulate Sit4 function in order to maintain a balance of 
phosphorylation on the Elp1 subunit (Mehlgarten et al., 2009). It is possible that Kti12 
could bind to Sit4 directly and inhibit its function and this may underlie the ‘hyper’ and 
‘hypo’ phosphorylation of Elp1 in multicopy KTI12 and kti12 deletion strains, 
respectively (Jablonowski et al., 2004). It would be interesting to test whether ‘hyper’ 
phosphorylation caused by a deletion of Sit4 would also lead to reduced Kti12 
association with Elp1 as was observed in Elp1-KR9A. The Sit4 phosphatase may also be 
less associated with the Elp1-KR9A mutant and this may underlie the increased 
phosphorylation assayed in this mutant.  
A speculative model for the complex interplay between Kti12 and Elp1 
phosphorylation may explain some of the observations so far made in our lab and in 
the literature.  Elp1 dephosphorylation at certain sites may cause a conformational 
change that allows it to bind a tRNA molecule. Once tRNA is bound to the complex, 
Kti12 may then be released from Elongator, at which point Elp1 undergoes 
phosphorylation at certain sites, thereby preventing further Kti12 association. Kti12 
may mediate Sit4 activity to regulate its own binding and release from the complex 
and other kinases, such as Hrr25 may also impinge on this. In this model balanced 
phosphorylation regulates the mechanism of tRNA binding and modification by 
Elongator and mutations that disrupt a part of this cycle could cause stalling in certain 
forms. This assumes that Elongator is a highly dynamic complex that undergoes 
multiple conformational changes for the binding, modification and release of tRNA.  
It is also possible that certain phosphorylation sites serve to activate or inactivate the 
function of the complex rather than cycling between phosphorylated and 
dephosphorylated states as part of the mechanism. The pattern of phosphorylation 
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could promote or enhance the association of accessory factors to increase the 
efficiency of tRNA modification. The balanced forms seen in the wild-type Elp1 may 
represent various states and all or nothing disruption of this balance causes 
dysfunction.  
The Elp1 basic region may also be required for a conformational change that involves 
interaction between this positively charged region and the upstream phosphorylation 
sites when they are phosphorylated and hence negatively charged. This may be 
intimately involved in the mechanism of tRNA binding and release and/or regulation of 
the tRNA modification reaction. By extension, it is possible that Elp1 binds to tRNA 
when upstream phosphorylation sites are dephosphorylated and releases tRNA when 
the region becomes highly phosphorylated. Testing this hypothesis would require a 
better knowledge of the interplay between Elp1 C-terminal phosphorylation sites. 
Determining whether the basic region may be involved in more extensive 
conformational changes during the mechanism of tRNA modification would likely 
require structural studies.  
The complex interplay between different phosphorylation sites in the Elp1 subunit and 
the role of the various accessory factor proteins is as of yet still elusive (see Figure 1.10 
and 1.11).  However, there is a clear interplay between the Elp1 basic region mutations 
and phosphorylation at the functionally important ser-1209 site.  
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6.6 Conditional regulation of Elongator function using Elp1 
“switch off” strains 
We and others have demonstrated that the C-terminal domain of Elp1 is important for 
tRNA wobble uridine modification (Fichtner et al., 2003, Mehlgarten et al., 2009). This 
was utilised to create strains in which Elongator function could be “switched off” either 
by conditional cleavage of the Elp1 C-terminal domain by TEV protease or by using the 
auxin inducible degron system to direct Elp1 for conditional proteosomal degradation. 
These strains will allow real time analysis of the timescale for loss of tRNA 
modifications and the acute changes in protein translation that are expected to occur 
as a result.  
The loss of mcm5 and ncm5 modifications due to lack of Elongator function has been 
shown not to affect the steady state stability of the tRNA molecule, so it is expected 
that the hypomodified tRNAs will persist but have reduced function in translation 
(Bjork et al., 2007). It is not known how quickly the modifications will begin to 
disappear once Elongator function is lost since it is thought that tRNAs have an 
extremely long half-life in the cell (Hopper and Phizicky, 2003). A time course 
experiment of Elp1 degradation coupled to analysis of modified tRNA nucleosides will 
allow the levels of these Elongator dependent modifications to be monitored in real-
time. Information as to how long after Elongator “switch off” the modifications are no 
longer detected will direct future experiments, where the aim would be to assay acute 
changes in protein expression occurring due to defects in the translational function of 
hypomodified tRNAs. Protein expression changes can be monitored by SILAC coupled 
mass spectrometry to identify changes in protein levels, while ribosome profiling can 
be used to determine which mRNAs may spend an increased amount of time being 
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translated compared to wild-type strains (Ong et al., 2002, Ingolia et al., 2009). These 
datasets can be compared to corresponding mRNA expression to account for 
transcriptional changes and then the patterns of codon usage across mRNAs showing a 
translational defect could be studied.  
It is expected that mRNAs enriched in AAA or CAA codons, that are translated by 
tRNALysUUU and tRNA
Gln
UUG respectively, will be enriched in mRNAs where expression is 
down-regulated because the hypomodified versions of these tRNAs can rescue nearly 
all phenotypes associated with Elongator dysfunction assayed so far (Esberg et al., 
2006). Other work that has begun to address the translational defects associated with 
Elongator has assayed these types of codon bias in proteins that rely on Elongator for 
their expression (Bauer et al., 2012, Fernandez-Vazquez et al., 2013, Rezgui et al., 
2013).  
Certain changes in protein expression may be masked in chronically adapted strains 
where an Elongator subunit has been deleted due to up-regulation of other pathways 
or transcriptional changes that compensate for any translational defects. It has been 
suggested that defects in charging of hypomodified tRNAs may be masked in Elongator 
deletion strains by increased expression of their charging enzymes and that 
hypomodified tRNAs may also impinge on cellular signalling pathways directly 
contributing to phenotypes arising from lack of modifications, although how this is 
mediated is not yet understood (Zinshteyn and Gilbert, 2013). Investigating the 
turnover and acute affects occurring due to lack of Elongator dependent tRNA 
modifications may help address this and other changes that are masked in Elongator 
deletion strains by secondary effects or adaptations.  
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Elongator function could conceivably be regulated, such as by phosphorylation, as a 
means of modulating gene expression. Our lab has already mapped functionally 
important sites within the C-terminus of Elp1 (Figure 1.11).  Knowledge of the 
timescale for turnover of tRNA modifications upon loss of Elongator function would 
give a better idea of how Elongator regulation might be utilised in vivo.  For example if 
tRNA modifications were undetectable within a short timescale then Elongator could 
be regulated dynamically, for example by nutrient availability or extracellular signals.  
This means that kinases and phosphatases upstream of Elongator may regulate tRNA 
modifications in response to changing conditions in order to cause translational 
changes that affect the proteome. This may allow certain mRNAs to be translated 
normally under normal growth conditions but be primed for translational inefficiency 
under conditions where Elongator dependent tRNA modifications are decreased. If 
tRNA modifications are quite persistent once Elongator function is lost then it is also 
still possible that this type of regulation may function in longer-term scenarios such as 
during certain growth phases, and in higher eukaryotes may be relevant to 
developmental stages. 
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6.7 The Elp1 basic region is required for tRNA binding 
Since the Elp1 basic region is essential to the function of the Elongator complex but is 
not involved in nuclear import, it seemed possible that it could be required for 
interaction with tRNA. The basic residues lysine and arginine are commonly known to 
be involved in interactions with nucleic acids and this region was annotated using 
BindN, which predicts putative RNA binding regions from primary sequence based on 
mathematical modelling with known RNA-protein structures (Nadassy et al., 1999, 
Draper, 1999, Jones et al., 2001, Wang and Brown, 2006)  
Although it is not yet known if Elongator is involved directly in tRNA modification it 
seems likely that this is the primary role of the complex at least in yeast (Esberg et al., 
2006, Huang et al., 2005). Purified Elongator was previously shown to bind ssRNA in 
vitro with a higher affinity than linear dsDNA, suggesting that the complex possessed 
RNA binding domains or motifs (Gilbert et al., 2004, Greenwood et al., 2009). More 
recently it was shown that immunoprecipitated Elp1 and Elp3 subunits can be 
crosslinked to exogenous tRNAGluUUC and that the recombinant Elp4-6 hexamer forms a 
complex with tRNA in EMSA assays (Huang et al., 2005, Glatt et al., 2012).  
The discovery that the Elp4-6 hexamer can bind tRNA is the first major evidence that 
Elongator is directly involved in tRNA modifications. The small subcomplex binds tRNA 
only when all three subunits are present, therefore the binding determinants for tRNA 
are formed across the subunit interfaces. The complex has a calculated KD for tRNA 
binding of 1.2-1.4 μM and does not form a complex with poly(U) or ssDNA. The 
interaction with tRNA is competed by addition of tRNA anticodon loop, suggesting that 
this region of the tRNA contains all or part of the recognition sites for the hexamer 
(Glatt et al., 2012). In general members of the RecA-like NTPase superfamily bind 
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nucleic acids using positively charged binding surfaces within the central ring of the 
hexamer (Lyubimov et al., 2011). The Elp4-6 hexamer does not contain a similar 
binding surface, but mutation of two amino acids within a protruding loop in Elp5 
reduced tRNA binding to the hexamer (Glatt et al., 2012). This suggests a different 
mechanism for binding to the tRNA anticodon loop that does not rely on charge 
interactions, although other subunits of Elongator may contribute to this in vivo. 
Interestingly, the Elp4-6 hexamer was shown to bind tRNAGlu with a similar affinity 
regardless of the identity of the base at the wobble position of the anticodon loop. 
This suggests that the specificity for wobble uridine modification may be imparted 
during the modification reaction itself rather than by discriminatory binding to 
Elongator. The Elp4-6 hexamer also has a basal ATPase activity, which has been 
proposed to regulate tRNA binding and release coupled to dynamic movement of this 
subcomplex (Glatt et al., 2012). 
The recombinant C-terminal domain of Elp1 and Elp1-KR9A was purified for use in 
EMSA binding assays with yeast tRNA in order to determine firstly whether Elp1 was 
involved in tRNA binding and secondly whether the Elp1 basic region was required for 
this. The wild-type Elp1 C-terminal domain formed a complex with yeast tRNA but this 
ability was lost in the Elp1-KR9A mutant. We propose that the conversed Elp1 basic 
region is involved in binding tRNA molecules to the Elongator complex.  
Preliminary work calculated that the KD of the Elp1 C-terminal domain and tRNA 
complex is in the low micromolar range (~0.37 μM) and demonstrated that this 
complex is resistant to competition from ssDNA and poly(U). The complex formed 
between the wild-type Elp1 C-terminal domain and tRNA appears quite large (~130 
kDa would be expected for 1:1 complex of Elp1 fusion protein and tRNA) since it is 
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poorly resolved in 4% polyacrylamide gels. However, migration in a native gel is not 
directly related to the molecular mass of protein or complex, factors such as the 
overall charge and mass of a complex will affect this (Hellman and Fried, 2007). It 
seems likely that Elp1 could bind to tRNA as a dimeric complex, since we and others 
have shown association between differentially tagged Elp1 proteins in vivo, and our 
work has suggested this occurs directly through the C-terminal domain. In order to 
confirm that the native Elp1 C-terminus is associated as a dimer we could use 
crosslinking and native gel electrophoresis to determine whether a ladder of dimeric 
and monomeric Elp1 can be observed. Stoichiometry of binding experiments could also 
be carried out using a known concentration of unlabelled tRNA mixed with a small 
amount of radiolabelled tRNA for binding reactions with the Elp1 C-terminal domain. 
The molar ratio of protein/RNA equivalents required to saturate the shift in the 
radiolabelled pool can be used to estimate the stoichiometry of binding by fitting the 
% bound curve to theoretical saturation curves (Ryder et al., 2008). 
Although we have shown that the Elp1 C-terminal domain in isolation associates with 
tRNA, it seems likely that other subunits may also contribute to the overall affinity and 
specificity of the Elongator complex, especially in view of the data presented by Glatt 
and coworkers. Competition experiments with different regions of a tRNA molecule 
such as the anticodon loop, the DHU loop and the TΨC loop (see figure 1.4) will be 
used to determine which region of the molecule interacts with Elp1. It might be 
expected that the Elp1 C-terminus binds to a part of the tRNA molecule distinct from 
that which interacts with the Elp4-6 hexamer in order to anchor it within the complex. 
However, although speculative, it is also possible that the flexible Elp1 C-terminus may 
bind tRNA and translocate it into an Elongator reaction centre where Elp3 is likely to 
be involved in the modification. In this scenario, Elp1 could be involved in imparting 
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some specificity to the modification reaction by discriminating between the anticodon 
loops of different tRNA species.  
The Elp1 basic region must contribute important binding determinants to the 
interaction with tRNA since mutations that replace the positively charged amino acids 
across this sequence disrupt tRNA binding. It has been shown that arginine and lysine 
residues are enriched in nucleic acid binding motifs and that these amino acids can 
make multiple types of interactions with nucleic acids, including electrostatic contacts 
with the negatively charged sugar phosphate backbone (Jones et al., 2001, Draper, 
1999). It is difficult based on primary structure to predict exactly what types of 
interactions are lost in Elp1-KR9A since protein and nucleic acid binding can typically 
rely on electrostatic interactions, hydrogen bonding and van der Waals forces between 
amino acids, nucleotide bases and the sugar phosphate backbone. The secondary 
structure of RNA also creates more diverse interaction surfaces for proteins than is 
typically found in DNA so the types of contacts made are not easily predicted (Jones et 
al., 2001, Draper, 1999). It is still also possible that an alteration in the secondary 
structure of Elp1-KR9A could contribute to loss of tRNA binding. However, the Elp1 
basic region resides across the junction between a region of random coli and alpha-
helix in the predicted Elp1 secondary structure (see Figure. 1.2) and the mutations in 
Elp1-KR9A do not alter this prediction.  
To determine whether the Elp1 basic region disrupts tRNA binding in vivo, Elp1 and 
Elp1-KR9A were pulled down and associated RNAs analysed by northern blot. Wild-
type Elp1 co-precipitated tRNAGlnUUG whereas only background levels were detected in 
association with Elp1-KR9A. The basic region therefore appears to be important for 
tRNA binding to Elongator in vivo. To test specificity of the association of wild-type 
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Elp1 with tRNA, co-precipitation of tRNALysCUU , which is not a substrate for Elongator-
dependent modification, was also assayed. The wild-type Elp1 still showed enrichment 
for this non-substrate tRNA, suggesting that association is not specific for Elongator-
dependent tRNAs under our conditions. This may support the hypothesis suggested by 
Glatt and co-workers, that specificity may be mediated once tRNA is bound to the 
complex rather than by discriminatory binding, but more work is required to confirm 
this.  
Although preliminary, the loss of tRNA association with Elp1-KR9A in vivo supports the 
importance of this region for the association of tRNA with Elongator and suggests that 
other subunits cannot compensate for loss of this region. In the future to address the 
same question, pulldowns of Elongator and crosslinking to exogenous tRNA could be 
carried out in an analogous manner to the experiments carried out by Byström and co-
workers (Huang et al., 2005) to confirm whether the reported association with tRNA is 
lost in Elp1-KR9A.  
Taken together, we have shown that the Elp1 basic region is required for tRNA binding 
to the C-terminal domain of Elp1 and therefore forms a highly conserved tRNA binding 
motif in Elongator.   
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6.8 Perspectives and future work 
The Elp1 subunit of Elongator contains a highly conserved C-terminal basic region and 
this work has shown that this is essential for wobble uridine tRNA modification. This 
region was previously annotated as a nuclear localisation sequence but in the context 
of the full length Elp1 polypeptide does not influence its distribution. The Elp1 basic 
region is also not required for the overall assembly of Elongator but mutations in this 
domain do cause increased phosphorylation at a functionally important upstream 
serine. The wild-type Elp1 C-terminal domain forms a complex with tRNA that is 
disrupted by mutation of residues in the basic region, suggesting that the true role of 
this region is in tRNA binding.  
Future work will be directed towards identifying the binding determinants within the 
tRNA molecule that are important for interaction with the Elp1 and attempting to 
address whether this binding shows any specificity towards substrate tRNAs containing 
a uridine at the wobble position. It seems likely that the Elp1 C-terminal domain 
associates as a dimer and that this may create an interface for the binding of tRNA. 
Although more work is required to confirm this, if Elp1 does dimerise directly through 
the C-terminal domain then in the future the determinants for this can be analysed by 
mutational analysis. This will allow us to address whether this dimerization is essential 
for tRNA binding.  
Since the Elp1 basic region is important for tRNA association this could explain some of 
the other differences observed in the Elp1-KR9A mutant when compared with wild-
type Elp1. A defect in tRNA binding to Elongator would be expected to arrest the 
mechanism of the complex, which is in line with the hypothesis that the Elp1-KR9A 
mutant protein may be trapped in a specific form that alters its interactions with other 
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subunits and accessory factors. The modification of tRNA by Elongator may proceed by 
dynamic alterations in conformation that transiently alter subunit contacts and 
interactions with accessory factors. In this scenario the wild-type Elp1 would be 
expected to cycle between different conformations during the mechanism of tRNA 
binding, modification and release. The Elp1-KR9A mutant is assembled into Elongator 
but cannot bind tRNA and so it may be trapped in a substrate binding-incompetent 
form. This could explain the decreased association with Kti12 and Elp5 if the complex 
was less stable without bound tRNA or if it makes tighter transient associations with 
these proteins later in the modification reaction. If phosphorylation is also involved in 
driving this mechanism then this could also account for the increased ser-1209 
phosphorylation observed in the basic region mutant. A better understanding of how 
Elongator interacts with tRNA and the interplay of this with accessory factors and Elp1 
phosphorylation would help to clarify this model.  
Since Kti12 association is reduced in the Elp1-KR9A mutant then it would be interesting 
to determine whether Kti11 and Kti13 are also similarly affected. Since 
phosphorylation of Elp1-KR9A is increased it seems possible that the activity of Sit4 
phosphatase could also be misregulated. Kti12 has been hypothesised to regulate the 
activity of Sit4 perhaps by direct association with the phosphatase or its SAP binding 
partners. Analysing the associations of Sit4, Hrr25 and Kti12 with each other and with 
this basic region mutant may reveal more about the interplay between these factors.  
Another hypothesis which has not yet been tested is that Kti12 may itself bind and/or 
modify tRNA molecules, perhaps alongside Kti11 and Kti13 and could bring them to the 
Elongator complex for further modification. Kti12 has an N-terminal P-loop motif and is 
closely related to O-phosphoseryl-tRNAsec kinase (PSTK), which has both a kinase 
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activity and binds to tRNA (Araiso et al., 2009).  Interestingly, PSTK acts as a dimer, 
which might imply that Kti12 could adopt a similar conformation although this is 
speculative. The accessory proteins Kti11 and 13 may also be involved in the activation 
of the tRNA before modification by Elongator. Kti11 has a zinc finger motif which is 
often found in nucleic acid binding proteins and Kti13 has been suggested to act as GEF 
protein which may regulate the function of Kti12 (Chen and Varani, 2005, Fichtner and 
Schaffrath, 2002).  In order to study what other Elongator subunits or accessory factors 
may be involved in tRNA binding, recombinant proteins could be made and similar 
analysis of complex formation by EMSA carried out. It would be especially interesting 
to determine whether Kti12 participates in tRNA modifications directly or as a 
regulator of Elongator. 
The mechanism of cm5 tRNA modification at the wobble uridine position still remains 
to be determined, though the Radical SAM and HAT domains of Elp3 are expected to 
be involved. An interesting finding in this work was that two SAM metabolic enzymes 
that could participate in this mechanism were identified in association with Elp1. This 
would require further work to confirm whether it represents a true association before 
any further studies to determine how these may impinge on Elongator function. More 
work is also needed to understand the function of Elp1 C-terminal domain 
phosphorylation since a balance between different phosphorylated forms appears to 
be essential.  The interplay between certain phosphorylation sites and other putative 
kinases that may impinge on them is currently under investigation in our lab.   
A summary of the complex regulation of the Elongator complex illustrating the known 
functional interactions and factors important for Elongator function is presented in 
Figure 6.1. The work presented in this thesis has contributed to this by demonstrating 
 242 
 
that the Elp1 C-terminal domain contains a conserved basic region that is essential for 
the wobble uridine tRNA modification function of the Elongator complex and that this 
is likely to be mediated by its role as a tRNA binding region.  
 
 
Figure 6.1: The complex regulation of the yeast Elongator complex. Double headed arrows 
denote putative transient associations with substrate tRNA and accessory factors and orange 
balls denote Elp1 phosphorylation. Note that the Elongator cartoon shown is not 
representative of the exact contacts between all subunits.    
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Appendix 
Reagent List 
[-32P]ATP (6000Ci/mmol)    Perkin-Elmer 
1-Naphthaleneacetic acid    Sigma-Aldrich 
Acetic Acid      AnalaR NORMAPUR 
Acetone      AnalaR NORMAPUR 
AEBSF       Melford 
Ampicillin      Formedium 
Anarctic phosphatase     New England Biolabs 
Antibodies       See Table 1.2  
Beta mercaptoethanol     Sigma-Aldrich 
Bis-Tris Gels      Novex 
Bradford reagent     Pierce 
Bromophenol Blue     Sigma-Aldrich 
CaCl2       AnalaR NORMAPUR 
Concanavalin A      Sigma-Aldrich 
Cyanogen bromide-activated-Sepharose 4B  GE Healthcare 
Dialysis membrane      SpectoPOR 
Dithiothreitol      Formedium 
DNA gBlocks      Integrated DNA technologies 
DNA Hyperladder I     Bioline 
DNA Oligo primers and probes    Sigma-Aldrich 
DNase I       Sigma-Aldrich 
DNase I (RNAse free)     Fermentas 
dNTPs       Fermentas 
ECL       Millipore 
EDTA        AnalaR NORMAPUR 
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Fast alkaline phosphatase    Fermentas 
G418       Formedium 
Galactose 20 %      Media Services 
Gel extraction kit     QIAGEN 
Gel pilot loading dye     QIAGEN 
Glass beads 0.5 mm     Biospec products 
Glucose 20 %      Media Services 
Glutathione Sepharose-4 Fast Flow   GE Healthcare 
Glycine       AnalaR NORMAPUR 
Glycogen (RNase free)     Fermentas 
HEPES       Formedium 
Herring Sperm DNA     Sigma-Aldrich 
HisPur Cobalt Resin     Thermo Scientific 
Hydrochloric Acid     AnalaR NORMAPUR 
Imidazole      Sigma-Aldrich 
Instant Blue      Expedeon 
Lithium Acetate      Sigma-Aldrich 
Lithium Chloride 8M     Sigma-Aldrich 
Lysozyme from egg white    Sigma-Aldrich 
Methanol      AnalaR NORMAPUR 
MgCl2       Sigma-Aldrich 
MgCl2 1 M (RNase free)     Ambion 
MOPS 20 x      Novex 
NuPage Antioxidant     Novex 
Pefecthyb plus hybridisation buffer   Sigma-Aldrich 
Phosphate buffered saline 10 x    Media Services 
PhosSTOP tablets     Roche 
Phusion DNA polymerase kit    Finnzymes 
pJET1.2 vector kit     Fermentas 
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Plasmid purification kit     Bioline 
Polyethylene Glycol     Sigma-Aldrich 
Polyuridylic acid potassium salt    Sigma-Aldrich 
Potassium Hydroxide     AnalaR NORMAPUR 
Protease Inhibitor tablets (EDTA free)   Roche 
Raffinose 20 %      Media Services 
Rapamycin      Sigma-Aldrich 
Rapid DNA ligation kit     Roche 
Reduced Glutathione     Sigma-Aldrich 
Restriction enzymes      New England Biolabs or Fermentas 
Ribolock RNAse inhibitor    Fermentas 
RNA Oligos      Integrated DNA technologies 
Saline-sodium citrate (SSC) 20 x    Sigma-Aldrich 
SDS       Sigma-Aldrich 
Sepharose 4B beads     Sigma-Aldrich 
Sodium acetate 3 M pH 5.5 (RNAse free)  Ambion 
Sodium Carbonate     GPR RectaPur 
Sodium Chloride 5M     Media Services 
Sodium Fluoride     AnalaR NORMAPUR 
Sodium Hydroxide     Sigma-Aldrich 
Sodium Orthovanadate     Sigma-Aldrich 
Sodium-Beta-Glycerophosphate    Alfa Aesar 
SYBR safe      Invitrogen 
SYPRO Ruby      Molecular Probes 
T4 polynucleotide kinase kit    Fermentas 
TAE 50 x      Media services 
Taq Polymerase Buffer 10 x    Fermentas 
TBE 10 x (Ultrapure)     Novex 
TBE UREA loading dye 2x    Novex 
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TBE-Urea Gels      Novex 
TE buffer (RNAse free)     Ambion 
Thrombin from Bovine Plasma    Sigma-Aldrich 
Tripure reagent      Roche 
Tris Base      Calbiochem 
Tris Buffered Saline 10 x    Media services 
Triton-X100      VWR 
Tween-20      VWR 
Ultrapure Agarose     Invitrogen 
Yeast tRNA      Sigma-Aldrich 
Zymolyase-T      Seika gaku Corp 
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Primers and Probes used in this study 
i) Primers for Gene Manipulation 
 
Amplify ELP1 Knockout cassette 
ELP1 _F1  
ATAGTAATGAAAAGCGATGCCTAGGCAAGAAACAGTACAAATGCCTAATGGCTTCGGATCCCCGGGTT
AATTAA  
ELP1 _R1 
CTTTCTTTACGAGCACTATAGACAGTAATTTATATAACTAAGAAAATGGTATGCGAATTCGAGCTCGTTT
AAAC  
Amplify KTI12 Knockout cassette 
KTI12_A  
AGTTGCAAATCATTATGTCATTCCT 
KTI12_D  
TCATAATAACCATCATAGCCAACCT 
Amplified from Euroscarf knockout strain containing kti12Δ::KanMX4 
Amplify region encoding Elp1 or Elp1 mutant CTD for cloning into pUG34 vector 
ELP1Cterm_F  
CACCACTAGTGAGAACCCATACGCCTTTTATGGC  
ELP1Cterm_R  
GCACCTCGAGAAAATGGTATGCTCAAAAATCAACAATATGACTCTTAGGGAAATC  
Amplify CORE cassette for integration into ELP1 
ELP1_P1_Cterm 
GGTTTAGGCGAAGGTTTTGGTATAATTGCAGAATTACTCGCCGATTGTAAAGGCGAGCTCGTTTTCGAC
ACTGG  
ELP1_P2_Cterm 
CAAAGTTCTTTTGAATTTGGTGAGCTTGCTCTCTCATGTTTCGTCTACAAAGACCCTCCTTACCATTAAGT
TGATC  
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Amplify ELP1 fragment for ‘delitto perfetto’ 
ELP1_fragment_F  
GCTTCTCTTGTGGCGATAAAGG  
ELP1_fragment_R  
TCTCTGGAACAGGTATTTCTGGG 
Amplify region encoding  Elp1 or Elp1 mutant CTD for cloning into pGEX4T-1 
EcoR1_ELP1_F  
GCTAGCGAATTCGCCACACGTGGTAATCTAGAAAC 
ELP1_HIStag_Xho1_R 
GTCACGATCTCGAGTTATCAATGGTGGTGGTGATGGTGAAAATCAACAATATGACTCTTAGGG 
Amplify cassette for NIC96 tagging with 4mcherry 
NIC96-4mcherry_ F 
AGAATGCCAAGGGAAACGTACAGCACTTTAATTAATATAGACGTCTCTCTATACGCTGCAGGTCGACGG 
NIC96-4mcherry_ R 
GCGCATACTGATATATAGATATAAACAAAAATATACAATATTTAAAAAAAGAATTCGAGCTCGTTTAAA
C  
Amplify cassette for Elp1 C-terminal tagging with GFP 
ELP1-Linker-F2 
CCCAGAAATACCTGTTCCAGAGATTCATGATTTCCCTAAGAGTCATATTGTTGATTTTGGTTCTGCTGGT
TCAGCTGCGGGTTCAGGACGGATCCCCGGGTTAATTAA  
Amplify cassette for Elp1-HA C-terminal tagging with Auxin degron sequence 
IAA17_F 
CGTCCCGGACTATGCAGGATCCTATCCATATGACGTTCCAGATTACGCTCGTACGCTGCAGGTCGAC 
IAA17_R 
CTTTCTTTACGAGCACTATAGACAGTAATTTATATAACTAAGAAAATGGTATGCATCGATGAATTCGAGC
TCG  
Amplify cassette for Arg4 C-terminal tagging with GFP 
ARG4_L_F2 
CGCTAAATCTGCTGTATTGAAGCAATTGGATAATTTGAAATCCCAATTAAATGGTTCTGCTGGTTCAGCT
GCGGGTTCAGGACGGATCCCCGGGTTAATTAA  
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ARG4_R1 
GAAGTCCTAGAAGTACCAGACCTGATGAAATTCTTGCGCATAACGTCGCCATCTGGAATTCGAGCTCGT
TTAAAC 
Amplify cassette for Kti12 C-terminal tagging with GFP 
KTI12_L_F2 
GATCAAGATAGGATCGGTCCGCTTTTCGCTGATTATCTTAACAAAAACTTGAATGGTTCTGCTGGTTCAG
CTGCGGGTTCAGGACGGATCCCCGGGTTAATTAA  
KTI1212_R1 
CAAGCAAATTTCGTCTTGCCATTTACCTTCTGATATTAATCACATGTATATCGAATTCGAGCTCGTTTAAA
C  
Amplify cassette for Elp5 C-terminal tagging with GFP 
ELP5_F2 
GAGTACGAAAAGGATGACGATTATGATGAAGAGGATCCATATGAGGATCCCTTTGGTTCTGCTGGTTC
AGCTGCGGGTTCAGGACGGATCCCCGGGTTAATTAA 
ELP5_R1 
CGTAGTTTACATAATCTGGAAGCACTCACTATTTACCATCAGTTTCTACTTTGAATTCGAGCTCGTTTAAA
C  
Amplify cassette for Elp3 C-terminal tagging with GFP 
ELP3_L_F2 
CTATGGTAAACTAGGATATGAACTAGACGGTCCATACATGTCGAAAAGAATTGGTTCTGCTGGTTCAGC
TGCGGGTTCAGGACGGATCCCCGGGTTAATTAA 
ELP3_R1 
CTGCTTGGAAAACCGGCCATGTCGGCGGCACATAAAAGTTCTATTTACCTGAATTCGAGCTCGTTTAAA
C  
ii) Primers for Verification of Strains 
 
Verify ELP1 Knockout 
ELP1_A  
CTGTTAAAAGATCCCGTCATTGATA 
KO10  
CGCACGTCAAGACTGTC 
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Verify KTI12 Knockout 
KTI12_D 
TCATAATAACCATCATAGCCAACCT 
RDS_KanMX_R  
GCCTCTTCCGACCATCA 
Verify CORE cassette integration into ELP1 
PELP1R  
GGGAAATCATGAATCTCTGG 
KO10  
CGCACGTCAAGACTGTC 
ELP1SEQ3  
GATGGCGTGAGGCCATGTCC 
KanMX_R  
GCCTCTTCCGACCATCA 
Verify ELP1 ‘delitto perfetto’ replacement of CORE 
Elp1_Verfication_F 
CCAGAGGAAGTTGAGTCAGTCGC 
Elp1_ Verfication_R 
GATTGTGTGGACAGGTAATGGTTG  
ELP1_D  
CTAAAGGATATTGCCAGAACTCAAA 
Verify Nic96-4mcherry C-terminal tagging 
NIC96_C 
ACGAAGACGGCAGAATATATGATAG 
NatR_B  
TGGTGAAGGACCCATCCAG 
Verify Elp1-HA C-terminal tagging with Auxin degron sequence 
0080_NAT1-5 (kind gift from Tomo Tanaka) 
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TGGAGGTCACCAACGTCAAC 
0595_ELP1_D 
CTAAAGGATATTGCCAGAACTCAAA 
ELP1_C  
TTATATCCCAGAAATACCTGTTCCA 
NatR_B  
TGGTGAAGGACCCATCCAG 
Verify integration of TIR1-9myc at the ADH1 locus 
ADH1_A 
GAAGAGGAAACAGCAATAGGG 
TIR1_R 
GAAGCTGAAGATGTGCTCCAC 
RDS_Int_F 
CAAACCGCCTCTCCCCG 
tADH-REVSEQ  
CCTAAGAGTCACTTTAAAATTTGTATACAC 
Verify presence of TEV-3myc at the TRP1 locus 
Cal_F  
GCAAACCGCCTCTCCCC 
TRP1_A 
AGAGACCAATCAGTAAAAATCAACG 
Verify integration of SUP4 ochre suppressor system at his3∆1 locus 
HIS3_A  
TGACGACTTTTTCTTAATTCTCGTT 
NatR_B  
TGGTGAAGGACCCATCCAG 
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Verify C-terminal tagging  
ELP1_C  
TTATATCCCAGAAATACCTGTTCCA 
ELP5_C 
GGGTGCTATTGTTTATGAGTACG 
KTI12_C 
GATCCGTTGAGTAAGGGCTTAC 
ARG4_C 
GCTGAAAGACTTGGTCTAAGCG 
ELP3_Calt 
CCAAAGAGACATTCCAATGCC 
GLN4_C 
GATAAGGATTCCAAAGAAGTGTGTAG 
CEX1_C 
CCTAGCACCAAGAAACATTGC 
Gene specific forward primers listed above are used with the following reverse 
primers; 
KO10 
CGCACGTCAAGACTGTC 
tADH-REVSEQ  
CCTAAGAGTCACTTTAAAATTTGTATACAC 
iii) Sequencing Primers 
Sequence across ELP1 ‘delitto perfetto’ replacement of CORE 
Elp1_Sequencing_F 
GTCAGTCGCAGAAGAGTTG 
Sequence across region encoding Elp1 CTD for pUG34 cloning 
pJET1.2_F 
CGACTCACTATAGGGAGAGCGGC 
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Sequence across region encoding Elp1 CTD cloned into pGEX4T-1 
GST-FORSEQ  
CGACCATCCTCCAAAATCG 
YIPLAC-INTF  
CATGTGTCAGAGGTTTTCACCGT 
iv) Primers as insert DNA 
Nuclear export sequence of HIV(Rev) insert 
NES_F 
GATCCCCGGGTTAATTAACTTGCCTCCATTAGAGAGGTTAACCCTTGATAT 
NES_R 
ATCAAGGGTTAACCTCTCTAATGGAGGCAAGTTAATTAACCCGGG 
v) ‘gBlocks’ 
 
Nuclear localisation sequence from Cbp80 for cloning into pFa6a-GFP(s65T)-HIS3MX 
GCTGAAGCTTCGTACGCTGCAGGTCGACGGATCCCCGGGTTAATTAACTTTAATAGAAAAAGAAGAGG
AGACTTCGATGAAGATGAAAATTACCGTGATTTTAGGCCTCGCATGCCTAAAAGACAGAGAATCCCACC
TGTTGTAAGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATGT
TAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAACATACGGAAAACTTACCCTTA
AATTTATTTGCACTACTGGAAAACTACCTGTTCCATGGCCAACACTTGTCACTACTTTCACTTATGGTGTT
CAATGCTTTTCAAGATACCCAGATCATATGAAACGGCATGACTTTTTCAAGAGTGCCATGCCCGAAGGT
TATGTACAGGAAAGAACTATATTTTTCAAAGATGACGGGAACTACAAG 
 
Mutant Nuclear import sequence from Cbp80 for cloning into pFa6a-GFP(s65T)-
HIS3MX 
GCTGAAGCTTCGTACGCTGCAGGTCGACGGATCCCCGGGTTAATTAACTTTAATAGAAAAGCAGCCGG
AGACTTCGATGAAGATGAAAATTACCGTGATTTTAGGCCTCGCATGCCTGCAGCCCAGAGAATCCCACC
TGTTGTAAGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATGT
TAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAACATACGGAAAACTTACCCTTA
AATTTATTTGCACTACTGGAAAACTACCTGTTCCATGGCCAACACTTGTCACTACTTTCACTTATGGTGTT
CAATGCTTTTCAAGATACCCAGATCATATGAAACGGCATGACTTTTTCAAGAGTGCCATGCCCGAAGGT
TATGTACAGGAAAGAACTATATTTTTCAAAGATGACGGGAACTACAAG 
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vi) Oligonucleotide DNA Probes 
 
Detection of tRNA by Northern blot 
tRNAGlnUUG 
GTCCGGATCAAAACCGAAAGTGATAACCACTACAC 
tRNALysCUU  
GAACCCCTAACCTTATGATTAAGAGTCATACGCG 
 
vii) Competitor Oligonucleotides 
 
ssDNA Competitor 
Arg4_C  
GCTGAAAGACTTGGTCTAAGC 
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Plasmids used in this study 
The table below summarises plasmids used or generated in this study. In addition, 
selected plasmid maps are shown with important sequence features. 
Appendix Table 1. Plasmids used and/or generated in this study. 
Plasmid Name Description Source 
pAE1 
Expression plasmid for Zymocin gamma subunit under the 
control of the GAL1-10 promoter 
A. Edlin 
pCORE 
Plasmid for amplification of CORE cassette containing KlURA3 
and KanMX4 
F. Storici  
YCplac181 
Multicopy expression plasmid used as an empty vector 
control for pJHW27 
M. Stark 
pJHW27  Multicopy expression plasmid containing yeast KTI12 gene  M. Stark 
pRS425 
Multicopy expression plasmid used as an empty vector 
control for pRS425-tK(UUU)-tQ(UUG) 
A. Bystrom 
pRS425-tK(UUU)-
tQ(UUG) 
Multicopy plasmid containing yeast tK(UUU) and tQ(UUG) 
genes for tRNA overexpression  
A. Bystrom 
pSB1 
SUP4 ochre suppressor system plasmid containing URA3, 
SUP4 and NatRMX genes 
S. Bandau 
pSB3 
SUP4 ochre suppressor system plasmid containing ura3oc22, 
SUP4 and NatRMX genes 
S. Bandau 
pT909 
Plasmid for amplification of C-terminal 4mCherry tagging 
cassette containing Nat1 marker 
T.Tanaka 
pT1075 
OsTIR1-9myc under the control of the ADH1 promoter and 
containing the URA3 marker 
T.Tanaka 
pT1450 
Plasmid for amplification of IAA17 AID degron sequence 
tagging cassette containing NatNT2 marker 
T.Tanaka 
yCplac111 
Expression plasmid used as empty vector control for 
ycplac111-ELP1-6HA and related plasmids 
D.Gietz 
yCplac111-ELP1-6HA Expression plasmid containing ELP1-6HA 
D. 
Jablonowski 
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yCplac111-elp1-6HA Expression plasmids containing elp1-6HA mutants1 DNA2.0 
pFa6a-GFP(S65T)-
HIS3MX6 
Plasmid for amplification of C-terminal GFP tagging cassette 
M. S. 
Longtine 
pFa6a-NES-
GFP(S65T)-HIS3MX6 
NES from HIV Rev protein cloned in frame upstream of GFP This study 
pFa6a-NLS-
GFP(S65T)-HIS3MX6 
NLS from Cbp80 protein cloned in frame upstream of GFP This study 
pFa6a-NLS4A-
GFP(S65T)-HIS3MX6 
NLS from Cbp80 protein with 4 alanine substitutions cloned 
in frame upstream of GFP 
This study 
pUG34 
Expression plasmid for N-terminal eGFP tagged fusion 
proteins expressed from a MET25 promoter 
J.Hegemann 
pUG34-ELP1 CTD 
Region encoding Elp1 C-terminal domain cloned into pUG34 
for fusion protein expression 
This study 
pUG34-elp1-KR9A 
CTD 
Region encoding Elp1-KR9A C-terminal domain cloned into 
pUG34 for fusion protein expression 
This study 
pUG34-elp1-KR5A 
CTD 
Region encoding Elp1-KR5A C-terminal domain cloned into 
pUG34 for fusion protein expression 
This study 
pUG34-elp1-KR4A 
CTD 
Region encoding Elp1-KR4A C-terminal domain cloned into 
pUG34 for fusion protein expression 
This study 
pGEX-4T-1 Bacterial expression plasmid for GST tagged fusion proteins A. Lamond 
pGEX-6T-His6 
Bacterial expression plasmid for GST-His6 tagged fusion 
proteins 
T. Owen-
Hughes 
pGEX4T-1-ELP1-CTD-
His6 
Sequence encoding Elp1 C-terminal domain cloned into 
pGEX4T-1 for bacterial fusion protein expression 
This study 
pGEX4T-1-elp1-
KR9A-CTD-His6 
Sequence encoding Elp1-KR9A C-terminal domain cloned into 
pGEX4T-1 for bacterial fusion protein expression 
This study 
1 Various plasmids containing mutant versions of elp1 were synthesised by DNA2.0 as described in 
Section 2.1.11. 
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i) pAE1 
 
 
ii) pCORE 
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iii) pJHW27 
 
 
iv) pRS425-tK(UUU)-tQ(UUG) 
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v) pSB3 
 
 
vi) ycplac111-ELP1-6HA 
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vii) pFa6a-NES-GFP(S65T)-HIS3MX6 
 
 
 
viii) pFa6a-NLS-GFP(S65T)-HIS3MX6 
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ix) pUG34-ELP1-CTD 
 
 
 
x) pGEX4T-1-ELP1-CTD-His6 
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Media Recipes 
The following recipes were used by Media Services, University of Dundee. All media 
and reagents provided are sterilised by autoclaving at 121 °C.  
 
i) Yeast Media 
Yeast extract-Peptone-Adenine-Dextrose (YPAD) 
Per litre                                     
Yeast extract (Merck)   10 g 
Peptone (LabM)   20 g 
Adenine Hydrochloride  0.01% (v/v) 
Glucose    2% (v/v) 
Granulated agar (BD Difco)  20 g  (For plates only) 
Deionised water   Up to 1 l 
 
For eclipse assays Roth agar is used instead of BD granulated agar. Glucose is replaced 
with Raffinose and Galactose for YPARG and Raffinose for YPAR. 
 
Synthetic complete (SC) or Drop out (DOA) 
Per litre 
Yeast nitrogen base (BD Difco) 6.7 g  
Adenine (if required)    0.0074% (v/v) 
Glucose    2% (v/v) 
Granulated agar (BD Difco)  20 g  (For plates only) 
NaOH      1 mM (For plates only) 
Appropriate Drop out mix (see below) 
Deionised water   Up to 1 l 
 
For SC media- Synthetic complete drop out mix is added  
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For DOA media –Appropriate drop out mix is added with omittion of the required 
amino acids or nucleobases. 
The final concentrations of amino acids and nucleobases used in yeast SC media are 
listed below.  
Adenine Sulphate  20 μg/ml 
Uracil    20 μg/ml 
L-Tryptophan   20 μg/ml 
L-Histidine HCl  20 μg/ml 
L-Arginine HCl   20 μg/ml 
L Methionine   20 μg/ml 
L-Tyrosine   30 μg/ml 
L-Leucine   100 μg/ml 
L-Isoleucine   30 μg/ml 
L-Lysine   30 μg/ml 
L-Phenylalinine  50 μg/ml 
L-Glutamic acid  100 μg/ml 
L-Aspartic Acid  100 μg/ml 
L-Valine   150 μg/ml 
L-Threonine   200 μg/ml 
L-Serine   400 μg/ml 
 
Glucose-Nutrient-Agar (GNA) 
Per litre 
Nutrient Broth (BD Difco)  30 g 
Yeast extract (BD Difco)  10g  
Granulated agar (BD Difco)  20 g 
Glucose    5% (v/v) 
Deionised water   Up to 1 l 
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Sporulation Agar (VB) 
Per litre 
Sodium acetate   8.2 g 
Potassium chloride   1.9 g 
Sodium chloride   1.2 g 
Granulated agar (BD Difco)  15 g 
Magnesium sulphate   1.4 mM  
Deionised water   Up to 1 l 
 
ii) Bacterial media 
Luria Browth (LB) 
Per litre 
LB granules (Merck)    25 g   
Deionised water   Up to 1 l 
 
Super optimal browth with catabolite repression (SOC) 
Per litre 
Tryptone (BD Difco)   20 g 
Yeast Extract (BD Difco)  5 g 
KCl     250 mM 
NaCl     10 mM 
MgSO4.7H2O    10 mM 
MgCl2.6H2O    10 mM 
Glucose    20 mM 
Select Agar (Invitrogen)  12 g (plates only) 
Deionised water   Up to 1 l 
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Autoinduction media 
Per litre 
Oxoid tryptone   10 g 
Yeast Extract (Merck)   5 g 
MgSO4     1 mM 
50 x 5052    20 ml 
Glycerol      5 g 
Glucose     0.5 g 
a-lactose    2 g 
(NH4)2SO4    3.3 g 
KH2PO4    6.8 g 
Na2HPO4    7.1 g 
Deionised water   Up to 1 l 
 
iii) Drug working concentrations 
ClonNAT   100 μg/ml 
G418    200 μg/ml 
Rapamycin   1 μg/ml 
Ampicillin   100 μg/ml 
 
iv) Reagents made by media services 
10 x Tris buffered Saline (TBS) 
Per litre     
Tris     1 M   
NaCl     1.4 M   
Conc HCl    approx. 60ml (to pH 7.4) 
Deionised water   Up to 1 l    
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50 x TAE 
Per litre       
Trizma Base (Sigma)   2 M    
Glacial Acetic Acid   57.1 ml  
EDTA     50 mM    
Deionised water   Up to 1 l  
   
10 x Phosphate buffered saline (PBS) 
Per litre      
NaCl     80 g    
KCl     2 g   
Na2HPO4    14.4 g   
KH2PO4    2.4 g   
Deionised water   Up to 1 l 
 
